Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011960	p-bnp	ng/l (ng/l)	28304	81270	0.00%
3011960	p-bnp	— (—)	5949	9303	100.00%	Distribution not available
3011960	p-bnp	ng/ml (ng/l)	14	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

All influenza

1846

7232

2.81

323.31

4.2

2.6

260.82

187.90

ng/l

7.15

1661

6508

Amiodarone users

1140

3565

4.09

318.85

6.0

3.0

411.59

217.95

ng/l

17.96

1094

3261

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1277

4041

3.46

313.85

3.9

3.0

217.07

173.39

ng/l

2.81

1169

3608

Aortic valve malfunction, age under 60 years

859

2203

4.73

312.85

3.4

2.8

205.22

148.67

ng/l

3.52

810

1964

Parasetamol

3953

10151

2.05

310.96

3.0

2.5

200.88

195.54

ng/l

0.25

3531

9120

Other septicaemia

2851

13212

2.26

308.55

4.5

2.8

358.95

206.17

ng/l

30.01

2647

12044

Other soft tissue disorders, not elsewhere classified

5420

18180

1.82

308.53

3.1

2.8

200.95

210.67

ng/l

0.70

4897

16489

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6590

16537

2.60

307.65

3.7

2.3

236.27

171.67

ng/l

18.29

6068

14951

Hypothyroidism, levothyroxine purchases

823

797

6.08

307.65

3.4

1.3

114.45

35.97

ng/l

14.00

724

687

Valvular heart disease excluding rheumatic fever

5040

7824

5.56

307.65

3.8

1.8

278.37

79.07

ng/l

124.34

4770

6928

Erysipelas

4081

17762

2.19

307.65

3.5

2.7

286.12

187.14

ng/l

21.95

3723

16178

Symptoms and signs involving cognition, perception, emotional state and behaviour

6294

22470

2.02

307.65

3.1

2.8

197.12

200.95

ng/l

0.23

5733

20348

Abnormalities of heart beat

2636

8498

3.35

307.65

3.6

2.4

204.36

199.26

ng/l

0.23

2406

7701

Pacemaker

3750

13013

3.32

307.65

5.0

2.9

361.58

234.45

ng/l

34.30

3555

11889

Any reimbursement code in KELA

2476

4666

2.76

307.65

3.1

1.8

150.57

96.06

ng/l

7.71

2202

4045

Viral Sepsis

1712

6389

3.04

307.65

5.2

2.6

278.46

196.26

ng/l

8.83

1589

5800

Bacterial pneumonia, not elsewhere classified

3760

11431

3.31

307.65

4.6

2.5

259.47

198.96

ng/l

10.00

3498

10400

Heart failure, strict

6781

14634

3.93

307.65

4.9

2.2

427.69

116.49

ng/l

249.70

6414

13285

Cerebrovascular diseases (FINNGEN)

1930

2278

6.61

307.65

3.3

1.5

205.40

49.08

ng/l

47.61

1738

1968

Continuous positive airway pressure

1257

1988

5.95

307.65

3.7

1.6

469.32

82.47

ng/l

50.76

1162

1749

Myocarditis

416

409

12.32

307.65

6.9

1.6

242.56

52.47

ng/l

3.49

384

349

Metabolic disorders

6591

18628

2.30

307.65

3.2

2.7

214.66

189.75

ng/l

3.35

6021

16783

Major coronary heart disease event excluding revascularizations

5074

12047

3.14

307.65

3.8

2.2

301.71

151.33

ng/l

58.18

4715

10772

Opioids

5446

15718

1.87

307.65

3.0

2.6

189.65

202.24

ng/l

1.06

4902

14217

Asthma (only as main-diagnosis), excluding more controls

4162

9034

2.80

307.65

3.3

1.8

165.57

90.83

ng/l

28.50

3745

8084

Implicit bacterial Sepsis

3981

13496

2.98

307.65

4.8

2.6

350.09

200.46

ng/l

37.72

3719

12289

Cardiomyopathies, Primary/intrinsic

1718

2453

9.73

307.65

5.9

1.8

424.83

86.63

ng/l

75.80

1665

2153

Cardiovascular diseases

3142

2882

6.25

307.65

3.3

1.5

130.56

46.70

ng/l

34.76

2763

2429

Pneumonia, organism unspecified

6509

19747

2.48

307.65

3.9

2.4

252.79

168.26

ng/l

29.61

6002

17801

Heart failure, not strict

8133

14286

4.58

307.65

4.3

1.9

309.36

89.61

ng/l

223.64

7602

12897

Heart failure and coronary heart disease

5135

9343

4.83

307.65

5.4

2.3

470.06

164.44

ng/l

159.56

4895

8392

Tramadol

4980

15153

2.13

307.65

3.0

2.7

191.68

206.89

ng/l

1.39

4478

13749

Pneumonias (Asthma/COPD co-morbidities)

7340

20883

2.54

307.65

3.8

2.4

241.34

166.54

ng/l

27.20

6767

18779

Septicaemia

3248

14258

2.32

307.65

4.4

2.8

347.50

201.98

ng/l

32.74

3009

12995

First line medication for Crohn's disease

6511

20125

1.82

307.65

3.7

2.5

205.68

197.91

ng/l

0.62

5868

18186

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

932

1582

4.79

307.65

4.1

2.3

211.49

225.50

ng/l

0.31

869

1458

ILD medications: prednisolone, methylprednisolone, prednisone

6820

20733

1.93

307.65

3.8

2.5

211.69

196.29

ng/l

1.70

6164

18750

Implicit bacterial Sepsis

4275

14200

2.95

307.65

4.7

2.6

343.10

196.50

ng/l

39.35

3992

12931

Type 2 diabetes, wide definition

5223

18146

1.95

307.65

3.4

2.6

231.19

191.07

ng/l

7.07

4762

16507

Condition for Implicit Sepsis (Organ dysfunction codes)

6562

19570

2.56

307.65

3.9

2.4

263.60

169.21

ng/l

35.65

6055

17649

Erysipelas

5159

19107

2.21

307.65

3.5

2.6

278.74

176.31

ng/l

27.46

4708

17345

Other pulmonary diagnosis

4532

11205

2.12

307.65

3.1

2.2

187.03

163.59

ng/l

2.99

4087

10112

Codeine

5465

15576

1.99

307.65

3.0

2.6

192.27

201.55

ng/l

0.66

4917

14102

Oral corticosteroids

7000

21675

2.02

307.65

3.8

2.5

199.31

201.12

ng/l

0.11

6352

19602

Asthma, excluding more controls

4656

9034

2.86

307.65

3.1

1.8

160.19

90.83

ng/l

29.80

4197

8084

Hypothyroidism, drug reimbursement

592

533

8.35

307.65

3.2

1.3

134.13

37.11

ng/l

11.24

537

467

Ischaemic heart disease, wide definition

6361

14984

2.92

307.65

3.6

2.4

224.74

155.24

ng/l

22.66

5918

13507

General symptoms and signs

6475

16701

2.03

307.65

3.2

2.6

199.85

181.94

ng/l

1.99

5857

15105

Asthma, unspecified (mode), excluding more controls

3623

8644

3.41

307.65

3.4

1.8

182.43

92.49

ng/l

35.56

3308

7764

Hypertensive Heart Disease

2104

5512

3.41

307.65

3.5

2.5

362.44

199.60

ng/l

25.16

1979

5013

Asthma, hospital admissions 3, pneumonia

2932

12977

2.48

307.65

4.3

3.0

236.34

240.61

ng/l

0.17

2709

11815

Cardiodefibrillation

3298

13983

2.70

307.65

4.0

2.9

327.45

214.70

ng/l

30.19

3071

12836

Implicit Sepsis

6501

19710

2.63

307.65

4.0

2.5

277.39

171.89

ng/l

36.94

5998

17808

Asthma-related infections

4024

19125

2.20

307.65

3.9

2.8

205.52

216.92

ng/l

0.81

3672

17360

COPD differential diagnosis

4484

11184

2.10

307.65

3.1

2.2

185.13

166.04

ng/l

2.00

4038

10090

Heart failure and bmi 25plus

3697

8062

3.69

307.65

4.9

2.2

390.95

112.14

ng/l

143.97

3512

7293

6590

16537

2.60

307.65

3.7

2.3

236.27

171.67

ng/l

18.29

6068

14951

Cardiomyopathy (excluding other)

1740

2684

8.89

307.65

5.9

1.8

423.77

85.51

ng/l

77.60

1687

2362

Implicit Sepsis

6210

19302

2.66

307.65

4.2

2.5

291.59

176.17

ng/l

39.39

5731

17486

Non-rheumatic valve diseases

4977

7796

5.49

307.65

3.8

1.8

278.56

78.84

ng/l

123.21

4708

6905

Percutaneous Coronary Intervention

7789

12964

4.25

307.65

3.9

2.1

233.57

133.29

ng/l

50.30

7298

11530

Bacterial infection, other or unspecified

4445

17288

2.36

307.65

3.9

2.7

313.85

190.21

ng/l

32.36

4077

15762

Coronary atherosclerosis

5526

11557

3.41

307.65

3.6

2.1

258.70

140.73

ng/l

44.10

5138

10308

Ischemic heart diseases

7505

13237

3.85

307.65

3.8

2.1

219.53

131.50

ng/l

40.55

6995

11751

All pneumoniae

7379

20855

2.54

307.65

3.8

2.4

240.70

166.59

ng/l

26.88

6797

18757

All chronic kidney diseases

3908

15921

2.16

307.65

4.5

2.7

428.71

183.17

ng/l

73.92

3625

14499

STROKE

3646

8535

3.15

307.65

3.4

1.9

210.15

115.85

ng/l

23.89

3292

7594

COPD/asthma related infections

6039

16539

1.91

307.65

3.4

2.3

212.41

171.66

ng/l

7.96

5480

14952

Persons encountering health services for specific procedures and health care

8089

19438

2.69

307.65

3.6

2.5

215.91

179.98

ng/l

7.83

7380

17479

Atrial fibrillation and flutter with reimbursement

2597

1804

11.04

307.65

3.8

1.5

254.02

52.62

ng/l

111.36

2455

1567

Complications of surgical and medical care, not elsewhere classified

6311

24021

1.89

307.65

3.4

2.8

236.59

195.32

ng/l

7.54

5795

21743

Asthma/COPD (KELA code 203)

5702

22020

1.85

307.65

3.2

2.7

175.05

200.65

ng/l

4.40

5163

19918

Cardiomyopathy, other and unspecified

1040

1526

9.46

307.65

5.1

1.8

362.61

85.03

ng/l

34.43

1010

1344

Diseases of arteries, arterioles and capillaries (FINNGEN)

2122

1781

9.67

307.65

3.2

1.5

282.01

52.79

ng/l

67.06

1978

1544

Speech therapy

2156

8841

2.74

307.65

3.3

2.9

199.91

201.11

ng/l

0.03

1927

8072

Myocardial infarction, strict

3798

9532

3.19

307.65

3.9

2.2

318.12

148.72

ng/l

53.68

3543

8515

Other arrhythmias

5329

10041

4.49

307.65

3.5

1.8

208.15

71.81

ng/l

84.55

4954

8834

Presence of cardiac and vascular implants and grafts

5529

12494

4.01

307.65

5.0

2.5

340.24

204.78

ng/l

42.78

5253

11335

Abnormalities of breathing

7090

12520

3.60

307.65

3.6

2.4

210.43

188.78

ng/l

2.41

6455

11231

Emergency coronary revascularization (for ACS)

8501

15147

3.91

307.65

3.9

2.2

246.40

155.29

ng/l

42.50

7954

13501

Dizziness and giddiness

4947

20618

2.01

307.65

3.3

2.8

196.22

208.59

ng/l

1.05

4523

18737

All-cause Heart Failure

6595

14381

3.88

307.65

4.7

2.2

424.67

116.40

ng/l

241.97

6231

13051

Condition for Implicit Sepsis (Organ dysfunction codes)

6541

19278

2.52

307.65

3.8

2.4

248.61

165.03

ng/l

30.61

6015

17354

Syncope and collapse

3233

12734

2.34

307.65

3.4

2.6

255.43

204.49

ng/l

4.43

2984

11621

Non-invasive ventilation

4015

2391

21.12

307.65

3.8

1.5

158.34

70.04

ng/l

33.24

3787

2105

Implicit viral Sepsis

2365

9648

2.73

307.65

4.5

2.6

269.68

192.13

ng/l

11.24

2199

8774

Cardiomyopathy

2377

3662

8.72

307.65

5.4

1.8

401.21

80.53

ng/l

99.19

2304

3209

Pain in throat and chest

6417

12354

3.39

307.65

3.1

2.4

190.24

188.65

ng/l

0.08

5824

11087

Cardiac arrhythmias

4766

5638

6.14

307.65

3.6

1.6

195.63

72.67

ng/l

58.37

4401

4908

Major coronary heart disease event

7849

14261

3.77

307.65

3.9

2.2

232.60

139.83

ng/l

44.38

7347

12703

Haemorrhage from respiratory passages

2707

8797

3.07

307.65

3.8

2.4

281.70

215.83

ng/l

7.34

2486

7984

Calcific aortic valvular stenosis, diagnosis (helper)

3023

12096

2.82

307.65

3.8

3.0

329.69

252.43

ng/l

10.39

2864

11057

Other bacterial diseases

7145

20884

2.32

307.65

3.6

2.6

251.38

167.31

ng/l

34.11

6537

18846

Pure hypercholesterolaemia

5850

16782

2.48

307.65

3.2

2.7

202.86

199.43

ng/l

0.19

5396

15228

Bleeding

5549

21790

1.92

307.65

3.6

2.8

269.36

196.55

ng/l

17.95

5087

19822

Malaise and fatigue

4028

13232

2.67

307.65

3.6

2.6

274.84

200.76

ng/l

11.29

3654

12082

Cardiac arrest

555

638

8.79

307.65

5.1

1.6

346.76

57.64

ng/l

25.92

522

558

Other heart diseases

4511

3092

11.07

307.65

3.9

1.5

202.05

45.53

ng/l

109.74

4169

2629

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6923

19535

2.47

307.65

4.1

2.3

246.62

164.31

ng/l

31.55

6415

17489

Care involving use of rehabilitation procedures

5710

17937

3.27

307.65

3.7

2.5

185.14

184.91

ng/l

0.01

5221

16232

Bacterial Sepsis

4397

14543

2.92

307.65

4.7

2.6

341.71

195.38

ng/l

41.46

4095

13235

COPD/asthma/ILD related infections

6039

16539

1.91

307.65

3.4

2.3

212.41

171.66

ng/l

7.96

5480

14952

Asthma

4921

11106

2.46

307.65

3.2

2.2

165.53

164.07

ng/l

0.08

4440

10026

Pain in limb

4966

17856

1.95

307.65

3.1

2.8

204.00

210.55

ng/l

0.39

4514

16221

Statin medication

3470

9294

2.19

307.65

3.2

2.4

198.07

157.49

ng/l

4.90

3118

8305

Hypertensive diseases

4738

10990

2.59

307.65

3.2

2.4

185.47

146.66

ng/l

6.98

4298

9823

Cardiovascular diseases (excluding rheumatic etc)

3720

3669

6.30

307.65

3.3

1.5

142.72

45.43

ng/l

47.78

3312

3095

Hypothyroidism and >3 levothyroxin purchases

823

797

6.08

307.65

3.4

1.3

114.45

35.97

ng/l

14.00

724

687

Symptoms and signs involving the circulatory and respiratory systems

6558

12539

2.79

307.65

3.1

2.4

191.13

188.55

ng/l

0.14

5870

11247

Implicit viral Sepsis

1711

6385

3.04

307.65

5.2

2.6

278.63

196.36

ng/l

8.83

1588

5796

Antihypertensive medication - note that there are other indications

2697

4091

3.66

307.65

3.3

1.8

149.95

71.73

ng/l

15.43

2395

3508

Asthma, hospital admission 2, infections

4024

19125

2.20

307.65

3.9

2.8

205.52

216.92

ng/l

0.81

3672

17360

Coronary revascularization (ANGIO or CABG)

7722

12968

4.20

307.65

3.9

2.1

233.47

133.27

ng/l

49.54

7238

11533

Influenza and pneumonia

7554

20384

2.53

307.65

3.7

2.4

233.19

165.01

ng/l

23.88

6920

18346

Explicit Sepsis

3315

14299

2.35

307.65

4.4

2.6

345.80

193.09

ng/l

37.28

3073

12988

Asthma (only as main-diagnosis)

4367

11106

2.41

307.65

3.3

2.2

170.18

164.07

ng/l

0.39

3929

10026

Dilated cardiomyopathy

1552

3985

5.25

307.65

6.0

2.8

433.17

207.19

ng/l

29.34

1502

3634

Heart failure and antihypertensive medication

3198

2204

12.24

307.65

5.2

1.8

387.32

90.32

ng/l

75.89

3056

1947

Calcific aortic valvular stenosis, operated

3034

12108

2.83

307.65

3.8

3.0

328.95

252.40

ng/l

10.27

2875

11069

Asthma, unspecified (mode)

3790

10626

2.90

307.65

3.4

2.2

190.13

166.46

ng/l

2.54

3462

9624

Operations 2 for CAVS

3023

12096

2.82

307.65

3.8

3.0

329.69

252.43

ng/l

10.39

2864

11057

Bacterial pneumoniae

3844

11986

3.21

307.65

4.5

2.5

258.82

196.87

ng/l

10.75

3573

10893

Hypertensive heart and/or renal disease

2291

5758

3.37

307.65

3.6

2.5

378.14

196.67

ng/l

27.98

2155

5236

Calcific aortic valvular stenosis, including rheumatic fever

3028

12129

2.81

307.65

3.8

3.0

329.42

252.38

ng/l

10.36

2868

11086

Fever of other and unknown origin

3424

14880

2.17

307.65

3.6

2.6

238.85

191.87

ng/l

5.31

3135

13521

Adjustment and management of implanted device

2312

6619

4.42

307.65

4.3

2.8

341.96

240.39

ng/l

15.11

2175

6077

Non-ischemic cardiomyopathy

3174

6867

4.46

307.65

4.2

2.0

356.96

109.23

ng/l

105.96

2974

6175

Hypertension

4721

10985

2.58

307.65

3.2

2.4

185.29

146.68

ng/l

6.91

4283

9819

ILD differential diagnosis

4484

11179

2.10

307.65

3.1

2.2

185.09

166.03

ng/l

1.99

4037

10087

Calcific aortic valvular stenosis

3034

12108

2.83

307.65

3.8

3.0

328.95

252.40

ng/l

10.27

2875

11069

Conduction disorders

2626

5611

4.37

307.65

4.3

1.8

302.54

80.65

ng/l

85.70

2471

4991

Inflammatory bowel disease treatment related agents

7036

21948

1.87

307.65

3.8

2.5

202.84

199.96

ng/l

0.19

6368

19835

ILD medications

6833

20874

1.85

307.65

3.8

2.5

211.18

195.76

ng/l

1.71

6161

18872

Valvular operations

1772

3017

7.68

307.65

4.1

1.9

315.83

85.70

ng/l

65.71

1683

2667

Paroxysmal tachycardia

1800

1944

8.91

307.65

4.5

1.5

268.84

49.99

ng/l

54.04

1667

1684

Asthma-related pneumonia or sepsis

2932

12977

2.48

307.65

4.3

3.0

236.34

240.61

ng/l

0.17

2709

11815

Asthma (mode)

4643

11179

2.35

307.65

3.1

2.2

162.69

166.03

ng/l

0.19

4186

10087

Anaemias

1201

780

10.89

307.65

4.2

1.4

221.40

41.55

ng/l

32.71

1098

675

Coronary artery bypass grafting

2184

5820

3.17

307.65

4.0

2.3

417.87

166.56

ng/l

48.20

2040

5243

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2121

2904

4.91

307.65

2.9

1.5

160.34

45.59

ng/l

34.32

1915

2486

Myocardial infarction, without ST-elevation

3474

15278

2.30

307.65

4.0

2.9

374.63

229.12

ng/l

28.55

3242

13982

Hard cardiovascular diseases

7256

12858

3.78

307.65

3.7

2.1

212.38

129.18

ng/l

35.88

6728

11421

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7258

20978

2.54

307.65

3.8

2.4

243.38

167.67

ng/l

27.52

6694

18878

Heart failure,strict

6281

11211

4.85

307.65

4.9

1.9

421.45

96.66

ng/l

263.37

5954

10166

Hypothyroidism (congenital or acquired)

827

799

6.08

307.65

3.4

1.3

115.86

35.92

ng/l

14.41

726

688

Atrial fibrillation and flutter

2986

2165

10.54

307.65

3.8

1.5

236.31

48.76

ng/l

124.74

2821

1872

Bacterial pneumonia (organism specified)

4006

14598

2.78

307.65

4.4

2.7

257.44

229.68

ng/l

2.74

3720

13256

Renal tubulo-interstitial diseases

6083

21941

2.20

307.65

4.0

2.6

326.68

165.62

ng/l

69.79

5581

19907

All kidney diseases

6328

22207

2.06

307.65

3.8

2.5

289.28

159.68

ng/l

59.68

5779

20077

Excluding asthma or asthma-COPD overlap

4508

11205

2.11

307.65

3.1

2.2

185.17

163.59

ng/l

2.60

4062

10112

Chronic lower respiratory diseases

7183

22040

1.81

307.65

3.2

2.7

190.43

200.66

ng/l

0.89

6492

19935

Nonischemic cardiomyopathy

1077

2490

5.46

307.65

5.0

2.4

352.63

150.63

ng/l

25.09

1025

2244

Complications of medical and surgical care

4776

23834

1.95

307.65

3.5

2.8

229.81

201.76

ng/l

3.54

4377

21664

Codeine or tramadol medication

6691

21822

1.74

307.65

3.0

2.8

192.84

205.47

ng/l

1.19

6041

19798

Hypertensive diseases (excluding secondary)

2919

3095

5.92

307.65

3.3

1.5

164.18

45.09

ng/l

50.30

2620

2633

Depression medications

942

836

5.88

307.65

2.6

1.3

108.36

34.36

ng/l

10.22

808

717

Asthma-related pneumonia

2930

12961

2.48

307.65

4.3

3.0

236.40

240.77

ng/l

0.18

2707

11800

Myocardial infarction

4106

9962

3.27

307.65

3.9

2.1

323.33

146.61

ng/l

62.62

3828

8894

Angina pectoris

4992

10918

3.46

307.65

3.7

2.1

237.98

144.37

ng/l

28.56

4665

9753

Asthma (diagnoses ohter than nonallergic)

5542

24734

1.96

307.65

3.3

2.8

181.63

208.02

ng/l

4.39

5026

22433

Congenital malformations of heart and great arteries

1100

2757

4.55

307.65

4.1

3.0

189.05

176.03

ng/l

0.46

1005

2456

AV-block

1723

3829

4.64

307.65

4.9

1.9

333.42

88.41

ng/l

59.11

1628

3427

Other heart diseases, wide

7974

11371

4.81

307.65

3.6

1.8

206.67

68.98

ng/l

131.57

7343

9932

Unstable angina pectoris

3046

9058

2.98

307.65

4.0

2.3

290.81

166.90

ng/l

23.12

2816

8136

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1227

3701

3.64

307.65

4.0

3.0

214.17

174.01

ng/l

2.36

1125

3301

Disorders of lipoprotein metabolism and other lipidaemias

6011

17441

2.29

307.65

3.1

2.7

212.94

196.26

ng/l

1.56

5518

15787

Congenital malformations of the circulatory system

1145

3179

4.03

307.65

3.9

3.0

182.45

173.10

ng/l

0.31

1045

2831

Left ventricular outflow tract obstruction (LVOTO), broad definition

955

2350

4.96

307.65

3.6

2.8

201.35

150.85

ng/l

3.21

901

2087

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6830

22988

2.18

307.65

3.8

2.6

267.32

181.33

ng/l

29.47

6253

20812

Other CVD (FINNGEN)

857

1033

7.43

307.65

3.9

1.5

268.63

60.13

ng/l

27.16

788

911

Diseases of arteries, arterioles and capillaries

5110

19290

2.11

307.65

3.4

2.8

307.18

200.65

ng/l

32.95

4732

17597

Bacterial infection, other or unspecified

4147

16665

2.35

307.65

3.9

2.7

320.89

192.35

ng/l

32.12

3799

15198

Hypertension, essential

4833

10816

2.70

307.65

2.8

2.3

180.32

147.12

ng/l

5.52

4385

9671

Renal failure

3789

16281

2.26

307.65

5.0

2.8

481.52

202.58

ng/l

81.12

3532

14877

COPD (mode)

2421

7661

2.74

307.65

3.7

2.3

296.36

190.61

ng/l

12.59

2255

6993

Dyspnoea

7942

21510

3.02

307.65

3.8

2.5

240.95

191.49

ng/l

12.15

7301

19450

Other bacterial diseases

7036

21301

2.39

307.65

3.7

2.6

271.50

172.83

ng/l

40.39

6448

19277

Infections, IBD-co-morbidities

1025

1957

4.08

306.55

4.0

2.4

254.86

200.72

ng/l

2.12

944

1796

Diseases of oesophagus, stomach and duodenum

6243

22383

1.74

302.98

3.2

2.8

205.88

200.57

ng/l

0.34

5632

20311

Other special examinations and investigations of persons without complaint or reported diagnosis

3920

10170

2.04

301.36

3.3

2.6

195.00

212.47

ng/l

1.38

3520

9195

Oedema, not elsewhere classified

2281

10046

2.43

298.29

3.4

2.7

231.01

201.05

ng/l

2.07

2054

9188

Asthma, including avohilmo

6839

23696

1.68

292.57

3.2

2.8

179.90

209.64

ng/l

5.91

6175

21481

Complications of procedures, not elsewhere classified

4881

23429

1.81

285.95

3.3

2.8

240.52

194.38

ng/l

7.15

4475

21242

Covid-19 confirmed case

2680

13079

2.23

282.64

4.4

2.9

205.01

223.58

ng/l

1.49

2513

11894

Endocrine, nutritional and metabolic diseases

3985

10645

1.96

279.56

3.1

2.5

191.61

164.75

ng/l

3.08

3554

9536

Conotruncal defects

241

182

24.50

276.21

5.8

4.4

166.06

186.73

ng/l

0.23

226

162

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1672

3015

2.89

275.30

3.0

2.1

171.59

166.36

ng/l

0.17

1490

2675

Type 2 diabetes

5654

19817

1.73

272.25

3.2

2.6

219.71

181.92

ng/l

7.16

5114

17942

Cough

2195

9380

2.34

271.37

3.2

2.5

198.02

194.45

ng/l

0.12

1984

8515

Early onset COPD, excluding more controls

1392

5169

2.96

270.25

3.6

2.3

233.36

185.97

ng/l

2.34

1269

4690

Polyarthropathies

3977

14216

1.91

269.42

3.5

2.8

278.10

202.80

ng/l

11.90

3593

12916

2648

12936

2.15

266.19

3.8

2.8

184.27

201.45

ng/l

1.24

2380

11670

Intracranial trauma

3039

10773

2.07

264.11

3.2

2.6

204.56

208.18

ng/l

0.13

2729

9809

Diabetes, varying definitions

5700

20281

1.71

262.33

3.2

2.6

218.80

180.25

ng/l

7.49

5156

18324

Status post-ami

1859

5995

2.60

262.20

4.8

2.3

433.78

165.45

ng/l

47.12

1745

5394

Headache

3457

14734

1.95

261.70

2.9

2.5

136.21

175.14

ng/l

6.75

3105

13334

COPD

3259

14163

2.03

260.27

3.7

2.8

286.40

233.32

ng/l

4.94

3020

12961

Congenital malformations of cardiac chambers and connections

156

94.70

260.10

6.8

6.9

155.83

164.93

ng/l

0.05

147

Diabetes mellitus

5705

20289

1.70

259.82

3.2

2.6

218.29

180.29

ng/l

7.31

5160

18332

Pulmonary heart disease, diseases of pulmonary circulation

2476

12194

2.22

256.79

4.0

3.0

220.01

232.68

ng/l

0.67

2270

11114

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3848

21481

1.87

255.37

3.4

2.8

233.21

201.63

ng/l

3.63

3528

19576

Aplastic and other anaemias

3376

17176

1.97

254.00

4.0

2.9

329.58

227.26

ng/l

20.29

3111

15713

Other intervertebral disc disorders

4888

17353

1.77

252.81

2.9

2.8

147.42

221.66

ng/l

29.63

4455

15724

Certain infectious and parasitic diseases

5361

16042

1.73

250.96

3.3

2.5

217.66

170.64

ng/l

9.72

4880

14484

Acute tubulo-interstitial nephritis

3831

18647

1.86

249.80

3.5

2.6

258.51

176.72

ng/l

16.21

3490

16995

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4278

22390

1.81

249.63

3.5

2.8

212.20

216.80

ng/l

0.26

3982

20393

Acute renal failure

1802

7956

2.54

248.73

5.3

2.8

451.15

201.14

ng/l

38.53

1690

7250

Asthma, hospital admissions , main diagnosis only

4696

24748

1.74

248.47

3.4

2.8

175.01

205.64

ng/l

5.00

4241

22439

Oxycodone

2623

11938

2.13

247.79

3.5

2.7

223.86

231.17

ng/l

0.32

2427

10933

Other chronic obstructive pulmonary disease

3131

13770

2.02

247.62

3.7

2.8

289.12

233.54

ng/l

5.23

2906

12601

Type 2 diabetes, definitions combined

5436

19455

1.70

246.88

3.2

2.6

212.16

183.98

ng/l

4.30

4907

17645

Left ventricular outflow tract obstruction, narrow definition

506

1037

6.24

246.32

4.2

2.9

165.81

172.86

ng/l

0.15

472

925

Type 2 diabetes, strict (exclude DM1)

5455

19555

1.70

246.26

3.3

2.6

211.80

184.60

ng/l

4.05

4924

17737

Medical observation and evaluation for suspected diseases and conditions

3692

10167

1.93

246.03

3.1

2.6

214.21

212.01

ng/l

0.09

3364

9192

Other diseases of pleura

3315

15904

1.97

245.24

4.3

2.9

305.47

231.07

ng/l

8.41

3100

14529

Transplanted organ and tissue status

755

2131

4.11

237.01

7.8

2.3

404.50

138.22

ng/l

20.59

727

1905

Other and unspecified anaemias

3131

16316

1.97

235.40

4.0

2.9

327.64

230.07

ng/l

17.54

2887

14939

Diseases of the respiratory system

3485

9347

1.94

234.82

3.0

2.3

190.89

172.69

ng/l

1.62

3146

8474

Other anaemias

3150

16415

1.96

234.74

4.0

2.9

327.57

229.71

ng/l

17.70

2903

15033

Non-allergic asthma (mode), excluding more controls

1148

4089

3.01

234.16

3.3

1.9

183.57

104.61

ng/l

9.26

1044

3693

Other diseases of intestines

5656

20010

1.66

233.76

3.1

2.8

201.56

195.10

ng/l

0.43

5096

18113

Type 2 diabetes, definitions combined, including avohilmo

5363

19251

1.68

232.55

3.2

2.6

210.20

183.81

ng/l

3.83

4836

17441

Other nutritional deficiencies

3489

18559

1.85

227.67

3.1

2.7

170.20

173.66

ng/l

0.19

3087

16848

Endocarditis

374

628

7.70

224.90

4.0

1.8

394.29

84.97

ng/l

13.00

356

559

Cerebrovascular diseases

4761

20479

1.72

224.72

3.4

2.8

259.77

205.82

ng/l

9.57

4358

18723

Other disorders of skin and subcutaneous tissue

4258

22705

1.75

224.36

3.3

2.9

265.80

204.60

ng/l

10.11

3892

20690

Congenital malformations of cardiac septa

544

1210

5.15

224.32

4.3

3.3

206.04

177.03

ng/l

0.69

492

1079

Vocal cord dysfunction

645

1456

4.25

223.35

3.2

1.6

160.45

72.78

ng/l

8.59

589

1284

GASTRO-related operations

4116

11816

1.80

223.15

3.2

2.4

200.83

176.28

ng/l

2.33

3679

10692

Any gastric operation

4116

11816

1.80

223.15

3.2

2.4

200.83

176.28

ng/l

2.33

3679

10692

Other neurological diseases

4580

21970

1.72

222.18

3.5

2.8

220.75

219.24

ng/l

0.07

4203

20032

6377

21268

1.60

221.63

3.5

2.6

215.42

200.98

ng/l

1.43

5760

19301

Concussion

2564

10696

2.04

221.09

3.3

2.6

196.83

208.74

ng/l

0.48

2296

9740

Episodal and paroxysmal disorders

5986

19366

1.62

220.70

3.2

2.8

171.37

219.84

ng/l

12.84

5370

17580

Other disorders of fluid, electrolyte and acid-base balance

2182

10267

2.19

220.25

4.1

2.8

315.24

217.49

ng/l

10.16

2021

9349

COPD-related respiratory insufficiency

1126

4265

3.12

219.70

4.7

2.9

326.58

246.61

ng/l

4.06

1065

3905

Obesity related asthma

2096

10223

2.20

218.77

3.4

2.7

150.83

183.26

ng/l

3.48

1891

9287

Pain, not elsewhere classified

1653

7331

2.41

217.57

3.0

2.6

181.19

175.23

ng/l

0.21

1493

6666

Other acute lower respiratory infections

3279

17635

1.86

217.17

4.0

2.9

240.83

220.77

ng/l

1.59

2945

16020

Obesity

3290

17912

1.85

216.47

3.0

2.7

163.69

171.88

ng/l

0.61

2905

16259

Chronic kidney disease

2350

11838

2.12

216.30

5.4

2.9

536.23

217.70

ng/l

58.50

2196

10796

Congenital malformations of aortic and mitral valves

426

842

6.49

216.15

4.2

2.8

156.76

172.41

ng/l

0.35

400

754

Dialysis, with operation codes

1038

3769

3.17

216.09

6.7

2.7

618.24

170.03

ng/l

37.24

1000

3415

Obesity and other hyperalimentation

3305

18001

1.85

216.05

3.0

2.7

163.71

172.65

ng/l

0.69

2919

16341

Other chronic obstructive pulmonary disease, including avohilmo

3668

17694

1.82

215.08

3.6

2.9

277.58

220.30

ng/l

6.55

3374

16194

Low back pain

4120

17577

1.75

213.93

3.1

2.8

171.74

217.88

ng/l

7.22

3735

15913

Provisional assignment of new diseases of uncertain etiology

3156

17714

1.87

213.51

4.1

2.8

202.63

208.87

ng/l

0.36

2935

16072

Codes for special purposes

3160

17745

1.87

213.44

4.1

2.8

202.59

208.77

ng/l

0.36

2939

16099

Diverticular disease of intestine

4408

17119

1.72

207.57

3.0

2.8

226.50

211.36

ng/l

1.08

4000

15644

Nerve, nerve root and plexus disorders

5993

23967

1.58

206.15

3.1

2.8

168.88

213.50

ng/l

12.42

5428

21768

Disorders of thyroid, IBD co-morbidities

910

2043

3.32

206.08

4.0

2.3

241.32

184.86

ng/l

1.34

830

1866

COPD related to multimorbidity

2907

13642

1.94

204.71

3.9

2.9

311.27

237.22

ng/l

7.48

2699

12514

Dorsalgia

5299

17972

1.63

201.06

2.9

2.8

172.99

219.98

ng/l

9.44

4782

16244

Gout

2065

9090

2.17

200.04

4.3

2.9

385.25

245.91

ng/l

14.64

1895

8316

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3506

20687

1.78

200.01

3.4

2.9

230.93

204.22

ng/l

2.59

3212

18882

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5168

19797

1.63

198.65

3.3

2.6

214.88

183.13

ng/l

5.15

4691

17915

Congenital malformations of great arteries

235

261

12.06

198.29

5.0

193.85

202.81

ng/l

0.08

215

233

Bronchitis

5923

24515

1.57

198.21

3.7

2.6

221.74

198.77

ng/l

3.07

5329

22259

Dental caries

1595

6966

2.36

197.76

4.5

2.8

288.06

212.70

ng/l

5.51

1481

6332

Secondary hypertension

398

759

5.69

197.74

3.4

1.6

419.97

55.29

ng/l

17.04

362

661

Symptoms and signs involving the nervous and musculoskeletal systems

3460

20429

1.78

197.10

3.2

2.9

186.64

210.15

ng/l

1.63

3125

18633

Pulmonary embolism

2131

10945

2.11

195.91

3.4

2.9

184.42

227.49

ng/l

5.07

1943

9972

Finngen Rheumatological endpoints

5005

17962

1.63

195.11

3.0

2.7

195.46

195.17

ng/l

0.01

4502

16223

Other dorsopathies, not elsewhere classified

5376

18001

1.61

194.10

2.9

2.8

169.59

219.60

ng/l

13.01

4841

16267

Venous thromboembolism

3530

20354

1.77

194.02

3.2

2.9

201.62

225.18

ng/l

2.25

3227

18602

Later onset COPD, excluding more controls

1613

5704

2.42

192.89

3.7

2.4

325.66

215.08

ng/l

8.73

1520

5247

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3625

17389

1.77

191.61

3.8

2.8

277.89

215.35

ng/l

9.89

3335

15940

COPD, hospital admissions

3153

15458

1.84

190.94

3.8

2.9

287.07

229.77

ng/l

5.47

2922

14161

Pulmonary heart disease

2131

11046

2.09

190.80

3.4

3.0

184.42

231.29

ng/l

5.87

1943

10068

COPD, early/later onset

3172

15560

1.84

189.49

3.7

2.9

291.49

228.54

ng/l

6.44

2941

14257

Caries of dentine

1433

6196

2.42

188.09

4.5

2.8

290.93

206.55

ng/l

6.11

1325

5635

Diabetes medication

5588

21692

1.58

188.04

3.2

2.7

206.96

189.82

ng/l

1.99

5048

19634

ILD medications: immunosuppressive drugs

3298

17980

1.77

187.50

4.1

2.4

208.76

176.18

ng/l

3.68

3020

16304

Other symptoms and signs involving cognitive functions and awareness

2973

15521

1.85

187.24

3.1

2.9

229.83

230.03

ng/l

0.01

2701

14181

Left bundle-branch block

561

1519

4.28

187.01

3.1

1.8

272.99

87.09

ng/l

13.80

526

1350

Ulcer of lower limb, not elsewhere classified

1222

5178

2.69

186.86

3.4

3.1

439.40

226.23

ng/l

17.79

1127

4748

Transient ischemic attack

3509

17035

1.77

185.30

3.7

2.8

236.13

224.22

ng/l

0.69

3232

15573

Examination and observation for other reasons

3079

10008

1.85

185.09

2.8

2.5

232.06

208.14

ng/l

1.45

2752

9055

Peripheral artery disease

3124

14475

1.84

184.99

3.8

2.9

394.04

222.57

ng/l

35.65

2896

13246

Neurological diseases

4305

13234

1.68

183.76

3.0

2.7

167.44

223.54

ng/l

11.34

3847

12021

Thoracic aortic aneurysm

1127

4664

2.75

180.98

2.7

2.9

212.37

193.73

ng/l

0.70

1057

4260

COPD, hospital admission 2, with asthma infections

2367

11008

1.99

180.46

4.2

3.0

299.61

247.65

ng/l

4.14

2211

10065

Fall on same level

5972

21747

1.54

180.45

3.0

2.8

211.46

182.85

ng/l

4.51

5426

19652

Atherosclerosis, excluding cerebral and coronary sclerosis

3003

13794

1.85

180.27

3.8

2.9

403.31

226.80

ng/l

34.92

2788

12642

Nephropathy related operations

960

3680

2.98

180.08

6.6

2.9

616.64

197.27

ng/l

29.69

925

3337

Other (not insulin) diabetes medications

5378

20935

1.57

179.80

3.2

2.7

203.27

193.85

ng/l

0.79

4857

19012

L04AD Calcineurin inhibitors

748

2498

3.39

178.67

8.2

2.7

375.00

149.48

ng/l

17.23

716

2240

Other medical care

2732

13908

1.86

178.21

3.8

2.6

253.50

204.21

ng/l

5.47

2511

12672

Other disorders of urethra and urinary system

3941

17556

1.68

178.08

3.1

2.8

196.07

211.93

ng/l

1.35

3588

15981

Use of hypnotics and sedatives

5787

22169

1.55

177.34

3.0

2.8

200.05

199.19

ng/l

0.04

5263

20087

Symptoms and signs involving the urinary system

4493

21914

1.63

177.11

3.2

2.9

226.50

207.95

ng/l

1.67

4083

19951

Non-allergic asthma (mode)

1149

4711

2.60

176.90

3.3

2.3

183.57

180.21

ng/l

0.09

1044

4278

Any death

3960

17682

1.69

175.92

3.9

2.6

370.02

147.83

ng/l

71.51

3662

16199

Constipation

5052

22915

1.58

175.70

3.1

2.9

198.44

211.57

ng/l

1.11

4562

20894

Pain in joint

3079

11292

1.80

175.11

2.7

168.01

205.62

ng/l

4.58

2735

10328

Biguanides

5293

21267

1.57

174.31

3.2

2.7

201.91

197.83

ng/l

0.27

4763

19350

Stroke, excluding SAH

3892

17702

1.69

173.37

3.5

2.8

268.66

221.53

ng/l

6.25

3572

16201

Lower back pain or/and sciatica

5686

24937

1.53

173.19

3.0

2.8

168.48

207.14

ng/l

7.77

5163

22597

DVT of lower extremities and pulmonary embolism

2806

16213

1.83

173.06

3.3

3.0

196.54

233.83

ng/l

4.04

2566

14806

Stroke, including SAH

4007

18244

1.67

172.51

3.5

2.8

268.30

216.78

ng/l

7.53

3669

16691

Persons encountering health services for examination and investigation

3456

10170

1.76

172.45

3.1

2.6

210.31

212.47

ng/l

0.09

3088

9195

Abnormal findings on diagnostic imaging of lung

3179

18313

1.76

171.08

3.6

2.9

219.77

226.65

ng/l

0.35

2974

16707

Obesity due to excess calories

2383

13161

1.90

169.85

3.0

2.7

165.39

169.14

ng/l

0.18

2112

11950

Mouth breathing

2265

12353

1.94

169.44

3.0

2.9

151.18

185.25

ng/l

4.54

2040

11234

Hypertrophic cardiomyopathy

466

1226

4.97

168.63

5.4

3.0

356.07

214.60

ng/l

5.04

454

1118

Diabetes, insulin treatment (Kela reimbursement)

5528

22373

1.54

168.17

3.3

2.7

218.23

193.15

ng/l

3.60

5020

20276

Spondylopathies

4416

16868

1.62

166.12

3.0

2.8

178.90

228.69

ng/l

11.19

4052

15315

COPD, hospital admissions 3, with asthma pneumonia sepsis

2077

9499

2.03

165.69

4.3

3.0

309.34

255.87

ng/l

3.76

1940

8692

Viral pneumonia

905

3482

2.88

165.61

4.7

2.6

259.39

180.17

ng/l

4.79

835

3140

Short Achilles tendon (acquired)

303

564

6.98

164.58

3.5

2.8

105.91

177.98

ng/l

3.36

293

502

Nutritional anaemias

3133

18237

1.74

164.49

4.2

2.9

305.49

219.71

ng/l

14.91

2882

16654

Spinal stenosis

3224

14752

1.75

164.15

3.2

2.8

196.88

242.97

ng/l

6.42

2969

13484

Congenital malformations of pulmonary and tricuspid valves

123

31.56

163.69

6.5

5.4

155.46

130.47

ng/l

0.20

117

Respiratory insufficiency

681

2291

3.40

161.11

5.6

2.5

271.82

242.22

ng/l

0.70

641

2100

Ischaemic Stroke, excluding all haemorrhages

3680

17164

1.68

160.90

3.6

2.8

275.68

224.70

ng/l

6.81

3383

15695

Congenital malformations, deformations and chromosomal abnormalities

2761

15344

1.78

160.17

3.1

2.8

184.98

168.50

ng/l

0.94

2488

13756

Obesity, other/unspecified

1712

8662

2.08

159.43

2.9

2.7

141.01

164.05

ng/l

2.22

1473

7819

Neurological diseases, wide definition

1239

2551

2.52

159.36

3.2

2.6

146.95

177.72

ng/l

1.59

1074

2309

Intestinal infectious diseases

5027

25545

1.54

159.18

3.7

2.7

233.59

196.12

ng/l

4.93

4562

23138

Other diseases of pericardium

366

817

5.36

158.64

4.2

1.8

312.55

86.35

ng/l

4.66

345

713

Iron deficiency anaemia

2692

15573

1.80

157.87

4.3

2.9

310.35

216.39

ng/l

16.20

2480

14200

Abdominal and pelvic pain

5397

18154

1.53

157.33

3.3

2.7

193.66

210.10

ng/l

1.53

4849

16464

Pain (limb, back, neck, head abdominally)

3901

12161

1.66

156.27

3.2

2.8

204.46

222.15

ng/l

1.29

3508

11100

Other antidepressants

5588

19380

1.52

155.54

3.0

2.9

182.56

218.49

ng/l

6.78

5029

17646

Other functional intestinal disorders

2663

14486

1.79

153.72

3.4

2.9

211.19

219.73

ng/l

0.30

2434

13222

Aortic aneurysm

1689

8555

2.11

153.06

2.9

3.0

258.57

237.26

ng/l

0.95

1580

7833

Factors influencing health status and contact with health services

1576

3697

2.22

152.65

3.1

2.0

221.14

187.39

ng/l

1.67

1429

3316

Right ventricular outflow tract obstruction

133

23.05

152.53

7.4

4.7

180.40

207.29

ng/l

0.18

127

Acute bronchitis

2468

13976

1.82

152.18

4.0

2.9

254.62

227.42

ng/l

1.92

2212

12696

Symptoms and signs involving the digestive system and abdomen

5376

18157

1.52

151.72

3.4

2.7

198.79

210.12

ng/l

0.88

4843

16467

Sleep apnoea

5037

21991

1.53

150.78

3.1

2.8

154.56

201.01

ng/l

13.65

4519

20036

Certain infectious and parasitic diseases

3921

12349

1.64

150.55

3.2

2.5

210.89

172.48

ng/l

5.63

3564

11174

Other symptoms and signs involving the nervous and musculoskeletal systems

2341

13390

1.84

149.49

3.3

2.9

154.75

201.14

ng/l

3.89

2115

12199

Disorders of gallbladder, biliary tract and pancreas

5399

23308

1.51

148.98

3.1

2.8

204.02

205.15

ng/l

0.06

4910

21208

Injuries to the head

5818

24790

1.48

148.94

3.2

2.8

217.95

195.68

ng/l

2.57

5297

22430

Lumbar disc prolapse

3371

16166

1.66

145.89

2.8

2.7

139.43

208.24

ng/l

21.65

3068

14666

Insulin medication

3421

18165

1.65

145.49

3.9

2.8

275.02

207.87

ng/l

10.81

3163

16514

ILD, hospital admission 2, with pulmonary infections

789

3062

2.94

144.45

4.7

2.6

242.77

216.84

ng/l

0.86

738

2815

Diarrhoea and gastroenteritis of presumed infectious origin

3726

21661

1.60

144.01

3.8

2.8

238.79

198.28

ng/l

4.81

3385

19590

Soft tissue disorders

5255

18364

1.51

143.91

3.0

2.8

190.96

212.09

ng/l

2.69

4700

16637

Other or ill-defined heart diseases

372

898

4.70

143.79

4.9

1.8

305.54

87.41

ng/l

8.67

341

779

Gastro-oesophageal reflux disease

3688

20587

1.60

140.97

3.2

2.8

169.96

200.13

ng/l

4.15

3303

18788

Gout, FINNGEN

2065

11681

1.90

139.63

4.3

2.9

385.25

232.81

ng/l

17.84

1895

10719

Other specific joint derangements/joint disorders

3509

14332

1.63

139.43

2.7

2.8

161.81

184.62

ng/l

2.80

3122

12977

Bicuspidal aortic valve syndrome

330

760

5.35

139.06

3.1

2.8

163.82

177.19

ng/l

0.25

310

681

Diseases of the skin and subcutaneous tissue

5306

18224

1.50

138.47

3.1

2.8

214.44

197.10

ng/l

1.58

4796

16494

Gout, idiopatic and unspecified

1784

9732

1.99

138.14

4.4

3.0

383.00

228.99

ng/l

16.66

1643

8927

Allergic asthma (mode), excluding more controls

929

3787

2.50

137.88

2.7

1.8

127.12

85.80

ng/l

3.62

817

3361

Undetermined asthma, excluding more controls

704

2593

2.92

137.61

3.3

1.9

160.15

99.44

ng/l

4.79

638

2345

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5183

22913

1.49

137.40

3.0

2.8

211.55

204.93

ng/l

0.42

4700

20834

Other respiratory disorders and diseases

1492

7680

2.12

137.26

4.8

3.0

276.07

251.66

ng/l

1.05

1391

7016

Other diseases of the respiratory system

1492

7680

2.12

137.26

4.8

3.0

276.07

251.66

ng/l

1.05

1391

7016

Congenital malformations, deformations and chromosomal abnormalities

2976

16978

1.67

136.99

3.1

2.8

187.15

170.17

ng/l

1.05

2677

15267

Other pulmonary heart/vessel disease

486

1510

4.04

136.79

7.0

3.1

386.55

241.14

ng/l

5.85

461

1388

Other respiratory diseases principally affecting the interstitium

1362

6823

2.20

136.46

4.2

3.0

268.46

239.54

ng/l

1.28

1275

6262

Secondary right heart disease

448

1337

4.25

134.62

7.1

3.1

387.85

244.12

ng/l

5.37

424

1226

Sleep apnoea, including avohilmo

5180

22223

1.49

133.93

3.0

2.8

152.98

201.49

ng/l

14.87

4662

20232

Dorsopathies

5165

18051

1.49

132.04

2.9

2.8

171.03

219.59

ng/l

12.02

4624

16314

Early onset COPD

1392

7066

2.13

131.83

3.6

2.8

233.36

196.47

ng/l

1.63

1269

6419

Septal defects

429

1196

4.00

131.62

4.0

3.7

188.23

182.61

ng/l

0.10

384

1072

Peripheral arterial reconstruction

1354

6885

2.18

130.96

4.0

3.1

419.07

252.42

ng/l

18.52

1266

6312

Other and unspecified nerve root and plexus disorders, also in other diseases

1167

5550

2.26

130.74

3.1

2.8

100.21

176.63

ng/l

18.49

1077

5026

Other headache syndromes

2058

11755

1.82

130.16

2.8

2.6

126.23

186.62

ng/l

15.21

1856

10694

Abnormal findings on examination of blood, without diagnosis

2821

16163

1.68

129.34

3.3

3.0

230.67

227.50

ng/l

0.11

2589

14761

Atrial septal defect

301

673

5.30

128.94

3.6

3.4

221.31

176.45

ng/l

0.72

264

601

Disorders of lens

3666

14923

1.59

128.44

3.2

2.7

228.12

193.85

ng/l

3.95

3378

13586

Falls/tendency to fall

5377

18779

1.47

127.19

3.0

2.8

198.78

184.09

ng/l

1.44

4867

16986

COPD, hospital admissions 1, only main diagnosis

2359

12111

1.78

127.07

3.9

3.0

291.32

245.28

ng/l

2.75

2190

11099

Exposure to unspecified factor

5117

25858

1.46

125.77

2.9

210.13

196.75

ng/l

1.16

4571

23501

Gonarthrosis [arthrosis of knee](FG)

4146

16161

1.54

125.27

2.8

2.7

179.88

206.89

ng/l

3.85

3776

14729

Hernia

4893

22906

1.47

122.70

3.1

2.8

214.22

197.63

ng/l

1.57

4424

20775

Unspecified haematuria

2614

13420

1.70

121.84

3.4

3.0

269.78

231.62

ng/l

2.87

2410

12229

Other and unspecified iron deficiency

2053

12020

1.80

121.84

4.1

2.9

306.45

213.01

ng/l

12.50

1893

10961

Shoulder lesions

4102

16755

1.53

121.47

2.9

2.8

163.69

213.58

ng/l

11.28

3720

15276

Disorders of eyelid, lacrimal system and orbit

4564

24064

1.48

121.14

3.0

2.9

179.52

212.19

ng/l

5.47

4134

21928

Insulin, intermediate and long-acting

3164

20114

1.59

118.35

3.8

2.9

273.40

212.53

ng/l

8.60

2925

18283

ILD, hospital admissions 3, with pneumonia sepsis

689

2771

2.84

117.94

4.9

2.7

254.26

213.38

ng/l

1.59

644

2538

Senile cataract

3459

13911

1.58

117.72

3.2

2.7

232.94

201.15

ng/l

3.24

3193

12687

Unspecified acute lower respiratory infection

945

4328

2.37

117.09

4.7

2.9

231.85

203.58

ng/l

1.18

842

3893

Gonarthrosis

3546

13304

1.57

116.06

2.9

2.8

181.14

210.20

ng/l

3.96

3236

12136

Systemic sclerosis (FG)

239

495

6.19

115.42

4.4

2.6

114.16

165.74

ng/l

1.79

230

452

Gastrointestinal diseases

2634

8020

1.69

114.89

3.0

2.5

183.73

174.88

ng/l

0.46

2331

7318

General examination and investigation of persons without complaint and reported diagnosis

3060

10130

1.62

114.21

3.8

2.5

183.70

210.59

ng/l

2.54

2788

9163

Certain disorders involving the immune mechanism

1124

5561

2.17

113.97

4.5

2.8

187.98

181.14

ng/l

0.20

1019

5032

Cholelithiasis, broad definition with cholecystitis

4659

22036

1.46

113.57

3.1

2.8

205.60

209.22

ng/l

0.20

4228

20082

Gout, strict definition

1314

6955

2.07

112.51

4.6

3.0

385.52

236.14

ng/l

11.51

1225

6382

Intestinal infectious diseases

5917

24631

1.40

112.51

3.5

2.7

226.23

196.80

ng/l

3.78

5365

22348

Osteopathies and chondropathies

3054

18647

1.58

112.11

3.4

2.9

219.11

200.80

ng/l

1.03

2803

16970

Autoimmune diseases excluding thyroid diseases

5346

20878

1.43

112.02

3.2

2.8

214.93

201.77

ng/l

1.06

4869

18851

Gout, unspecified

1443

7883

1.99

111.50

4.5

3.0

395.11

226.48

ng/l

14.66

1332

7223

Arthrosis

3747

13814

1.53

110.29

2.9

2.8

179.56

206.11

ng/l

3.43

3404

12560

Nausea and vomiting

1574

8582

1.89

110.28

3.8

2.8

240.75

224.38

ng/l

0.58

1442

7805

L04AA Selective immunosuppressants

1198

6122

2.08

109.95

5.7

2.7

282.18

158.02

ng/l

11.90

1126

5518

ILD-related respiratory insufficiency

365

1097

4.34

109.82

5.9

3.0

268.25

243.30

ng/l

0.42

343

1010

Dental operations

3638

12490

1.54

108.79

3.1

2.9

224.10

250.78

ng/l

2.26

3280

11399

ILD, hospital admissions

1109

5618

2.18

108.10

4.1

3.0

229.71

239.86

ng/l

0.31

1045

5164

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5773

22893

1.40

107.99

3.2

2.8

203.68

197.43

ng/l

0.45

5211

20825

Tetralogy of Fallot, a congenital heart defect.

34.80

107.75

3.2

3.4

174.17

100.60

ng/l

0.98

Sciatica+with lumbago

2553

14884

1.63

107.66

2.9

2.7

153.93

208.31

ng/l

9.12

2326

13534

Other interstitial pulmonary diseases

1121

5738

2.15

106.02

4.1

3.0

230.51

238.32

ng/l

0.23

1055

5272

Autoimmune diseases excluding thyroid diseases, strict definition

5154

20270

1.42

105.92

3.2

2.8

213.85

200.59

ng/l

1.04

4697

18298

Diseases of the digestive system

2703

17450

1.61

105.76

3.8

3.0

270.05

229.78

ng/l

3.54

2478

15893

Disorders of choroid and retina

4467

22499

1.45

105.53

3.2

2.9

247.15

209.35

ng/l

4.87

4093

20506

All influenza (not pneumonia)

820

3682

2.38

105.47

4.0

2.6

227.58

174.51

ng/l

2.22

727

3279

Interstitial lung disease endpoints

1121

5751

2.15

105.35

4.1

3.0

230.51

240.56

ng/l

0.31

1055

5287

Interstitial lung disease

1121

5751

2.15

105.35

4.1

3.0

230.51

240.56

ng/l

0.31

1055

5287

Undetermined asthma

704

2957

2.55

105.29

3.3

2.3

160.15

163.87

ng/l

0.09

638

2687

Heart failure and hypertrophic cardiomyopathy

230

517

6.36

104.07

7.8

3.2

534.52

226.87

ng/l

6.94

225

471

Other CVD

1420

7883

1.95

103.95

4.1

3.0

278.25

249.56

ng/l

1.33

1308

7217

Allergic asthma (mode)

929

4271

2.21

103.95

2.7

2.2

127.12

143.86

ng/l

0.75

817

3814

Hernia of abdominal wall, postoperative

1065

5326

2.13

103.92

3.5

2.5

230.75

179.48

ng/l

2.60

968

4870

GI-bleeding

2071

12713

1.72

103.60

4.0

3.0

302.74

244.25

ng/l

4.69

1914

11597

Systemic connective tissue disorders

2012

12249

1.73

103.22

3.3

2.8

188.04

204.28

ng/l

0.98

1828

11181

Any operation in hilmo

126

21.47

102.90

3.1

1.4

105.71

92.54

ng/l

0.12

104

Systemic sclerosis

239

550

5.53

101.96

4.4

2.9

114.16

168.05

ng/l

1.98

230

497

Other diseases of urinary system

5044

20473

1.42

101.08

3.1

2.8

213.10

205.94

ng/l

0.45

4592

18576

Insulin, combination of fast acting with intermediate-acting or long-acting

3430

21483

1.51

101.04

3.9

2.9

275.16

215.34

ng/l

8.96

3171

19494

Ventricular septal defect, a heart condition

185

337

6.65

100.89

4.9

4.4

187.60

191.89

ng/l

0.04

172

299

Other diseases of the digestive system

2049

12637

1.71

100.65

4.0

3.0

300.29

243.60

ng/l

4.50

1894

11527

ILD, hospital admissions 1, main diag only

1003

5037

2.21

100.49

4.2

3.0

232.52

231.16

ng/l

0.03

942

4623

Other symptoms and signs involving the circulatory and respiratory systems

402

1301

3.42

100.46

4.3

2.5

164.05

182.12

ng/l

0.39

366

1172

729

3180

2.46

100.42

4.4

2.7

235.98

156.35

ng/l

3.26

652

2870

Other arthrosis

2821

12753

1.59

100.36

2.7

2.8

167.95

201.00

ng/l

4.27

2566

11656

Other diseases of intestine

935

4545

2.24

100.28

3.4

2.8

224.90

202.67

ng/l

0.80

862

4150

Visual disturbances

2569

16664

1.60

100.10

3.3

2.8

178.65

200.54

ng/l

2.01

2334

15210

Cholelithiasis

4429

21767

1.44

100.06

3.1

2.8

206.08

210.28

ng/l

0.23

4024

19835

Other/unspecified dorsalgia

1936

11613

1.72

99.99

3.1

2.8

181.51

221.65

ng/l

4.25

1752

10576

Operations for atrial fibrillation

196

401

7.29

99.59

3.1

2.8

286.03

203.25

ng/l

1.81

185

363

Other joint disorders

4094

15017

1.47

99.27

2.7

2.8

181.03

196.60

ng/l

1.39

3663

13575

Infections of the skin and subcutaneous tissue

2819

18459

1.56

99.21

3.4

2.8

227.86

187.12

ng/l

4.36

2538

16681

Systemic sclerosis, icd10

236

550

5.46

99.16

4.4

3.0

114.60

166.91

ng/l

1.86

228

500

Other external causes of accidental injury

4044

14036

1.48

99.13

3.0

2.8

203.06

187.30

ng/l

1.29

3645

12762

Unspecified kidney failure

802

3724

2.41

98.82

4.6

2.9

530.29

214.30

ng/l

19.43

756

3389

Benign neoplasm of colon, rectum, anus and anal canal

3657

22160

1.49

98.09

3.1

2.9

237.90

215.60

ng/l

1.84

3335

20312

Sequelae of external causes of morbidity and mortality

1517

8692

1.85

97.93

3.7

2.9

222.25

201.57

ng/l

1.20

1404

7891

Other systemic involvement of connective tissue (FG)

1448

8062

1.87

97.46

3.1

2.7

183.99

202.69

ng/l

0.96

1309

7377

Lung transplantation

114

134

13.99

97.05

7.5

3.5

136.24

173.68

ng/l

0.50

109

115

Intracranial injury

3089

19796

1.52

96.32

3.4

2.9

230.32

210.32

ng/l

1.22

2776

17965

Hypokalaemia

774

3554

2.38

96.01

3.9

2.7

262.24

194.44

ng/l

2.39

710

3205

Sleep disorders (combined)

5701

22174

1.38

95.96

3.0

2.9

172.21

213.36

ng/l

9.82

5168

20156

Accidents

4021

14036

1.47

95.65

3.0

2.8

203.38

187.30

ng/l

1.32

3621

12762

Lung transplant status

113

134

13.85

95.56

7.6

3.5

136.69

173.68

ng/l

0.49

108

115

Special screening examination for other diseases and disorders

625

2601

2.58

95.52

3.4

2.5

207.24

182.06

ng/l

0.74

520

2365

Care involving dialysis

529

2062

2.87

95.18

5.2

2.6

815.42

182.17

ng/l

24.14

508

1867

Any mental disorder

5570

20592

1.38

95.03

3.1

2.8

184.92

202.26

ng/l

1.93

5044

18736

Injuries to the knee and lower leg

5921

24577

1.36

94.85

2.9

196.08

200.31

ng/l

0.29

5383

22255

Diseases of the musculoskeletal system and connective tissue

2397

7504

1.64

94.21

2.9

2.8

176.84

212.66

ng/l

3.61

2148

6748

Hypertension, Pulmonary Arterial

120

155

11.67

93.82

9.5

2.6

313.57

254.25

ng/l

0.46

115

137

Streptococcal septicaemia

620

2634

2.62

93.16

4.4

2.6

336.26

187.25

ng/l

8.52

567

2388

Sarcoidosis

811

3843

2.29

92.90

4.8

2.8

158.78

183.09

ng/l

1.05

737

3483

Other cataract

2441

11949

1.61

92.64

3.1

2.7

239.94

208.89

ng/l

2.16

2232

10890

Explicit bacterial Sepsis

694

3092

2.45

92.59

4.5

2.6

330.52

189.14

ng/l

8.90

635

2800

Pericarditis

240

585

4.71

92.21

3.9

1.8

216.35

84.80

ng/l

5.13

219

510

Visual disturbances and blindness

2746

18403

1.55

91.60

3.3

2.9

188.22

206.73

ng/l

1.50

2495

16789

Diagnoses used for exclusion with ILD

1560

9184

1.80

91.55

4.3

3.0

207.47

228.53

ng/l

1.08

1425

8350

Functional dyspepsia

1417

8170

1.82

88.44

3.4

2.7

157.35

182.29

ng/l

1.33

1285

7451

Liquid cancers, helper endpoint

2250

12712

1.62

87.58

3.2

3.0

236.36

222.55

ng/l

0.72

2068

11620

Coxarthrosis [arthrosis of hip](FG)

3024

14537

1.51

87.10

3.1

2.8

199.86

218.47

ng/l

1.52

2769

13297

Symptoms and signs involving the skin and subcutaneous tissue

3504

24282

1.45

86.64

3.0

2.8

175.85

200.58

ng/l

3.17

3181

22097

Coarctation of the aorta

121

171

9.77

86.47

4.7

3.3

171.69

174.23

ng/l

0.02

107

155

Dronedarone medication

232

591

4.74

85.69

3.5

1.8

252.57

91.89

ng/l

13.02

218

514

Psychiatric diseases

5010

18529

1.38

85.42

3.1

2.8

185.68

203.26

ng/l

1.80

4560

16835

Coxarthrosis

2777

12347

1.54

84.96

3.1

2.8

200.07

219.08

ng/l

1.53

2540

11300

Gonarthrosis,primary

4841

22126

1.38

84.70

2.9

179.16

220.05

ng/l

9.97

4420

20196

Enlarged lymph nodes

822

4029

2.16

84.44

3.6

2.6

201.77

174.08

ng/l

0.95

747

3658

Rotator cuff syndrome

3196

15948

1.48

83.71

2.9

2.8

164.27

211.93

ng/l

8.85

2886

14589

Other pleural conditions

755

3653

2.29

83.48

4.1

2.8

378.78

244.42

ng/l

5.13

713

3351

External causes of morbidity and mortality

3137

10739

1.50

82.62

3.0

2.7

193.73

184.70

ng/l

0.54

2836

9764

Retention of urine

2074

10951

1.63

82.59

3.2

3.0

282.85

245.34

ng/l

2.05

1893

9991

Subjective visual disturbances

1345

7807

1.81

82.39

3.1

2.8

160.98

184.70

ng/l

1.43

1224

7116

Deforming dorsopathies

1412

8288

1.78

82.29

3.1

2.7

157.83

195.98

ng/l

1.51

1294

7526

Diseases of oral cavity, salivary glands and jaws

3416

12263

1.47

82.20

3.1

3.0

230.37

245.95

ng/l

0.93

3092

11184

Implicit fungal Sepsis

482

1944

2.79

81.54

4.7

2.6

265.83

174.13

ng/l

2.77

455

1767

Personality disorders, excluding more controls

970

5077

1.98

81.00

2.4

2.5

119.97

141.06

ng/l

1.11

856

4522

Persons encountering health services in other circumstances, wide

5888

23130

1.34

80.97

3.2

2.8

216.40

201.32

ng/l

1.41

5299

21023

Other disorders of ear

4677

22774

1.38

80.74

3.1

2.8

177.56

215.11

ng/l

8.09

4296

20643

Dysphagia

1430

8518

1.77

79.96

3.5

2.7

186.09

222.30

ng/l

2.65

1323

7776

Hypo-osmolality and hyponatraemia

1080

5931

1.93

79.36

3.9

2.8

256.51

221.44

ng/l

1.55

1000

5401

Arthropathies

4103

15047

1.41

78.82

2.8

194.09

196.99

ng/l

0.14

3651

13600

Atrial septal defect, secundum type

209

519

4.72

78.70

3.2

4.1

198.23

200.90

ng/l

0.03

193

473

Diseases of the eye and adnexa

3428

12053

1.45

78.01

3.1

2.6

174.49

180.36

ng/l

0.32

3071

10798

Asthma and allergy, excluding more controls

425

1583

2.75

77.71

2.4

1.8

79.27

74.81

ng/l

0.16

369

1396

Hyperlipidaemia, other/unspecified

2150

13043

1.58

77.69

3.0

2.7

270.22

215.15

ng/l

4.61

2005

11888

Other retinal disorders

3552

19971

1.43

77.26

3.3

2.9

267.92

220.02

ng/l

5.59

3253

18221

Benzodiazepine use

4933

25645

1.35

77.06

3.0

2.8

190.97

204.58

ng/l

1.23

4443

23270

Other diseases of anus and rectum

1689

10578

1.67

76.45

3.3

2.8

244.82

218.17

ng/l

1.23

1566

9660

Sequelae with surgical and medical care as external cause

1192

6876

1.84

75.68

3.7

2.9

224.95

198.44

ng/l

1.51

1112

6263

Other gastritis (incl. Duodenitis)

1307

7721

1.79

75.65

3.4

2.8

225.90

211.13

ng/l

0.57

1209

7048

Injuries to the abdomen, lower back, lumbar spine and pelvis

2146

14103

1.56

75.03

3.4

2.9

243.41

221.43

ng/l

1.22

1953

12795

Familial hypercholesterolemia, with ischemic heart disease

622

2914

2.35

74.38

3.6

2.5

291.57

195.36

ng/l

3.45

580

2651

Other bacterial intestinal infections

1075

6042

1.89

74.30

4.1

2.8

286.31

212.17

ng/l

4.41

990

5489

Other degenerative diseases of the nervous system

1518

6891

1.72

74.21

3.1

2.6

189.07

245.66

ng/l

6.29

1387

6346

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

541

2387

2.47

73.83

3.9

2.9

194.65

185.77

ng/l

0.19

492

2152

Carpal tunnel syndrome

2990

18641

1.45

73.65

3.1

2.7

156.31

201.65

ng/l

8.35

2693

16997

Benign neoplasm: Colon

3076

20994

1.45

73.47

3.2

2.9

236.67

218.88

ng/l

1.15

2805

19274

Hypotension

1185

6917

1.84

73.30

4.0

3.1

280.93

256.19

ng/l

0.92

1094

6336

Benign neoplasms

4609

19034

1.36

72.71

3.1

2.8

199.87

201.86

ng/l

0.10

4168

17192

CR(E)ST syndrome

156

336

6.03

72.50

3.8

2.6

98.74

140.47

ng/l

1.34

151

310

Peripheral artery operations in Hilmo

864

4599

2.03

71.95

4.1

3.0

467.12

236.92

ng/l

17.45

808

4199

Chronic gastritis

1633

10368

1.66

71.23

3.1

2.9

250.03

225.00

ng/l

1.10

1480

9511

Disorders of synovium and tendon

2455

14744

1.50

70.96

2.9

2.7

166.20

197.70

ng/l

1.95

2244

13424

Unspecified fall

2615

17983

1.48

70.79

3.2

3.0

219.32

214.84

ng/l

0.18

2371

16346

Migraine with aura

896

4778

1.94

70.79

2.8

2.4

100.27

155.67

ng/l

7.25

787

4305

Chronic sinusitis

1983

13077

1.56

70.75

2.8

157.64

192.01

ng/l

3.41

1788

11923

Genitourinary diseases

2690

9236

1.49

70.17

3.4

2.6

207.36

169.06

ng/l

3.94

2425

8277

Other and unspecified drugs and medicaments

516

2287

2.47

69.96

3.9

3.0

195.61

191.42

ng/l

0.08

468

2066

Idiopathic pulmonary fibrosis

610

2930

2.35

69.93

4.6

3.0

224.86

258.61

ng/l

1.04

577

2685

Presence of other devices

1424

8748

1.71

69.89

3.4

2.6

225.54

217.20

ng/l

0.31

1298

7970

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

620

2970

2.28

69.68

3.9

3.0

259.58

208.72

ng/l

1.26

569

2700

Sequelae of cerebrovascular disease

2186

12765

1.54

69.54

3.9

3.0

291.99

241.22

ng/l

4.23

1992

11692

Abnormal serum enzyme levels

1732

10921

1.62

69.47

2.9

3.0

205.39

238.40

ng/l

2.08

1581

10023

Cholecystectomy

3591

22813

1.39

69.32

3.0

2.8

188.40

212.70

ng/l

2.55

3266

20805

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1338

8120

1.72

68.97

3.0

2.7

120.22

162.05

ng/l

6.80

1192

7414

Glucagon-like peptide-1 (GLP-1) analogues

1338

8120

1.72

68.97

3.0

2.7

120.22

162.05

ng/l

6.80

1192

7414

Viral and other specified intestinal infections

1101

6072

1.80

68.96

4.4

2.7

174.36

171.30

ng/l

0.09

985

5359

Diaphragmatic hernia

2012

13468

1.56

68.69

2.9

217.24

207.38

ng/l

0.38

1823

12327

Injuries to the thorax

2417

16751

1.49

68.26

3.3

3.0

231.87

222.68

ng/l

0.30

2201

15251

Follow-up examination after treatment for conditions other than malignant neoplasms

1921

8286

1.57

67.34

2.3

2.5

193.58

201.70

ng/l

0.32

1727

7508

Convulsions, not elsewhere classified

1032

5778

1.83

67.18

3.1

2.7

212.94

185.10

ng/l

1.07

927

5195

Other bacterial intestinal infections

1250

7525

1.74

67.08

3.9

2.8

270.50

206.65

ng/l

4.20

1151

6819

Used for control exclusion in common control thyroid runs

5046

19534

1.33

66.97

3.3

2.8

203.09

200.66

ng/l

0.13

4555

17628

Other specified/unspecified arthritis

1312

7982

1.71

66.84

3.2

2.7

243.12

193.10

ng/l

3.17

1189

7286

Pleural effusion

990

5634

1.88

66.57

4.4

2.8

358.93

243.45

ng/l

8.25

927

5166

Diseases of liver

1769

11583

1.59

66.55

3.3

2.9

256.67

196.42

ng/l

3.15

1609

10521

Other arthritis (FG)

1487

9342

1.65

66.45

3.2

2.7

245.55

190.33

ng/l

3.92

1347

8500

Periodontitis

4736

24337

1.33

65.42

2.9

2.8

189.70

195.61

ng/l

0.36

4276

22155

Asthma and allergy

425

1728

2.52

64.94

2.4

2.2

79.27

116.70

ng/l

2.32

369

1534

Missing teeth due to accident, extraction or parodontitis

3108

21398

1.41

64.49

3.4

2.8

171.77

207.54

ng/l

5.58

2872

19548

Chronic periodontitis, including avohilmo

4716

24329

1.33

64.35

2.9

2.8

189.77

195.38

ng/l

0.34

4258

22150

Diarrhoea and gastroenteritis of presumed infectious origin

4833

24575

1.32

64.27

3.4

2.7

219.46

196.62

ng/l

2.36

4357

22292

Conductive and sensorineural hearing loss

4142

21207

1.35

63.22

3.1

2.8

185.25

222.91

ng/l

7.14

3832

19300

Bacterial intestinal infections, IBD co-morbidities

1065

6258

1.80

63.16

4.1

2.9

292.43

221.42

ng/l

3.93

980

5681

Artrosis, including avohilmo

4040

16617

1.36

62.80

2.8

2.9

184.04

219.35

ng/l

5.54

3651

15096

Migraine

1789

9522

1.56

62.51

2.9

2.5

110.82

155.19

ng/l

6.36

1564

8583

Idiopathic gout

645

3294

2.16

61.84

3.9

2.9

388.48

217.48

ng/l

6.17

596

3035

Unspecified privation

618

3084

2.16

61.67

2.7

3.0

315.35

204.03

ng/l

4.57

559

2790

Chronic rhinitis, nasopharyngitis and pharyngitis

1436

9106

1.63

61.48

2.4

2.8

134.39

180.56

ng/l

5.46

1253

8290

Caries of dentine, including avohilmo

4221

16341

1.35

61.46

3.0

217.61

226.24

ng/l

0.51

3806

14914

L04AX Other immunosuppressants

2554

18202

1.44

61.14

3.5

2.8

175.12

181.04

ng/l

0.31

2323

16518

Second line medication for Crohn's disease

2601

18607

1.43

60.86

3.5

2.8

173.79

180.32

ng/l

0.36

2364

16886

Implicit fungal Sepsis

282

1012

3.22

60.64

5.4

2.8

261.09

187.49

ng/l

1.84

268

919

Cardiac murmurs and other cardiac sounds

388

1574

2.57

60.62

3.1

2.8

163.28

173.88

ng/l

0.18

355

1406

Insulin, fast-acting

1789

11960

1.55

60.55

4.1

2.8

276.50

201.67

ng/l

7.04

1661

10797

Spondylosis

2673

15628

1.43

60.33

2.9

2.8

157.78

223.70

ng/l

17.10

2434

14252

Autoimmune diseases

5272

20976

1.30

59.92

3.3

2.8

202.86

201.48

ng/l

0.07

4774

18931

Fungal Sepsis

299

1113

3.08

59.92

5.2

2.8

261.33

191.21

ng/l

1.79

283

1013

Viral and other specified intestinal infections

830

4450

1.88

59.75

5.0

2.7

179.52

178.70

ng/l

0.02

744

3903

Soft tissue disorders related to use, overuse and pressure

1374

8723

1.64

59.22

3.1

2.7

185.55

202.14

ng/l

0.80

1240

7955

Substance abuse, excluding more controls

2541

15444

1.44

59.20

2.9

2.8

236.94

205.51

ng/l

1.31

2275

14057

Polyuria

1263

7892

1.68

59.07

3.1

3.0

227.25

226.92

ng/l

0.01

1153

7219

Injury, poisoning and certain other consequences of external causes

2436

8487

1.47

58.83

3.0

2.7

192.62

180.85

ng/l

0.69

2201

7701

Other systemic involvement of connective tissue

1465

9474

1.61

58.68

3.1

2.8

183.44

203.18

ng/l

1.08

1323

8661

Injuries to the shoulder and upper arm

4113

25463

1.33

58.50

2.9

202.42

204.76

ng/l

0.10

3720

23137

Neoplasms

3101

11966

1.40

57.97

2.9

2.8

173.50

188.19

ng/l

1.01

2753

10711

Dental caries, including avohilmo

4018

15627

1.34

57.28

3.0

220.55

229.25

ng/l

0.49

3630

14271

ILD medications: azathioprine

658

3419

2.02

57.22

5.6

2.6

218.09

157.73

ng/l

2.93

612

3081

Anxiety disorders, excluding more controls

3626

17772

1.35

56.98

3.0

2.7

145.01

186.46

ng/l

7.77

3238

16115

Cutaneous abscess, furuncle and carbuncle

1183

7301

1.68

56.98

3.4

2.8

218.17

174.40

ng/l

2.77

1081

6571

Amputation

675

3593

2.04

56.72

4.5

2.9

487.33

241.10

ng/l

15.10

630

3288

Rheumatoid arthritis

1583

9351

1.57

56.69

3.0

2.7

201.09

205.92

ng/l

0.18

1451

8565

Artificial opening status

347

1422

2.72

56.65

3.0

2.4

224.60

168.28

ng/l

1.70

310

1286

Fracture of rib(s), sternum and thoracic spine

1657

11098

1.56

56.53

3.5

3.0

234.83

224.91

ng/l

0.26

1515

10085

Other diseases of hard tissues of teeth

3158

12014

1.39

56.42

3.0

2.9

202.12

239.82

ng/l

4.27

2858

10973

Selective serotonin reuptake inhibitors

4781

19457

1.30

56.26

2.8

2.9

169.89

218.67

ng/l

11.85

4293

17721

Meniscus derangement

2681

13041

1.42

56.22

2.7

2.8

181.53

199.45

ng/l

1.26

2429

11906

Varicose veins

3197

18032

1.37

55.60

3.1

2.8

211.20

218.81

ng/l

0.40

2915

16488

Benign neoplasm: Colon, unspecified

1455

9544

1.60

55.47

3.2

3.0

239.73

221.72

ng/l

0.68

1327

8758

Primary gonarthrosis, bilateral

2769

17419

1.40

55.30

2.9

177.06

227.47

ng/l

9.44

2537

15975

Mixed connective tissue disease

362

1525

2.60

55.17

3.2

2.9

132.62

183.66

ng/l

1.94

339

1375

Enterocolitis due to Clostridium difficile

685

3691

2.00

55.16

4.8

3.0

332.52

240.27

ng/l

3.90

636

3355

Fibromyalgia

399

1738

2.43

55.09

2.9

2.7

84.99

143.07

ng/l

3.47

363

1561

Personality disorders

970

5724

1.75

54.76

2.4

2.7

119.97

137.41

ng/l

0.86

856

5081

Acute upper respiratory infections of multiple and unspecified sites

3359

18723

1.35

54.62

3.6

2.7

197.38

197.85

ng/l

0.02

3022

16939

Mood disorders, excluding more controls

4291

19845

1.31

54.34

2.9

2.8

152.34

196.85

ng/l

9.19

3837

18045

Other diseases of upper respiratory tract

5441

22566

1.28

54.28

2.8

3.0

174.87

219.13

ng/l

11.81

4903

20527

Disturbances of skin sensation

1172

7311

1.66

53.84

2.8

2.7

119.36

166.59

ng/l

7.04

1030

6590

Diseases of pulp and periapical tissues and dental caries

3647

14140

1.35

53.76

3.0

228.93

236.18

ng/l

0.35

3299

12916

Azathioprine

658

3497

1.97

53.53

5.6

2.6

218.09

164.34

ng/l

2.41

612

3142

Autoimmune diseases related-to ILD

3895

25747

1.32

53.29

3.0

2.8

193.38

199.10

ng/l

0.33

3509

23307

Iron deficiency anaemia secondary to blood loss (chronic)

952

5696

1.77

53.14

5.0

2.9

341.66

218.22

ng/l

9.12

875

5191

Disorders of adult personality and behaviour

1003

6023

1.71

52.99

2.5

2.7

116.04

136.54

ng/l

1.15

881

5343

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

966

5716

1.73

52.92

2.9

2.6

129.20

157.34

ng/l

1.45

850

5117

Reimbursement for rheumatic diseases

2681

19662

1.39

52.85

3.0

2.8

189.78

194.11

ng/l

0.19

2438

17885

Hyperkalaemia

397

1786

2.47

52.77

5.6

2.9

538.59

229.87

ng/l

11.40

371

1623

Procreative management

1216

6361

1.64

52.51

3.2

2.7

112.69

136.46

ng/l

1.79

1091

5629

Acute sinusitis

2108

13770

1.45

52.50

3.1

2.6

156.49

173.91

ng/l

1.18

1878

12433

Sensorineural hearing loss

3936

20669

1.32

52.44

3.1

2.8

193.16

226.10

ng/l

4.78

3651

18835

Embolic stroke with flimmer

217

732

3.46

52.28

3.8

2.4

366.94

196.78

ng/l

4.16

200

658

Neuromuscular dysfunction of bladder

540

2731

2.13

52.27

3.1

3.0

161.63

209.04

ng/l

2.72

483

2479

Somatoform disorder

736

4089

1.88

52.15

3.0

2.7

127.10

163.92

ng/l

2.24

654

3683

Depression or dysthymia

3208

13231

1.36

51.96

2.8

168.51

210.70

ng/l

5.53

2892

12051

Other specified congenital malformation syndromes affecting multiple systems

113

240

5.51

51.91

3.6

5.1

155.64

163.00

ng/l

0.08

106

213

Familial hypercholesterolemia

891

5274

1.79

51.81

3.3

2.7

258.19

227.76

ng/l

0.83

831

4797

Invasive ventilation

448

2127

2.30

51.76

3.3

3.0

359.62

212.65

ng/l

4.64

417

1952

Artificial joint operation, meniscal resection

4608

23620

1.29

51.64

2.9

172.32

215.00

ng/l

10.55

4207

21513

Superficial injury of head

1211

7711

1.63

51.60

3.3

2.9

241.63

216.28

ng/l

1.04

1114

6971

Cervical disc disorders

1732

11887

1.50

51.53

2.9

2.8

130.48

215.54

ng/l

22.01

1594

10848

Other peripheral vascular diseases

443

2088

2.29

51.46

3.3

2.9

185.37

175.19

ng/l

0.20

405

1874

Maze procedure for atrial fibrillation

103

11.65

51.42

2.7

3.6

317.74

269.71

ng/l

0.30

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2335

16403

1.42

51.21

2.9

2.8

158.17

195.67

ng/l

2.63

2102

14968

Abnormal findings on diagnostic imaging of other body structures

742

4186

1.88

50.94

3.4

2.8

165.85

187.07

ng/l

0.87

688

3814

Other specified/unspecified systemic involvement of connective tissue

326

1359

2.63

50.84

3.4

2.9

159.19

178.88

ng/l

0.39

308

1221

Presence of other functional implants

2871

14820

1.38

50.43

3.2

2.4

227.19

190.31

ng/l

3.86

2638

13447

Specific personality disorders

831

4819

1.78

50.06

2.4

2.6

121.12

136.28

ng/l

0.60

740

4284

Injuries to the hip and thigh

2578

17242

1.39

49.92

3.3

3.0

278.74

230.82

ng/l

4.29

2340

15725

Gingivitis and periodontal diseases

5066

20834

1.28

49.92

2.9

192.14

212.44

ng/l

2.28

4552

18989

Spondylolisthesis/Spondylolysis

907

5433

1.75

49.67

3.0

2.6

141.94

196.57

ng/l

6.03

827

4950

Post-traumatic stress disorder

273

1040

2.74

49.62

2.7

2.5

91.87

113.04

ng/l

0.46

243

918

Diseases of pulp and periapical tissues, including avohilmo

5109

21128

1.27

49.52

2.8

2.9

192.31

212.57

ng/l

2.44

4595

19218

Fracture of lumbar spine and pelvis

1293

8461

1.60

49.38

3.6

3.0

254.56

236.23

ng/l

0.73

1184

7706

Insulin, fast-acting or short human

1800

12549

1.48

49.26

4.1

2.9

278.99

207.94

ng/l

6.40

1671

11338

Myocardial infarction, with ST-elevation

1092

6908

1.67

49.15

4.0

3.1

371.73

256.13

ng/l

4.95

1012

6300

Diabetic nephropathy, excluding more controls

842

4071

1.81

49.06

4.2

3.0

469.75

204.19

ng/l

19.62

793

3673

Congenital aortic valve stenosis

12.33

49.05

4.4

4.3

121.68

146.87

ng/l

0.28

Disorders of lacrimal system

2034

14488

1.44

48.77

3.2

2.8

170.61

199.26

ng/l

2.61

1843

13252

Misadventures to patients during surgical and medical care

750

4302

1.84

48.48

3.5

2.8

234.24

192.97

ng/l

1.83

698

3901

Poisoning by drugs, medicaments and biological substances

902

5404

1.72

48.38

3.1

2.7

152.93

154.59

ng/l

0.04

812

4794

Malignant neoplasm, wide definition for exclusion

3986

18228

1.30

48.04

2.7

2.9

183.12

193.32

ng/l

0.74

3612

16493

Sequelae of injuries, of poisoning and of other consequences of external causes

1071

6735

1.65

48.01

2.8

147.00

174.14

ng/l

2.09

971

6067

Open wound of lower leg

784

4565

1.81

47.89

3.4

3.0

264.45

203.76

ng/l

3.30

702

4100

Vascular disorders of the intestines

469

2342

2.19

47.68

4.3

2.8

404.26

246.14

ng/l

5.71

434

2137

Irritable bowel syndrome

1162

7455

1.61

47.37

2.7

2.6

139.68

174.76

ng/l

2.68

1044

6761

Other disorders of lacrimal gland

1652

11430

1.49

47.36

3.2

2.8

158.16

193.99

ng/l

3.44

1490

10427

Amputation of toe

488

2486

2.16

47.29

4.2

3.0

482.72

233.79

ng/l

11.00

455

2281

Later onset COPD

1808

10140

1.49

47.28

3.8

3.0

335.10

263.36

ng/l

4.39

1697

9300

Malignant neoplasm

3900

17992

1.30

47.19

2.8

2.9

182.76

194.68

ng/l

0.91

3533

16293

Organic, including symptomatic, mental disorders

2940

15859

1.36

46.88

3.1

3.0

234.14

241.87

ng/l

0.33

2697

14573

Extracorporeal dialysis

372

1712

2.39

46.72

6.1

2.9

840.62

203.40

ng/l

20.70

359

1570

Disorders of skin appendages

1954

13917

1.43

46.61

3.1

2.7

174.75

177.15

ng/l

0.08

1755

12540

Paralytic ileus and intestinal obstruction

1370

9171

1.55

46.58

3.1

2.8

208.35

229.37

ng/l

1.02

1260

8387

Kidney transplant status

283

1151

2.69

46.55

4.2

3.1

565.33

161.73

ng/l

12.72

271

1038

Alzheimer disease, excluding more controls

1070

4416

1.68

46.43

3.1

2.6

205.53

260.28

ng/l

3.87

992

4075

Chronic apical periodontitis

5231

24077

1.26

46.30

2.9

2.8

190.64

199.65

ng/l

0.72

4713

21877

Emphysema

462

2318

2.17

46.13

3.9

2.9

219.49

252.49

ng/l

0.74

428

2117

Complications of internal orthopaedic prosthetic devices, implants and grafts

1282

8514

1.58

46.12

3.2

2.9

221.99

215.34

ng/l

0.23

1193

7807

Hallux valgus (acquired)

1574

7717

1.51

46.08

2.8

2.7

184.56

194.46

ng/l

0.27

1444

7065

Hernia of abdominal wall

2236

16392

1.40

45.94

3.4

2.9

225.57

207.92

ng/l

0.88

2036

14948

Viral hepatitis, IBD co-morbidity

191

626

3.20

45.90

3.3

2.2

178.08

144.53

ng/l

0.43

171

551

Dermatitis

2863

21668

1.35

45.82

3.1

2.8

196.16

201.51

ng/l

0.24

2590

19747

Other infectious diseases

530

2795

2.04

45.48

4.1

3.0

270.71

228.64

ng/l

1.08

490

2529

Abnormalities of gait and mobility

714

4140

1.84

45.23

2.8

3.0

283.76

223.14

ng/l

1.57

648

3794

Cellulitis

1055

6714

1.63

45.19

3.7

2.8

250.28

189.19

ng/l

3.28

945

6067

Poisoning by medicine

806

4774

1.74

45.18

3.1

2.7

147.80

150.38

ng/l

0.07

727

4242

Chronic ulcer of skin, not elsewhere classified

446

2230

2.19

45.18

4.1

2.9

373.68

228.74

ng/l

3.17

406

2034

Other and unspecified polyneuropathies, also in other diseases

1071

6878

1.64

45.03

3.4

3.0

242.00

223.49

ng/l

0.56

980

6286

Symptoms and signs concerning food and fluid intake

534

2815

2.00

44.92

3.3

2.7

222.01

191.03

ng/l

0.86

492

2584

Pain in thoracic spine

685

3905

1.83

44.55

3.2

2.7

135.56

188.79

ng/l

4.84

635

3520

Other disorders of eyelid

2377

16832

1.38

44.55

3.1

2.9

197.89

228.70

ng/l

2.57

2158

15469

Delirium, not induced by alcohol and other psychoactive substances

770

4574

1.80

44.48

3.6

3.2

338.28

270.46

ng/l

2.02

706

4170

Cervicobrachial syndrome

960

5986

1.66

44.39

2.8

2.7

112.58

190.28

ng/l

13.29

854

5417

Polyneuropathies and other disorders of the peripheral nervous system

1191

7852

1.59

44.32

3.4

3.0

239.94

223.87

ng/l

0.51

1091

7175

Any event in cancer register

4107

19122

1.28

44.31

2.7

2.9

183.87

191.63

ng/l

0.51

3713

17316

Osteoporosis

1504

9710

1.51

44.10

3.8

2.9

219.61

221.65

ng/l

0.06

1404

8867

Schizophrenia or delusion, excluding more controls

1196

7771

1.56

43.73

2.8

2.7

148.68

181.68

ng/l

1.90

1068

6966

Congenital malformations of trachea and bronchus

212

5.89

43.56

4.8

3.2

151.91

225.21

ng/l

1.07

190

Exclusion endpoint for clefts

120

306

4.44

43.45

3.5

4.6

152.50

160.72

ng/l

0.10

113

273

Phlebitis and thrombophlebitis (not including DVT)

1119

7293

1.60

43.34

2.9

2.8

187.22

196.96

ng/l

0.33

1026

6636

Other reaction to severe stress, and adjustment disorders

1279

8535

1.53

43.03

3.5

2.6

147.47

148.13

ng/l

0.02

1145

7631

Haemorrhage, not elsewhere classified

272

1137

2.68

42.97

4.0

2.9

364.72

222.84

ng/l

3.92

248

1045

Viral pneumonia (known virus, not influenza)

194

687

3.27

42.97

5.9

3.5

258.75

216.62

ng/l

0.55

179

629

Diseases of the ear and mastoid process

5240

21392

1.25

42.65

3.0

2.8

168.74

208.08

ng/l

8.63

4723

19290

Benign neoplasm of other and ill-defined parts of digestive system

964

6116

1.66

42.65

3.3

2.9

201.90

199.80

ng/l

0.05

868

5583

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1509

10473

1.48

42.47

3.6

2.8

207.21

176.12

ng/l

1.67

1358

9506

Candidiasis

1258

8425

1.54

42.42

3.2

2.8

198.28

177.24

ng/l

0.78

1136

7651

Anxiety (asthma-related co-morbidities)

2230

12685

1.38

42.20

2.8

2.7

133.18

156.72

ng/l

1.88

1962

11398

Other disorders of the musculoskeletal system and connective tissue

783

4734

1.75

42.04

3.2

2.9

165.74

199.06

ng/l

1.89

725

4304

Heartburn

537

2910

1.94

41.65

3.4

2.6

168.97

184.20

ng/l

0.42

492

2629

Disorders of other endocrine glands

1977

14179

1.41

41.58

3.4

2.9

217.28

196.82

ng/l

1.02

1800

12835

Postprocedural musculoskeletal disorders, not elsewhere classified

438

2244

2.13

41.53

3.7

2.9

189.08

203.49

ng/l

0.32

410

2049

Disorder of lipoprotein metabolism, unspecified

735

4387

1.77

41.48

2.8

2.7

277.79

219.25

ng/l

2.11

686

3984

Osteoporosis with pathological fracture (FG)

459

2396

2.09

41.26

4.3

2.9

211.93

229.59

ng/l

0.39

431

2197

Congenital malformations of the respiratory system

136

397

4.00

41.26

4.5

3.7

139.54

205.05

ng/l

1.58

124

366

Fracture of lower leg, including ankle

2497

18690

1.35

41.24

2.9

2.8

206.10

192.02

ng/l

0.81

2276

16961

Other skin changes

992

6383

1.63

41.20

3.5

2.9

195.94

214.62

ng/l

0.83

932

5851

Memory loss

585

3316

1.91

40.65

2.3

3.1

233.32

252.73

ng/l

0.39

536

3025

Need for immunization against other single viral diseases

139

417

3.89

40.54

3.6

3.0

546.90

179.69

ng/l

2.60

133

377

Other metabolic disorders

549

3022

1.90

40.14

4.0

2.5

177.39

152.21

ng/l

0.59

501

2727

Ascites

443

2301

2.08

40.00

4.5

2.7

392.18

202.89

ng/l

6.57

418

2093

Right bundle-branch block

192

693

3.03

39.90

3.6

1.8

257.20

88.04

ng/l

4.74

172

607

Superficial injury of lower leg

1087

7155

1.57

39.75

3.2

2.9

219.35

186.38

ng/l

1.40

983

6422

Other anxiety disorders

1603

9794

1.44

39.67

2.8

2.6

133.75

154.38

ng/l

1.30

1401

8747

Unknown and unspecified causes of morbidity

345

1628

2.25

39.61

3.3

2.7

212.24

193.69

ng/l

0.36

310

1477

Phobic anxiety disorders

410

2043

2.07

39.57

2.9

2.6

127.46

117.51

ng/l

0.25

364

1785

Mycoses

1241

8434

1.52

39.23

3.7

2.8

210.95

195.95

ng/l

0.60

1134

7636

Acute upper respiratory infections

4860

24479

1.24

39.18

3.3

2.8

189.75

208.06

ng/l

1.94

4387

22232

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

149

467

3.47

39.15

3.3

4.0

136.45

147.94

ng/l

0.18

135

413

Extreme obesity with alveolar hypoventilation

248

1035

2.66

39.12

4.5

3.0

186.63

194.62

ng/l

0.12

232

941

Lung cancer and mesothelioma

951

5211

1.63

39.06

3.0

2.3

221.10

203.33

ng/l

0.62

887

4774

Neurotic, stress-related and somatoform disorders

3692

20552

1.27

38.78

3.0

2.7

142.08

176.92

ng/l

5.83

3282

18587

Migraine without aura

561

3121

1.84

38.77

2.7

2.6

85.16

133.63

ng/l

2.85

484

2804

Cystitis

3831

18159

1.27

38.71

2.9

2.8

208.72

210.26

ng/l

0.07

3491

16517

Fall on same level involving ice and snow

2595

19919

1.33

38.68

2.8

2.9

193.41

193.78

ng/l

0.01

2366

18124

Non-selective monoamine reuptake inhibitors

1786

12497

1.41

38.68

2.9

2.8

157.49

218.14

ng/l

7.80

1606

11434

Anxiety disorders

3750

20841

1.27

38.59

3.0

2.7

143.63

178.40

ng/l

5.81

3336

18857

Transport accidents

1887

11834

1.40

38.55

2.9

2.8

174.57

178.05

ng/l

0.13

1715

10750

Congenital malformations of the respiratory system

125

362

4.04

38.46

4.5

3.8

138.32

206.51

ng/l

1.54

114

332

Ventral hernia

1208

8210

1.53

38.44

3.5

2.9

223.30

207.43

ng/l

0.50

1102

7501

Other complications of surgical and medical care, not elsewhere classified

477

2559

1.97

38.39

3.5

2.8

234.33

182.79

ng/l

0.87

439

2305

Solid cancers, helper endpoint

3794

17859

1.27

38.38

2.7

2.9

180.83

195.01

ng/l

1.15

3438

16180

Myalgia

965

6252

1.59

37.81

2.8

2.7

156.71

181.10

ng/l

0.74

862

5671

Polyarthrosis

1026

6269

1.58

37.74

3.1

2.7

204.74

205.58

ng/l

0.01

951

5761

Other other unspecified disorders of the circulatory system

246

1046

2.64

37.56

4.7

3.0

272.17

214.49

ng/l

1.07

224

967

Coagulation defects, purpura and other haemorrhagic conditions

917

5906

1.62

37.50

3.5

3.0

282.29

195.47

ng/l

5.67

833

5365

Symptoms and signs involving speech and voice

1582

11348

1.44

37.35

3.3

2.8

170.20

203.59

ng/l

3.06

1451

10366

Asthma and opportunity respiratory infection

305

1431

2.37

37.01

3.5

2.9

214.56

209.32

ng/l

0.06

276

1304

2348

16452

1.35

36.91

3.4

3.0

241.89

243.97

ng/l

0.08

2172

15131

Sequelae of other external causes

309

1446

2.31

36.88

4.1

2.8

232.36

198.76

ng/l

0.71

286

1305

Polycystic ovarian syndrome, consortium definition

2697

12260

1.32

36.81

2.8

2.6

134.03

171.61

ng/l

7.25

2462

11074

Speech and linguistic disorders, excluding more controls

285

1193

2.34

36.78

5.0

3.1

183.09

188.06

ng/l

0.07

266

1053

Gonarthrosis, primary, with knee surgery

2990

18705

1.30

36.71

2.9

180.57

229.04

ng/l

9.50

2737

17169

Voice disturbances

1235

8500

1.50

36.68

3.0

2.8

154.16

188.24

ng/l

2.90

1124

7772

Other hammer toe(s) (acquired)

910

5421

1.62

36.68

3.0

2.7

207.17

206.69

ng/l

0.01

850

4985

Emotionally unstable personality disorder

365

1798

2.10

36.61

2.3

2.6

83.82

105.25

ng/l

1.06

327

1574

Persons encountering health services for specific procedures, not carried out

355

1743

2.14

36.58

2.1

2.4

274.14

162.87

ng/l

2.92

320

1552

Rheumatism, unspecified

631

3729

1.77

36.48

2.9

2.6

138.55

176.96

ng/l

1.50

565

3399

Fibrosis and cirrhosis of liver

436

2335

2.01

36.04

3.9

3.0

264.85

199.71

ng/l

2.11

405

2138

Substance abuse

2541

18430

1.32

35.89

2.9

236.94

203.96

ng/l

1.42

2275

16698

Injuries to the elbow and forearm

3078

21386

1.29

35.63

2.9

2.8

209.66

189.76

ng/l

1.12

2787

19374

Seropositive rheumatoid arthritis

1191

8158

1.50

35.45

3.1

2.7

209.47

200.45

ng/l

0.32

1105

7447

Epilepsy

1364

9572

1.46

35.41

3.0

2.9

163.70

231.54

ng/l

11.41

1246

8728

All anxiety disorders

2238

13378

1.34

35.29

2.8

2.6

133.15

156.83

ng/l

1.91

1969

12005

Other viral diseases

1061

7089

1.53

35.27

4.1

2.9

181.65

165.83

ng/l

0.64

949

6319

Degeneration of macula and posterior pole

2670

16567

1.32

35.19

3.2

2.9

246.62

235.55

ng/l

0.52

2447

15211

Intestinal stricture

1606

11686

1.42

35.10

3.1

3.0

217.12

225.40

ng/l

0.31

1471

10661

Other disorders of veins

1818

13387

1.38

34.97

2.9

2.7

220.37

192.48

ng/l

1.94

1631

12225

Mental and behavioural disorders due to psychoactive substance use

2599

18732

1.31

34.54

2.9

239.20

203.14

ng/l

1.66

2330

16968

Bronchiectasis

462

2558

1.94

34.47

3.5

2.9

205.90

216.99

ng/l

0.20

423

2334

Skin changes due to chronic exposure to nonionizing radiation

2244

15878

1.35

34.47

3.3

3.0

245.42

244.92

ng/l

0.02

2074

14601

Traumatic subdural haemorrhage

726

4337

1.68

34.43

3.4

2.7

281.40

286.75

ng/l

0.09

657

3996

Open wound of head

2567

19255

1.31

34.36

3.2

2.9

237.48

216.03

ng/l

1.44

2351

17475

Coxarthrosis, primary

3129

21145

1.28

34.00

3.0

2.9

202.66

229.16

ng/l

2.98

2873

19388

Other diseases of blood and blood-forming organs, wide

1042

7055

1.53

33.84

3.3

2.9

227.39

193.24

ng/l

1.62

950

6429

Other viral diseases, not elsewhere classified

741

4626

1.65

33.81

4.2

2.9

193.02

179.40

ng/l

0.38

671

4147

Diseases of inner ear

2629

19913

1.30

33.78

3.1

2.9

171.55

213.00

ng/l

5.81

2425

18187

Viral infections characterized by skin and mucous membrane lesions

1842

13733

1.37

33.64

3.5

2.9

197.27

193.09

ng/l

0.10

1670

12456

Preparatory care for dialysis

265

1221

2.40

33.50

2.7

2.9

889.51

193.81

ng/l

12.25

255

1114

Other infectious diseases

435

2382

1.95

33.42

4.1

3.0

286.41

232.70

ng/l

1.29

398

2167

Thyrotoxicosis

1122

7720

1.50

33.31

3.8

2.8

256.77

181.45

ng/l

2.90

1020

7014

Pruritus

523

3016

1.82

33.21

3.2

2.9

218.84

191.66

ng/l

0.65

486

2742

DVT of lower extremities

979

6580

1.55

33.17

3.0

2.9

220.58

218.26

ng/l

0.04

889

5998

Injuries to unspecified part of trunk, limb or body region

511

2934

1.84

33.13

3.3

2.9

279.56

204.38

ng/l

1.89

462

2656

Osteomyelitis

374

1964

2.05

32.87

4.0

2.9

381.99

220.43

ng/l

5.85

349

1797

Pneumonia due to other infectious organisms, not elsewhere classified

194

783

2.73

32.79

3.9

2.6

168.63

173.54

ng/l

0.07

180

710

Actinic keratosis

2188

15601

1.34

32.76

3.4

3.0

248.09

246.09

ng/l

0.07

2021

14346

Alcohol use disorder, Swedish definition

2452

17485

1.31

32.71

3.0

2.9

237.50

208.35

ng/l

1.52

2209

15866

Thyrotoxicosis, other and/or unspecified

877

5760

1.57

32.69

4.1

2.7

241.92

179.55

ng/l

2.56

800

5235

Volume depletion

527

3070

1.82

32.62

4.2

2.9

365.46

245.09

ng/l

4.49

478

2770

Other and unspecified injuries of head

378

1993

2.03

32.52

3.9

3.0

200.97

206.52

ng/l

0.10

352

1799

Other and unspecified coagulation defects

233

1019

2.45

32.50

3.0

2.9

224.81

169.58

ng/l

0.81

207

923

Viral infections characterized by skin and mucous membrane lesions

3762

26255

1.24

32.41

3.0

2.8

187.26

195.34

ng/l

0.43

3418

23802

Mood [affective] disorders

4463

23924

1.22

32.35

2.8

151.61

196.60

ng/l

9.69

3974

21718

Other and unspecified nonorganic psychotic disorders

659

4049

1.67

32.20

2.6

2.7

144.36

144.40

ng/l

0.00

571

3565

Other blood glucose lowering drugs, excl. Insulins

879

5824

1.58

32.20

3.2

2.8

220.33

218.02

ng/l

0.05

807

5335

Mood disorders

4475

23971

1.22

32.13

2.9

2.8

151.33

196.91

ng/l

9.98

3986

21760

Mycoses

3701

26279

1.24

31.95

2.9

2.8

195.73

192.11

ng/l

0.18

3337

23849

Disorders of psychological development

362

1725

2.01

31.89

5.1

3.3

170.76

165.32

ng/l

0.09

332

1501

Bipolar affective disorders

636

3889

1.68

31.65

2.7

114.66

145.93

ng/l

1.45

551

3484

Other and unspecified dermatitis

2276

17641

1.32

31.62

3.1

2.8

197.31

196.14

ng/l

0.04

2051

16067

Other viral diseases, not elsewhere classified

953

6358

1.53

31.61

3.8

2.9

174.87

167.42

ng/l

0.22

858

5679

Migraine with aura and triptan purchases

464

2601

1.83

31.56

2.5

2.7

69.19

125.29

ng/l

9.88

396

2317

Gastroduodenal ulcer

1383

9970

1.43

31.46

3.7

2.9

284.80

250.09

ng/l

1.48

1257

9112

Flat foot [pes planus] (acquired)

432

2392

1.90

31.41

3.2

2.8

183.05

179.31

ng/l

0.03

394

2169

Other diseases of liver

803

5226

1.60

31.41

3.0

2.8

218.96

174.17

ng/l

2.04

727

4734

Viral pneumonia (unknown virus, not influenza)

334

1705

2.08

31.36

4.2

2.7

243.22

183.18

ng/l

1.37

307

1553

Other disorders of eye and adnexa

605

3680

1.71

31.34

3.1

2.9

181.25

178.82

ng/l

0.04

557

3324

Other viral diseases

1292

9116

1.43

31.33

3.8

2.8

166.07

159.39

ng/l

0.25

1153

8155

Other coagulation defects

353

1837

2.04

31.31

3.7

2.9

271.67

197.14

ng/l

1.81

317

1664

Gastric ulcer

962

6527

1.53

31.20

3.7

2.9

286.30

237.38

ng/l

2.02

887

5966

Depression

4033

22480

1.23

31.15

2.9

2.8

149.53

190.28

ng/l

7.28

3588

20385

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

966

6518

1.51

31.03

2.9

2.7

129.20

149.38

ng/l

0.91

850

5820

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

861

5604

1.55

30.92

4.3

2.7

188.57

153.76

ng/l

1.19

772

5007

Abnormal blood-pressure reading, without diagnosis

193

791

2.60

30.89

2.7

2.2

186.65

157.80

ng/l

0.41

163

702

Disorders of vestibular function (Vertigo)

2270

17381

1.31

30.83

3.1

2.9

170.74

209.24

ng/l

4.58

2103

15885

Nonorganic sleeping disorders, excluding more controls

689

4331

1.63

30.73

2.7

172.94

171.58

ng/l

0.03

597

3889

2554

18189

1.29

30.60

3.0

2.9

239.40

208.65

ng/l

1.71

2309

16472

Trochanteric bursitis

669

4211

1.66

30.39

2.8

2.7

157.12

197.36

ng/l

2.08

602

3837

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

789

5173

1.60

30.33

3.1

216.34

217.40

ng/l

0.02

736

4732

Family history of certain disabilities and chronic diseases leading to disablement

176

694

2.67

30.31

2.5

2.1

108.42

95.26

ng/l

0.24

156

618

Glomerular diseases

866

5783

1.56

30.26

3.7

3.0

469.93

205.50

ng/l

16.86

809

5257

Myocardial infarction, unclassifiable

1343

8680

1.43

30.21

4.5

3.1

426.87

278.54

ng/l

10.79

1231

7925

Benign neoplasm: Stomach

529

3162

1.78

30.15

3.5

2.9

205.67

205.82

ng/l

0.00

474

2888

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1931

14673

1.34

30.05

3.0

2.9

231.90

205.06

ng/l

1.04

1738

13293

Other or unspecified ileus, impaction or obstruction

939

6379

1.53

30.03

3.1

2.9

225.22

230.51

ng/l

0.13

862

5822

Cardiomyopathy in other diseases

7.51

29.90

6.4

1.7

486.78

119.82

ng/l

3.00

Paracetamol or NSAID medication

713

2218

1.65

29.81

3.0

222.07

272.44

ng/l

1.84

636

2019

2653

18553

1.28

29.73

3.0

2.9

237.91

206.72

ng/l

1.83

2392

16812

Other and unspecified local infections of skin and subcutaneous tissue

466

2690

1.82

29.67

3.6

2.9

252.67

185.36

ng/l

2.25

422

2435

Sequelae of injuries of upper limb

433

2443

1.86

29.67

3.0

2.8

111.46

169.32

ng/l

5.76

403

2201

Primary_lymphoid and hematopoietic malignant neoplasms

1248

8970

1.44

29.66

3.3

3.0

248.22

225.83

ng/l

0.98

1152

8201

Abnormal involuntary movements

633

3959

1.67

29.63

3.5

2.8

173.93

198.60

ng/l

0.95

571

3602

Decubitus ulcer and pressure area

384

2111

1.97

29.56

4.5

3.1

353.62

253.14

ng/l

1.95

344

1934

Cirrhosis of liver, NAS

317

1638

2.11

29.53

4.2

2.9

275.56

213.56

ng/l

1.51

296

1506

Postprocedural endocrine and metabolic disorders, not elsewhere classified

476

2754

1.79

29.53

3.9

2.5

177.41

152.15

ng/l

0.54

432

2479

Abnormal findings on antenatal screening of mother

190

782

2.50

29.44

1.8

2.4

37.04

69.05

ng/l

2.63

172

686

Amyloidosis, other/unspecified

134

481

3.23

29.23

5.3

2.9

443.05

221.71

ng/l

3.20

127

445

Candidiasis

605

3751

1.68

29.21

3.8

2.9

219.01

185.13

ng/l

1.02

547

3405

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

458

2662

1.84

29.03

4.3

2.9

291.87

231.81

ng/l

1.72

427

2427

SLE (Finngen)

175

710

2.68

29.02

4.0

2.7

203.14

171.40

ng/l

0.39

162

639

Chronic periodontitis, complicated

2491

19583

1.29

28.94

2.8

201.74

192.12

ng/l

0.50

2245

17914

Speech and linguistic disorders

292

1390

2.09

28.82

5.0

3.6

181.73

180.37

ng/l

0.02

273

1215

Childhood asthma (age<16), excluding more controls

235

824

2.28

28.78

2.8

1.6

59.41

46.38

ng/l

0.55

185

679

Type 1 diabetes

980

6734

1.49

28.77

3.5

2.8

318.24

185.97

ng/l

8.69

917

6028

Alcohol abuse, main dg, excluding more controls

594

3674

1.67

28.62

3.2

2.7

207.47

186.03

ng/l

0.56

539

3296

Other congenital malformations

321

1659

2.02

28.59

3.3

3.5

151.19

170.68

ng/l

0.41

291

1479

Glomerular disorders in diseases classified elsewhere

589

3661

1.69

28.56

3.7

2.9

519.97

204.27

ng/l

18.06

552

3327

Type 1 diabetes, wide definition, subgroup 1

784

5166

1.56

28.38

3.6

2.7

302.85

167.94

ng/l

7.11

725

4621

Panic disorder

450

2590

1.78

28.04

3.3

2.6

124.19

135.47

ng/l

0.19

392

2289

Other diseases of arteries and capillaries

462

2709

1.80

28.03

3.1

2.9

277.30

199.84

ng/l

2.39

431

2453

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

318

1683

2.07

27.90

3.4

3.1

311.03

229.68

ng/l

1.72

287

1551

Other and unspecified effects of external causes

1012

7049

1.47

27.85

3.0

2.9

155.61

169.44

ng/l

0.57

896

6315

Schizophrenia or delusion

1196

8585

1.42

27.78

2.8

148.68

170.90

ng/l

1.05

1068

7673

Other disorders of binocular vision

181

4.52

27.55

2.7

2.4

66.98

115.52

ng/l

1.16

155

Other disorders of kidney and ureter

673

4358

1.62

27.52

3.4

3.0

339.07

209.43

ng/l

6.53

622

3981

Systemic lupus erythematosus, unspecified

150

581

2.82

27.47

3.8

2.8

216.63

165.30

ng/l

0.62

140

530

Other local infections of skin and subcutaneous tissue

483

2883

1.76

27.25

3.5

2.9

248.74

185.84

ng/l

2.11

435

2607

Elevated blood glucose level

408

2327

1.85

27.23

3.9

2.9

267.53

205.50

ng/l

0.98

375

2111

Diabetic retinopathy, excluding more controls

1242

4997

1.44

27.12

3.7

2.9

289.68

195.29

ng/l

7.67

1152

4493

Agoraphobia

108

348

3.28

27.03

2.6

2.4

102.04

97.18

ng/l

0.07

100

304

ILD medications: pirfenidone

313

3.95

27.00

4.6

2.8

139.20

188.91

ng/l

0.97

289

Fracture of femur

1541

10522

1.37

26.96

3.4

3.1

338.92

254.41

ng/l

5.97

1390

9608

Pulmonary oedema

146

573

2.95

26.95

5.6

3.1

548.59

253.17

ng/l

5.07

134

529

Alcohol use disorder, ICD-based

1765

13527

1.33

26.85

3.0

2.9

222.25

203.92

ng/l

0.58

1593

12250

Systemic lupus erythematosus

175

737

2.57

26.84

4.0

2.7

203.14

172.57

ng/l

0.37

162

668

Mental and behavioural disorders due to alcohol

2195

16616

1.29

26.76

2.9

236.24

206.17

ng/l

1.39

1981

15054

Follicular cysts of skin and subcutaneous tissue

799

5377

1.54

26.75

3.2

2.8

197.91

189.43

ng/l

0.17

719

4869

Disorders of continuity of bone

412

2365

1.82

26.58

2.8

186.86

167.39

ng/l

0.14

370

2130

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2475

13377

1.28

26.57

2.9

3.0

240.40

223.31

ng/l

0.91

2262

12253

Suppurative and necrotic conditions of lower respiratory tract

313

1666

2.02

26.55

3.9

3.0

280.90

225.19

ng/l

1.10

289

1521

Dermatitis and eczema

4937

25999

1.19

26.53

3.0

2.9

188.60

203.29

ng/l

1.40

4459

23575

Oter anti-inflammatory and antirheumatic agents, non-steroids

1233

4886

1.43

26.51

2.9

3.4

246.29

314.72

ng/l

4.26

1107

4510

Pyothorax

253

1254

2.20

26.48

3.7

3.0

275.25

232.87

ng/l

0.67

232

1136

Pneumocystosis

134

509

3.05

26.40

3.6

3.0

166.22

199.84

ng/l

0.51

124

466

Other embolism and thrombosis

635

4098

1.62

26.15

2.9

194.22

209.62

ng/l

0.39

568

3729

Benign neoplasm: Small intestine

245

1212

2.23

26.01

3.4

2.9

214.80

217.05

ng/l

0.03

221

1119

Amyloidosis

149

598

2.81

25.99

5.2

2.9

433.12

223.62

ng/l

3.34

138

550

Cervicalgia

894

6181

1.49

25.95

3.0

2.7

159.65

207.71

ng/l

3.68

806

5616

Dislocation, sprain and strain of joints and ligaments of knee

2215

16126

1.28

25.88

2.7

140.35

160.78

ng/l

2.16

2012

14504

Hyperplasia of prostate

1823

7929

1.34

25.88

3.0

215.40

252.87

ng/l

2.46

1660

7208

Raynaud syndrome

357

1984

1.89

25.74

2.9

139.52

169.57

ng/l

0.69

319

1781

Cytomegalovirus infection, IBD co-morbidity

130

487

2.98

25.73

6.9

3.5

261.89

176.09

ng/l

1.28

121

440

Stomatitis and related lesions

804

5457

1.52

25.69

3.2

2.9

202.73

181.33

ng/l

0.48

722

4940

Dissection of aorta

207

966

2.37

25.53

3.8

3.0

253.16

216.89

ng/l

0.64

197

878

Osteonecrosis due to drugs

111

390

3.38

25.49

3.8

3.1

204.23

202.18

ng/l

0.02

103

359

Pain associated with micturition

541

3381

1.67

25.48

3.2

3.0

153.30

202.32

ng/l

3.29

491

3074

SLE, strict definition

168

713

2.55

25.38

4.1

2.8

208.30

167.16

ng/l

0.52

156

647

SLE, ICD10

168

713

2.55

25.38

4.1

2.8

208.30

167.16

ng/l

0.52

156

647

Cholecystitis

740

4971

1.55

25.37

3.5

3.0

218.49

245.49

ng/l

0.96

671

4537

Unspecified mental disorder

1525

11529

1.35

25.35

2.8

130.89

179.85

ng/l

6.08

1343

10361

Presbycusis

891

6173

1.50

25.24

3.6

3.1

255.90

292.50

ng/l

1.79

817

5645

Diseases of the myoneural junction and muscle

617

3994

1.62

25.24

3.0

232.60

223.49

ng/l

0.17

558

3623

Vascular dementia

606

3777

1.64

25.21

4.0

3.4

344.79

336.38

ng/l

0.14

561

3445

1767

11929

1.33

25.21

3.4

3.0

259.82

259.21

ng/l

0.02

1621

10958

Schizophrenia, schizotypal and delusional disorders

1188

8664

1.40

25.14

2.8

147.68

170.82

ng/l

1.12

1061

7746

Cytomegaloviral disease

130

493

2.92

25.07

6.9

3.4

261.89

176.57

ng/l

1.27

121

445

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

721

4837

1.55

24.95

3.7

2.9

287.93

210.29

ng/l

1.70

673

4397

Kyphosis

301

3.61

24.87

4.2

3.2

162.05

209.56

ng/l

0.72

276

Childhood asthma (age<16)

236

882

2.14

24.84

2.8

2.0

59.41

74.55

ng/l

0.51

185

734

Impotence

302

1627

2.00

24.74

4.4

2.9

222.37

231.26

ng/l

0.13

286

1491

Problems related to lifestyle

399

2316

1.79

24.55

3.1

2.8

192.16

157.86

ng/l

0.83

355

2073

Arterial embolism and thrombosis

340

1903

1.91

24.53

4.6

2.9

351.55

236.69

ng/l

3.45

320

1735

Any dementia, excluding more controls

2068

11241

1.30

24.47

3.2

3.0

246.58

262.29

ng/l

0.64

1908

10347

Other/unspecified cytomegaloviral diseases

112

399

3.15

24.41

7.2

3.6

254.63

171.86

ng/l

1.27

104

360

Glaucoma

2860

20179

1.24

24.39

3.2

2.9

209.91

231.99

ng/l

1.86

2636

18486

Charcot foot

277

3.55

24.15

3.6

2.1

394.91

106.28

ng/l

4.80

250

Other enthesopathies

1176

8624

1.39

24.14

2.8

2.7

152.12

185.50

ng/l

2.09

1058

7846

Deviated nasal septum

1411

10641

1.35

24.05

2.7

2.9

165.55

207.34

ng/l

1.69

1260

9723

Other congenital malformations

448

2700

1.71

23.90

3.0

3.2

163.91

169.41

ng/l

0.11

402

2410

Substance use, excluding alcohol

701

4688

1.53

23.87

2.8

202.28

159.45

ng/l

0.59

608

4169

Protozoal diseases

172

768

2.47

23.57

3.6

2.9

184.59

202.00

ng/l

0.25

158

697

Benign paroxysmal vertigo

1391

10537

1.36

23.54

3.2

2.8

151.03

204.66

ng/l

8.26

1280

9624

Vascular dementia (mixed)

157

685

2.66

23.46

4.7

3.2

297.35

321.67

ng/l

0.23

149

627

Recurrent aphthous stomatitis , including avohilmo

611

4004

1.58

23.33

3.3

3.0

209.98

186.19

ng/l

0.43

544

3636

Other shoulder lesions

382

2226

1.79

23.33

2.9

2.8

162.05

174.40

ng/l

0.18

347

2012

Fentanyl

531

3372

1.64

23.33

3.7

2.8

220.76

255.44

ng/l

1.14

497

3055

Other specified and unspecified personality disorders

310

1696

1.90

23.28

2.7

157.72

136.87

ng/l

0.34

277

1509

Fracture of shoulder and upper arm

1643

12727

1.32

23.10

3.2

3.0

226.97

210.18

ng/l

0.72

1491

11558

Immunodeficiencies

215

1050

2.18

23.01

3.9

2.8

178.13

178.06

ng/l

0.00

194

954

Unspecified visual impairment (binocular)

105

375

3.19

23.00

3.6

2.8

281.40

212.77

ng/l

0.61

343

Glaucoma suspect

1796

14123

1.30

22.97

3.4

2.9

183.78

217.69

ng/l

3.30

1656

12955

Abnormal results of function studies

389

2295

1.78

22.97

3.8

2.8

247.41

186.46

ng/l

1.46

356

2080

Neuroendocrine tumor and carcinoma of small intestine

102

362

3.31

22.96

3.5

3.3

111.65

223.04

ng/l

4.08

334

Sulfasalazine

1128

8288

1.39

22.91

2.8

2.5

186.08

182.27

ng/l

0.12

1024

7509

Other diseases of stomach and duodenum

341

1949

1.86

22.88

3.4

2.9

208.15

201.40

ng/l

0.11

300

1777

Lesion of ulnar nerve

596

3905

1.58

22.77

3.4

2.8

185.99

186.48

ng/l

0.01

541

3552

Malignant neoplasm of small intestine, including Hilmo

191

906

2.33

22.74

3.4

3.0

136.08

211.66

ng/l

3.70

177

833

Impingement syndrome of shoulder

1014

7345

1.42

22.73

3.0

2.7

147.14

188.86

ng/l

3.40

914

6708

Other and unspecified visual disturbances

459

2837

1.69

22.72

3.1

2.8

171.78

188.78

ng/l

0.42

413

2573

Kela-code for severe mental illness

1376

10425

1.34

22.69

2.8

127.21

180.16

ng/l

6.82

1212

9372

Disorders of the thyroid gland

4171

23081

1.19

22.67

3.3

2.8

204.37

207.25

ng/l

0.13

3788

20986

Fall on and from stairs and steps

1143

8453

1.39

22.58

2.8

2.9

203.17

195.33

ng/l

0.21

1033

7663

Ptosis of eyelid

579

3797

1.60

22.57

2.8

3.0

176.44

210.60

ng/l

1.38

512

3471

Fall involving bed

223

1129

2.19

22.53

4.0

3.2

299.26

270.78

ng/l

0.23

205

1038

Chronic pancreatitis

582

3816

1.59

22.43

2.9

2.8

222.81

197.62

ng/l

0.49

534

3464

Embolic stroke

299

1660

1.94

22.39

3.6

3.2

358.50

280.39

ng/l

1.11

278

1516

Vascular diseases of the intestine

239

1235

2.10

22.37

4.2

3.0

455.33

228.21

ng/l

4.97

221

1123

Hepatic failure, not elsewhere classified

208

1022

2.21

22.30

3.4

3.0

323.82

214.47

ng/l

1.69

193

935

Bronchitis, not specified as acute or chronic

387

2300

1.76

22.18

3.8

2.8

195.40

214.96

ng/l

0.37

341

2074

Patent foramen ovale

112

418

2.94

22.18

3.7

3.8

179.92

173.60

ng/l

0.05

381

Disorders of sclera, cornea, iris and ciliary body

2297

18610

1.25

22.12

3.1

2.9

177.60

195.27

ng/l

1.20

2081

16899

Asthma mixed form (mode), excluding more controls

191

898

2.22

22.12

3.9

1.9

113.31

113.89

ng/l

0.01

171

803

Fracture of forearm

2345

17421

1.25

22.08

2.9

2.8

202.30

187.23

ng/l

0.75

2136

15781

Basal cell carcinoma, including avohilmo

2316

12899

1.26

22.07

2.9

3.0

242.85

224.53

ng/l

0.87

2122

11827

Diseases of male genital organs

2301

9306

1.27

22.00

3.1

3.0

193.67

233.76

ng/l

3.81

2064

8345

Diabetic nephropathy

847

5947

1.47

21.93

4.2

3.4

474.45

240.16

ng/l

15.59

798

5418

Carbimazole or st.post thyroidectomy, condition for graves disease

820

5773

1.46

21.67

4.0

2.7

222.76

166.97

ng/l

1.97

739

5243

Recurrent or chronic depression

1389

7396

1.34

21.66

2.6

2.7

127.67

163.60

ng/l

3.20

1240

6660

Injury of unspecified body region

365

2156

1.78

21.63

3.6

2.9

295.53

206.69

ng/l

2.05

334

1943

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2316

12866

1.26

21.61

2.9

3.0

245.39

225.07

ng/l

1.14

2125

11800

Acute posthaemorrhagic anaemia

210

1050

2.17

21.54

4.1

2.9

373.99

225.91

ng/l

2.87

199

959

Lichen simplex chronicus and prurigo

308

1738

1.88

21.53

2.9

2.8

221.02

191.14

ng/l

0.45

281

1575

Dialysis

196

952

2.21

21.48

4.9

3.0

843.35

166.69

ng/l

9.88

183

861

Zoster [herpes zoster]

895

6430

1.44

21.47

3.6

3.0

238.72

219.76

ng/l

0.30

813

5863

Noninfective enteritis and colitis

1899

15095

1.28

21.41

3.1

2.9

218.56

194.10

ng/l

1.19

1712

13652

Hyperkinetic disorders, excluding more controls

223

1066

2.04

21.36

3.7

2.5

123.05

97.21

ng/l

0.36

184

910

Disorders resulting from impaired renal tubular function

197

968

2.21

21.17

3.3

3.2

585.53

211.56

ng/l

8.03

183

883

Inguinal hernia

2710

14922

1.23

21.10

3.1

3.0

242.79

216.28

ng/l

1.74

2472

13516

Other overlap syndromes

102

374

3.03

21.08

2.7

2.9

77.42

185.00

ng/l

6.05

340

Alzheimer’s disease (Late onset), excluding more controls

842

3895

1.47

21.07

3.1

2.6

216.88

273.32

ng/l

3.03

774

3591

Other aneurysm

298

1683

1.89

20.98

3.7

2.9

298.47

215.10

ng/l

2.03

278

1550

Immunodeficiency with predominantly antibody defects

122

489

2.70

20.89

3.9

2.7

188.18

167.29

ng/l

0.17

105

443

Hypertensive Renal Disease

193

942

2.20

20.87

3.1

2.4

627.59

234.93

ng/l

3.67

179

849

Striking against or struck by other objects

1221

9200

1.35

20.84

3.2

2.9

175.25

173.62

ng/l

0.05

1075

8248

Fitting and adjustment of other devices

1670

11858

1.30

20.82

3.2

2.6

211.30

221.78

ng/l

0.47

1501

10835

Suicide or other Intentional self-harm

833

5912

1.44

20.80

3.0

2.7

137.95

156.25

ng/l

0.68

735

5288

Other inflammation of eyelid

593

3963

1.55

20.78

3.0

2.9

162.97

191.58

ng/l

1.51

536

3613

Mental and behavioural disorders due to opioids

127

516

2.59

20.72

2.6

2.8

116.54

130.94

ng/l

0.19

108

434

Acidosis

121

489

2.74

20.70

3.2

2.8

400.11

190.44

ng/l

2.20

109

449

Adverse effects, not elsewhere classified

706

4871

1.49

20.70

3.0

2.9

150.50

166.17

ng/l

0.53

627

4397

Disorders of ocular muscles, binocular movement, accommodation and refraction

1734

13582

1.28

20.68

3.2

2.8

157.25

179.20

ng/l

1.59

1560

12266

Glucosamine medication

2483

16307

1.24

20.55

2.9

3.0

213.57

226.22

ng/l

0.73

2271

14987

Umbilical hernia

1149

8629

1.36

20.50

3.2

2.9

236.34

194.75

ng/l

1.92

1045

7852

Zoster [herpes zoster]

2302

18534

1.24

20.47

3.1

2.9

210.52

210.39

ng/l

0.00

2112

16947

Neuralgia and neuritis, unspecified

235

1235

2.01

20.47

2.7

2.9

156.98

188.46

ng/l

0.59

213

1109

Carcinoid syndrome

244

3.74

20.46

4.0

2.9

97.12

192.48

ng/l

3.17

218

Exclusions for E4_PCOS_BROAD

658

4491

1.51

20.45

3.4

3.0

141.62

177.27

ng/l

2.08

593

4051

Rheumatoid arthritis, including avohilmo

1722

13657

1.29

20.36

2.9

2.8

193.96

200.45

ng/l

0.29

1571

12451

Lack of expected normal physiological development

155

3.85

20.36

8.0

4.9

172.81

187.07

ng/l

0.08

131

Ocular pain

328

1907

1.79

20.35

3.3

2.9

129.25

173.14

ng/l

1.95

300

1712

Urticaria and erythema

1338

10256

1.33

20.34

3.3

2.8

166.88

171.98

ng/l

0.19

1187

9274

Artificial joint re-operation

385

2361

1.74

20.30

3.0

193.21

209.59

ng/l

0.37

357

2161

Mental and behavioural disorders due to sedatives or hypnotics

257

1389

1.93

20.29

2.4

2.7

143.62

167.12

ng/l

0.38

217

1231

Type 1 diabetes, wide definition

803

5686

1.44

20.24

3.6

2.7

316.22

179.74

ng/l

7.23

744

5083

Nonalcoholic fatty liver disease

376

2272

1.72

20.22

2.4

2.8

155.32

159.00

ng/l

0.06

334

2045

Diplopia

600

4048

1.54

20.19

3.4

2.9

175.96

202.77

ng/l

0.88

539

3676

Alzheimer’s disease (Atypical or mixed), excluding more controls

504

2597

1.62

20.18

3.8

2.8

247.39

317.59

ng/l

2.66

472

2384

Malignant neoplasm of small intestine

143

635

2.53

20.18

3.5

3.2

122.84

216.54

ng/l

4.64

132

588

Pneumonia derived septicemia

178

855

2.24

20.15

4.6

2.9

338.25

213.55

ng/l

2.10

162

788

Postmenopausal osteoporosis with pathological fracture

380

2334

1.75

20.10

4.3

3.0

219.15

222.70

ng/l

0.05

356

2125

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

920

6721

1.42

20.09

2.7

3.1

158.30

219.97

ng/l

5.96

846

6173

Erectile dysfunction

454

2907

1.66

20.07

8.2

3.0

300.39

237.19

ng/l

1.32

423

2677

Other disorders of adrenal gland

209

1064

2.09

20.05

5.3

3.1

123.68

195.94

ng/l

2.70

193

963

Other dialysis

161

748

2.35

19.99

3.9

3.3

771.82

195.53

ng/l

8.00

151

678

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

371

2251

1.73

19.99

3.4

3.0

256.66

208.45

ng/l

1.20

344

2043

Molar incisor enamel hypoplasia

102

363

2.84

19.93

9.7

4.2

240.03

129.57

ng/l

1.19

315

Exposure to other specified factors

3015

23236

1.20

19.81

2.7

2.9

190.36

183.89

ng/l

0.35

2676

21066

Basal cell carcinoma

2234

12602

1.25

19.80

2.9

3.0

247.46

227.06

ng/l

0.98

2045

11560

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

501

3246

1.58

19.79

2.8

2.7

122.97

136.40

ng/l

0.45

446

2874

Other necrotizing vasculopathies (FG)

306

1770

1.83

19.77

3.3

2.8

208.67

211.89

ng/l

0.04

278

1622

Any dementia

2241

12721

1.25

19.74

3.3

3.1

258.72

264.19

ng/l

0.17

2064

11719

Cerebral palsy and other paralytic syndromes

485

3139

1.60

19.71

3.4

3.0

197.46

207.73

ng/l

0.21

422

2844

Necrosis of pulp, including avohilmo

2113

17125

1.25

19.65

2.6

2.7

137.28

167.29

ng/l

4.47

1886

15452

Fracture of foot, except ankle

890

6464

1.41

19.52

3.0

2.8

169.88

165.21

ng/l

0.13

800

5810

Acute pancreatitis

888

6467

1.41

19.51

3.1

2.9

238.57

214.65

ng/l

0.83

819

5865

Seborrhoeic keratosis

1087

8180

1.37

19.49

3.1

2.8

190.11

204.70

ng/l

0.62

997

7509

Adrenocortical insufficiency

176

853

2.22

19.44

5.9

3.2

111.84

183.59

ng/l

2.72

163

773

Excessive, frequent and irregular menstruation

1374

5754

1.33

19.38

2.9

2.7

138.18

200.28

ng/l

7.33

1256

5220

Acute bronchiolitis

174

742

2.18

19.36

6.2

4.0

232.86

181.52

ng/l

0.67

162

646

KRA_PSY_EATING, excluding more controls

170

797

2.17

19.28

2.3

2.4

57.18

90.34

ng/l

2.06

139

704

Other problems related to primary support group, including family circumstances

326

1858

1.75

19.23

5.7

3.1

201.89

137.40

ng/l

1.22

295

1642

Cervicocranial syndrome

434

2752

1.63

19.20

2.8

2.7

141.63

194.81

ng/l

2.65

393

2481

Social phobias

218

1131

1.98

19.11

2.4

2.5

101.45

114.55

ng/l

0.30

188

982

Need for other prophylactic measures

263

1468

1.89

19.05

3.0

179.92

188.58

ng/l

0.13

225

1324

Retinal detachments and breaks

1722

13781

1.28

19.04

3.0

2.9

215.34

215.68

ng/l

0.01

1584

12606

Dermatopolymyositis (FG)

305

3.17

19.03

4.4

3.1

182.30

200.38

ng/l

0.18

288

Malignant neoplasm of skin

2430

13742

1.23

18.98

2.8

3.0

242.45

221.16

ng/l

1.22

2219

12570

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

418

2316

1.63

18.95

4.2

2.9

110.81

109.30

ng/l

0.03

355

1960

Pyogenic arthritis

318

1878

1.78

18.89

3.9

2.9

360.07

211.10

ng/l

1.33

291

1718

Somnolence, stupor and coma

207

1073

2.05

18.88

4.0

3.0

236.62

241.51

ng/l

0.06

192

971

Follow-up examination after treatment for malignant neoplasms

471

3062

1.60

18.83

3.0

2.6

234.39

225.63

ng/l

0.12

440

2819

Drug-induced thyroiditis

9.13

18.76

4.7

2.5

265.86

103.73

ng/l

2.08

Sequelae of injuries of lower limb

378

2336

1.68

18.69

2.5

2.8

175.85

174.12

ng/l

0.03

334

2102

Retinal vascular occlusion

657

4599

1.49

18.68

3.4

3.0

264.45

232.81

ng/l

0.90

617

4213

Amputation of foot

167

817

2.27

18.58

4.2

3.1

515.88

234.89

ng/l

5.73

158

745

Nonorganic sleeping disorders

689

4829

1.46

18.57

2.7

2.9

172.94

165.20

ng/l

0.17

597

4332

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

250

1378

1.89

18.57

3.3

2.8

187.58

187.46

ng/l

0.00

223

1234

Pneumothorax

343

2081

1.73

18.53

3.7

2.8

290.55

229.64

ng/l

0.44

316

1904

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

210

1092

1.99

18.47

3.0

2.8

109.27

139.51

ng/l

0.64

179

942

Other sleep disorders

445

2864

1.61

18.46

3.0

2.7

182.36

206.52

ng/l

0.40

389

2601

Other noninfective gastroenteritis and colitis

1038

7796

1.36

18.44

3.3

3.0

237.69

199.78

ng/l

1.31

935

7054

Ovarian cyst

1267

5573

1.33

18.40

2.6

2.7

149.68

194.86

ng/l

3.19

1149

5067

Benign neoplasm: Other and unspecified parts of small intestine

107

436

2.79

18.33

3.4

3.1

191.41

198.23

ng/l

0.07

405

Malignant neoplasm of digestive organs

1913

12238

1.26

18.32

3.0

3.1

216.39

229.82

ng/l

0.65

1742

11215

Specific development disorders of speech and language

210

1056

1.99

18.27

5.0

3.5

192.73

204.45

ng/l

0.18

200

929

Extrapyramidal and movement disorders

1801

14554

1.26

18.24

2.9

3.0

192.55

220.78

ng/l

2.37

1635

13320

Other disorders of skin and subcutaneous tissue, not elsewhere classified

657

4602

1.48

18.23

4.1

2.9

313.23

205.31

ng/l

3.44

594

4184

Inflammatory disease of uterus

413

2617

1.62

18.05

2.3

2.6

85.76

135.96

ng/l

4.19

369

2355

Symptoms and signs involving emotional state

120

509

2.50

18.05

4.6

3.3

241.87

173.45

ng/l

0.76

108

459

Alcohol abuse, main dg

594

4079

1.50

18.04

3.2

2.9

207.47

176.03

ng/l

0.98

539

3654

Reactive arthropathies

352

2157

1.69

17.97

2.7

2.9

160.92

183.99

ng/l

0.55

318

1956

Ulcer of oesophagus

370

2313

1.69

17.95

4.1

2.8

234.14

219.90

ng/l

0.27

344

2121

Combinations of oral blood glucose lowering drugs

1273

9897

1.32

17.90

3.3

2.7

199.53

201.77

ng/l

0.07

1166

9074

1253

9161

1.33

17.89

3.5

3.1

254.43

258.57

ng/l

0.10

1162

8399

Assault

397

2498

1.63

17.87

2.6

2.8

129.02

136.20

ng/l

0.16

359

2166

Hypoplasia of dental enamel , including avohilmo

343

2.79

17.84

9.1

4.5

207.40

139.74

ng/l

0.56

298

Injuries to the ankle and foot

2583

19181

1.21

17.84

2.9

2.8

176.12

171.17

ng/l

0.25

2305

17294

Cluster headache, strict

132

586

2.37

17.82

2.0

2.5

83.97

152.73

ng/l

2.99

116

521

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

559

2364

1.52

17.77

2.2

56.03

71.10

ng/l

1.22

489

2070

Retinal vascular disorders

663

4692

1.47

17.74

3.4

3.0

263.14

237.73

ng/l

0.67

623

4299

Personal history of other diseases and conditions

295

1715

1.75

17.67

4.8

2.3

201.40

114.73

ng/l

2.80

267

1518

Other diseases of lip and oral mucosa

1618

12956

1.27

17.57

2.6

2.8

153.95

180.00

ng/l

2.31

1448

11785

Panniculitis affecting regions of neck and back

170

843

2.14

17.56

2.6

2.8

154.26

207.31

ng/l

1.20

152

761

Other diseases of oesophagus

471

3117

1.58

17.56

3.5

2.9

208.89

226.82

ng/l

0.43

434

2850

Traumatic subarachnoid haemorrhage

194

1012

2.05

17.54

2.7

2.6

257.78

238.44

ng/l

0.22

173

921

Polymyalgia rheumatica

725

5225

1.45

17.51

3.2

3.0

220.43

234.38

ng/l

0.44

660

4785

Anankastic personality disorder

134

603

2.33

17.49

2.5

2.6

73.02

131.18

ng/l

2.21

123

538

Hypotension due to drugs

107

448

2.74

17.49

4.6

3.2

263.65

261.22

ng/l

0.02

413

Mental retardation, excluding more controls

142

636

2.28

17.46

2.7

3.2

164.87

167.16

ng/l

0.02

134

574

Other hearing loss

1463

11365

1.29

17.42

3.4

3.0

223.71

263.48

ng/l

3.28

1352

10371

Pure hyperglyceridaemia

121

529

2.49

17.39

3.4

2.7

240.42

187.80

ng/l

0.51

106

480

Radiculopathy

735

5292

1.43

17.37

3.2

2.8

167.43

232.45

ng/l

6.50

673

4832

Drug-induced adrenocortical insufficiency

390

2.78

17.33

6.9

3.8

126.90

192.68

ng/l

1.01

355

Other mental disorders due to brain damage and dysfunction and to physical disease

619

4346

1.49

17.32

3.4

3.2

195.00

244.73

ng/l

1.90

576

3976

Dermatopolymyositis

327

2.97

17.31

4.3

3.3

182.30

175.53

ng/l

0.06

303

Secondary and unspecified malignant neoplasm of lymph nodes

402

2581

1.63

17.28

3.4

3.1

277.33

212.63

ng/l

1.74

377

2363

Menorrhagia

1290

5521

1.32

17.25

2.8

2.7

149.84

205.17

ng/l

5.15

1184

5029

Caries of enamel

2542

21847

0.83

17.16

2.7

2.8

142.53

170.45

ng/l

4.34

2256

19779

Pneumonia due to Streptococcus pneumoniae

188

974

2.04

17.15

3.7

2.6

229.06

188.84

ng/l

0.59

169

879

Schizoaffective disorder

259

1477

1.82

17.15

2.7

2.9

120.90

143.66

ng/l

0.52

229

1313

Parkinson's disease, strict definition, excluding more controls

611

4065

1.48

17.12

3.1

2.6

215.71

263.69

ng/l

2.06

555

3752

Other disorders of binocular movement

389

2.70

17.11

3.0

145.43

160.11

ng/l

0.14

343

Superficial injury of hip and thigh

711

5111

1.43

17.03

3.5

3.0

257.62

232.94

ng/l

0.66

643

4632

Disorders of muscles

417

2697

1.60

17.02

3.2

2.8

188.21

195.07

ng/l

0.13

376

2432

Cluster headache, wide

141

656

2.26

17.00

2.2

2.5

91.74

161.92

ng/l

3.25

123

585

Osteonecrosis

300

1802

1.76

16.99

3.6

2.8

174.80

187.47

ng/l

0.25

270

1629

Benign neoplasm of other and unspecified endocrine glands

568

3926

1.50

16.97

3.1

2.9

201.77

181.31

ng/l

0.55

527

3570

Weight loss

468

3124

1.56

16.81

3.2

2.9

235.45

212.08

ng/l

0.51

433

2839

Fibroblastic disorders

1045

7979

1.34

16.77

3.1

2.9

221.01

235.71

ng/l

0.27

966

7308

Other extrapyramidal and movement disorders in other diseases

1070

8207

1.34

16.74

2.9

182.30

201.48

ng/l

0.98

982

7507

Postprocedural disorders of digestive system, not elsewhere classified

174

891

2.10

16.73

3.0

3.1

224.24

217.26

ng/l

0.07

154

818

Scoliosis

309

1864

1.71

16.70

3.1

2.8

145.22

194.70

ng/l

2.48

287

1668

Blepharochalasis

1388

11013

1.29

16.68

3.1

2.8

179.35

209.70

ng/l

1.94

1257

10110

Shoulder region

334

2.92

16.67

3.7

3.0

183.78

206.21

ng/l

0.29

303

Other localized connective tissue disorders

105

440

2.62

16.64

4.1

3.0

303.72

176.91

ng/l

0.48

404

Lung diseases due to external agents

713

5162

1.43

16.56

3.8

3.1

259.79

260.09

ng/l

0.01

655

4721

Parkinson's disease, excluding more controls

641

4280

1.46

16.55

3.0

2.6

215.88

258.93

ng/l

1.82

582

3952

Other obstetric conditions, not elsewhere classified

572

2476

1.48

16.42

2.2

55.83

71.47

ng/l

1.34

500

2172

Ill-defined and unknown causes of mortality

179

3291

0.52

16.37

3.7

3.1

416.42

266.55

ng/l

2.42

166

3013

Open wound of ankle and foot

418

2731

1.58

16.34

3.2

2.9

247.72

190.11

ng/l

1.88

378

2458

Progressive vascular leukoencephalopathy

258

1521

1.85

16.33

2.8

3.2

303.06

263.27

ng/l

0.92

243

1390

Other and unspecified tonsillitis

922

5789

1.36

16.30

3.1

2.6

133.10

136.82

ng/l

0.10

803

5108

Unspecified misadventure during surgical and medical care

264

1553

1.80

16.17

3.7

2.9

233.81

208.81

ng/l

0.41

242

1413

Hypothyroidism, strict autoimmune

3089

17342

1.18

16.12

3.1

2.7

188.84

205.23

ng/l

1.45

2811

15743

Event of undetermined intent

233

1315

1.84

16.10

2.7

2.9

152.52

174.55

ng/l

0.47

207

1185

Intestinal adhesions without obstruction

405

2647

1.60

16.06

2.9

2.8

194.81

205.80

ng/l

0.21

372

2419

Fracture of skull and facial bones

841

6257

1.37

16.03

3.1

2.8

215.21

188.36

ng/l

0.83

767

5618

Pneumococcal septicemia

167

855

2.09

16.01

4.5

3.0

313.39

218.90

ng/l

1.49

153

785

Disorders of tooth development and eruption

551

3068

1.48

15.93

4.1

2.7

171.31

182.84

ng/l

0.31

499

2749

Viral warts

361

2293

1.63

15.92

3.4

2.8

162.75

168.69

ng/l

0.11

334

2066

Other inflammatory liver diseases

289

1748

1.73

15.80

3.5

2.8

258.18

188.34

ng/l

0.90

250

1577

Lesion of lateral popliteal nerve

228

1293

1.86

15.80

2.7

2.8

156.35

208.88

ng/l

1.42

205

1190

Other secondary gonarthrosis

249

1450

1.81

15.79

4.0

2.9

170.21

203.67

ng/l

0.96

233

1316

Coxibs

1290

5297

1.30

15.78

2.9

3.4

225.77

300.36

ng/l

5.48

1150

4859

Other enthesopathy of foot (+metatarsalgia)

389

2522

1.59

15.70

2.9

2.7

120.24

173.37

ng/l

3.32

354

2277

Fissure and fistula of anal and rectal regions

951

7226

1.34

15.69

2.6

2.7

192.87

187.14

ng/l

0.13

851

6554

Acetic acid derivatives and related substances

1301

5276

1.30

15.67

2.8

3.4

229.55

301.16

ng/l

4.45

1153

4841

Hydronephrosis

512

3525

1.50

15.66

3.2

2.7

248.22

190.84

ng/l

2.43

473

3202

D07AA Corticosteroids, weak (group I)

521

3577

1.49

15.66

2.8

3.2

170.56

179.22

ng/l

0.19

465

3196

Superficial injury of abdomen, lower back and pelvis

595

4202

1.45

15.64

3.2

2.9

225.01

193.55

ng/l

0.94

539

3759

Polymyositis

170

3.74

15.54

4.8

3.5

183.76

191.54

ng/l

0.06

159

Mixed and other personality disorders

240

1378

1.80

15.49

2.4

2.8

121.39

124.61

ng/l

0.05

201

1208

Intussusception

109

479

2.47

15.48

2.8

2.5

103.12

167.30

ng/l

1.52

103

444

Embedded teeth, including avohilmo

230

1301

1.81

15.47

3.3

2.8

126.41

125.74

ng/l

0.01

206

1132

Overexertion and strenuous or repetitive movements

381

2471

1.59

15.42

2.6

2.9

147.62

174.30

ng/l

0.77

330

2217

Urticaria

1024

7871

1.32

15.40

3.5

2.8

162.35

165.04

ng/l

0.08

907

7102

Anaemia in chronic diseases classified elsewhere

141

694

2.23

15.37

6.8

3.4

427.99

194.89

ng/l

4.81

131

631

Hypothyroidism, other/unspecified

3778

21621

1.16

15.32

3.1

2.8

188.47

206.27

ng/l

1.81

3433

19670

Faecal incontinence

425

2835

1.56

15.32

2.7

2.6

150.85

195.23

ng/l

2.15

384

2573

Occupational exposure to risk-factors

173

914

2.03

15.25

4.6

2.8

177.23

197.87

ng/l

0.24

165

825

Abnormal weight loss

433

2908

1.55

15.20

3.3

2.9

230.32

214.33

ng/l

0.31

399

2653

Suggestive for eosinophilic asthma

389

2549

1.58

15.17

3.3

2.8

139.31

200.31

ng/l

4.41

344

2315

Thyroiditis, ILD-related definition

411

2717

1.56

15.15

2.8

171.81

158.51

ng/l

0.32

374

2464

Disorders of mineral metabolism

345

2200

1.63

15.14

3.5

2.7

241.32

183.27

ng/l

0.96

305

1997

Other female pelvic inflammatory diseases

583

4129

1.45

15.10

2.7

142.53

155.45

ng/l

0.33

532

3749

Malignant neoplasm of gum, including Hilmo

267

3.14

15.10

2.2

3.5

162.15

261.53

ng/l

1.11

250

Diseases of peritoneum

459

3120

1.53

15.08

3.4

2.9

337.16

212.89

ng/l

4.19

425

2833

Chondrocostal junction syndrome [Tietze]

168

879

2.03

15.04

3.4

2.8

166.12

198.02

ng/l

0.61

151

798

Fracture at wrist and hand level

1303

10338

1.28

15.03

3.0

2.8

166.02

178.69

ng/l

0.57

1182

9296

Acute pancreatitis (for exclusion)

888

6741

1.35

15.01

3.1

2.9

238.57

213.35

ng/l

0.91

819

6126

Congenital malformations and deformations of the musculoskeletal system

262

1547

1.73

14.97

2.8

3.6

141.46

168.23

ng/l

0.55

237

1368

Hypothyreosis and Thyroxine purchase for inclusion criteria

3927

22519

1.15

14.93

3.1

2.8

188.04

208.17

ng/l

2.24

3564

20487

Benign neoplasm: Adrenal gland

357

2312

1.62

14.89

3.1

2.9

231.45

189.34

ng/l

0.97

337

2115

Reactive arthropathies, FINNGEN

266

1595

1.73

14.86

2.6

2.7

157.63

173.48

ng/l

0.29

239

1447

Metatarsalgia

364

2358

1.59

14.80

3.0

2.7

123.26

174.48

ng/l

2.85

332

2130

Diabetic maculopathy, excluding more controls

460

3138

1.51

14.72

3.8

2.7

372.05

200.40

ng/l

6.53

424

2867

Haemorrhoids and perianal venous thrombosis

1417

11391

1.26

14.71

3.1

2.8

199.50

219.24

ng/l

0.95

1291

10422

Seropositive rheumatoid arthritis, wide

1190

9413

1.29

14.67

3.1

2.8

209.31

197.45

ng/l

0.47

1104

8579

Inflammatory diseases of female pelvic organs

2070

12670

1.21

14.64

2.6

133.90

160.66

ng/l

2.57

1864

11486

Benign neoplasm: Duodenum

149

763

2.14

14.62

3.7

3.1

224.37

223.74

ng/l

0.01

134

699

Other ill-defined and unspecified causes of mortality

161

2948

0.52

14.60

3.8

3.1

433.57

266.69

ng/l

2.43

148

2697

Sicca syndrome [Sjögren]

356

2310

1.60

14.56

3.1

2.8

171.57

176.64

ng/l

0.08

315

2097

Malignant neoplasm of oral cavity, including Hilmo

233

1368

1.81

14.51

2.2

3.0

266.11

208.41

ng/l

0.59

215

1252

Lyme disease

732

9795

0.73

14.50

2.1

2.8

141.81

177.80

ng/l

3.33

663

8909

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1154

9111

1.29

14.46

3.0

2.8

208.28

195.76

ng/l

0.48

1068

8310

Noninfectious colitis NAS

555

3932

1.45

14.45

3.3

2.9

257.57

197.37

ng/l

1.43

498

3557

Disorders of vitreous body and globe

2277

18491

1.20

14.39

3.0

2.8

193.68

199.45

ng/l

0.23

2095

16962

149

769

2.12

14.35

3.7

3.0

284.81

240.38

ng/l

0.32

138

706

Female genital prolapse

1182

5233

1.30

14.31

2.6

2.8

134.41

213.74

ng/l

10.00

1088

4774

Cauda equina syndrome

277

2.92

14.29

4.0

3.1

181.99

169.10

ng/l

0.09

253

Other and unspecified injuries of lower leg

268

1626

1.70

14.29

3.4

2.7

222.25

180.56

ng/l

0.68

242

1448

Colectomy operation

804

6073

1.36

14.28

3.4

2.9

216.27

216.10

ng/l

0.00

727

5565

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1281

8862

1.27

14.26

2.3

2.4

128.40

122.38

ng/l

0.24

1141

8014

Other disorders of white blood cells

246

1469

1.76

14.25

3.8

3.0

268.43

216.66

ng/l

0.87

222

1343

Asthma mixed form (mode)

191

1053

1.88

14.25

3.9

2.5

113.31

205.11

ng/l

5.45

171

948

Other disorders involving the immune mechanism, not elsewhere classified

133

653

2.17

14.25

3.8

2.8

362.70

172.82

ng/l

2.22

120

585

Assault by bodily force

224

1292

1.78

14.24

2.6

2.8

138.91

130.94

ng/l

0.11

203

1128

Spirochaetal infections, other/unspecified

741

9870

0.74

14.22

2.1

2.8

142.63

177.32

ng/l

3.14

668

8981

Cramp and spasm

190

1052

1.90

14.21

2.7

2.9

158.98

181.37

ng/l

0.36

165

959

Other/unspecified seropositive rheumatoid arthritis

1174

9311

1.29

14.17

3.0

2.8

209.99

197.64

ng/l

0.48

1088

8490

L01XE Protein kinase inhibitors

269

1654

1.72

14.13

3.0

167.64

197.38

ng/l

0.88

246

1516

Disorders of speech understanding and production

168

877

1.97

14.12

5.3

3.7

204.88

218.09

ng/l

0.19

159

781

Other spirochaetal diseases

744

9891

0.74

14.09

2.1

2.8

142.79

177.34

ng/l

3.13

671

8996

Tubulo-interstitial nephritis, not specified as acute or chronic

315

2004

1.64

14.07

3.6

2.8

258.62

206.76

ng/l

1.00

289

1792

Lesion of plantar nerve

271

1665

1.71

14.07

2.6

2.8

157.66

182.23

ng/l

0.52

252

1516

Other fall from one level to another

841

6380

1.34

14.07

2.9

3.0

171.03

193.81

ng/l

1.03

747

5733

Other bursopathies

560

3999

1.44

14.02

3.0

2.8

186.59

206.97

ng/l

0.60

517

3634

Arterial embolism and thrombosis of lower extremity artery

197

1115

1.89

14.00

5.3

3.0

354.66

237.93

ng/l

2.31

186

1011

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

357

2345

1.59

13.91

3.1

3.0

232.42

251.61

ng/l

0.36

331

2136

Family history of malignant neoplasm

326

2084

1.60

13.90

2.3

2.2

152.53

112.62

ng/l

0.33

287

1868

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1141

8938

1.29

13.87

2.7

3.0

164.18

219.30

ng/l

4.45

1049

8217

Chromosomal abnormalities, not elsewhere classified

289

2.75

13.80

3.5

4.9

124.16

175.01

ng/l

0.74

255

Injuries to the neck

803

6069

1.35

13.78

2.6

2.8

183.98

176.10

ng/l

0.10

716

5453

Other and unspecified myopathies

426

2914

1.52

13.75

3.0

3.1

266.16

232.01

ng/l

0.61

388

2656

Arthropathies in other diseases classified elsewhere

164

879

1.98

13.70

3.1

2.8

290.09

199.41

ng/l

1.61

145

802

Haemolytic anaemias

169

918

1.96

13.65

4.4

3.0

328.15

215.91

ng/l

1.90

155

846

Muscular dystrophy

174

3.50

13.63

3.1

2.6

159.41

210.57

ng/l

0.39

154

Other and unspecified mood [affective] disorders

195

1094

1.83

13.61

3.0

2.8

168.77

134.80

ng/l

0.39

156

969

Tooth eruption problems

313

1935

1.60

13.58

3.6

3.1

122.43

127.62

ng/l

0.11

278

1662

Gingival hyperplasia

159

847

1.99

13.58

6.0

3.0

223.90

182.21

ng/l

0.45

146

777

Mental retardation, wide definition

155

810

1.99

13.53

2.7

3.9

159.65

186.53

ng/l

0.23

145

723

Autoimmune hyperthyroidism

229

1354

1.76

13.53

3.0

2.7

194.53

156.01

ng/l

0.89

206

1223

Purpura and other haemorrhagic conditions

569

4104

1.43

13.49

3.3

3.0

304.82

203.30

ng/l

4.59

519

3739

Meralgia paraesthetica

152

800

2.02

13.44

3.6

2.8

168.89

187.61

ng/l

0.30

140

729

Other symptoms and signs involving general sensations and perceptions

189

1067

1.87

13.40

3.1

3.4

188.34

248.21

ng/l

1.68

173

970

Other necrotizing vasculopathies

348

2299

1.59

13.36

3.3

3.0

228.80

214.29

ng/l

0.22

319

2105

Abdominal aortic aneurysm (AAA)

534

3792

1.45

13.36

3.1

3.2

347.57

274.77

ng/l

2.14

495

3489

Infective dermatitis

475

3325

1.47

13.35

3.4

2.9

211.23

195.92

ng/l

0.23

431

3035

Non-allergic asthma

369

2458

1.55

13.34

3.4

3.2

181.25

198.57

ng/l

0.31

348

2234

Kela reimbursement Agammaglobulinemia (D80-84)

134

3.76

13.32

5.8

2.3

210.98

113.00

ng/l

0.44

118

Other spirochaetal diseases

761

10002

0.75

13.30

2.1

2.8

141.80

178.40

ng/l

3.55

685

9095

Other arterial embolism and thrombosis

153

816

2.01

13.18

3.9

3.1

376.99

224.19

ng/l

2.61

143

737

Other symptoms and signs involving the urinary system

460

3213

1.48

13.17

2.8

2.9

215.66

217.13

ng/l

0.02

415

2949

Internal derangement of knee

1403

11368

1.24

13.09

2.6

2.8

193.45

192.60

ng/l

0.02

1273

10344

Amenorrhoea

164

883

1.90

13.04

2.8

99.93

138.75

ng/l

1.50

144

786

Papulosquamous disorders

1598

13210

1.23

13.01

2.9

2.8

189.66

191.17

ng/l

0.05

1442

12009

Degenerative diseases of the nervous system

1980

12255

1.21

12.97

3.3

3.1

238.09

273.68

ng/l

2.66

1822

11271

Orchitis and epididymitis

408

2792

1.51

12.97

3.6

3.0

217.43

251.34

ng/l

0.65

366

2536

Disorders of vitreous body

2191

18004

1.19

12.94

2.9

2.8

192.48

198.61

ng/l

0.24

2013

16526

Acute laryngitis and tracheitis

303

1901

1.60

12.91

3.6

2.8

140.54

145.67

ng/l

0.08

270

1656

Cyst of kidney

352

2351

1.57

12.91

3.0

205.83

210.37

ng/l

0.08

325

2158

Mental retardation

142

732

2.02

12.90

2.7

4.0

164.87

185.05

ng/l

0.15

134

650

Irregular menses

1326

8451

1.25

12.87

2.5

97.19

138.05

ng/l

8.28

1187

7587

Alzheimer disease, including avohilmo

2062

12282

1.21

12.87

3.2

3.1

240.97

273.68

ng/l

2.38

1885

11312

Superficial injury of thorax

613

4508

1.39

12.86

3.3

2.9

224.97

209.38

ng/l

0.29

557

4070

Keratitis

1390

11341

1.24

12.84

3.1

2.8

181.06

191.27

ng/l

0.35

1249

10253

Vascular dementia (subcortical)

215

1288

1.80

12.83

3.8

3.3

321.01

316.85

ng/l

0.04

205

1176

Other disorders starting during childhood or adolecense, excluding more controls

100

431

2.28

12.82

7.5

3.6

132.69

138.83

ng/l

0.07

371

Other specified and unspecified disorders of eye and adnexa

172

957

1.90

12.82

2.8

2.9

320.31

199.29

ng/l

0.95

156

865

Hidradenitis suppurativa

115

554

2.16

12.77

2.8

2.7

143.46

121.60

ng/l

0.24

101

487

Disorders of refraction and accommodation

876

6744

1.31

12.74

3.0

2.9

139.56

161.57

ng/l

1.20

797

6038

Otitis media, unspecified

315

1871

1.58

12.74

4.3

2.9

126.81

163.08

ng/l

1.18

287

1654

Enthesopathies of lower limb, excluding foot

786

5994

1.33

12.70

2.8

2.7

132.84

191.23

ng/l

7.14

708

5434

Persistent mood disorders

729

5507

1.35

12.67

2.9

2.8

152.41

184.28

ng/l

1.45

658

4980

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1210

9743

1.26

12.67

3.6

2.8

194.26

191.73

ng/l

0.07

1121

8783

Olecranon bursitis

279

1773

1.64

12.64

3.0

2.9

260.06

208.27

ng/l

0.92

254

1612

Special screening examination for neoplasms

228

1374

1.72

12.62

2.6

2.5

238.63

193.46

ng/l

0.68

207

1255

Specific development disorders of scholastic skills

102

462

2.24

12.61

4.3

3.2

140.25

130.28

ng/l

0.07

375

Vitamin B12 deficiency anaemia

526

3797

1.43

12.60

3.3

2.9

274.73

235.88

ng/l

0.78

482

3450

Dementia in Alzheimer disease

609

6900

0.73

12.57

3.6

3.3

242.56

304.66

ng/l

3.05

553

6338

Unspecified lump in breast

589

4321

1.40

12.54

2.6

2.7

181.76

165.73

ng/l

0.46

530

3939

Other and unspecified vascular occlusions

499

3582

1.45

12.53

3.4

3.0

259.58

235.46

ng/l

0.50

464

3267

Congenital malformations and deformations of the musculoskeletal system

322

2091

1.57

12.52

2.7

3.4

139.43

166.38

ng/l

0.69

289

1856

Vascular syndromes of brain in cerebrovascular disorders

251

1569

1.70

12.50

3.4

3.1

229.49

268.07

ng/l

0.74

232

1438

Redundant prepuce, phimosis and paraphimosis

771

5821

1.34

12.49

3.1

3.0

161.88

220.61

ng/l

4.70

691

5203

Other noninflammatory disorders of uterus, except cervix

932

4886

1.31

12.46

2.9

2.8

158.88

219.46

ng/l

6.82

847

4473

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

121

605

2.12

12.40

3.5

2.8

373.54

171.18

ng/l

2.16

110

539

Secondary parkinsonism, excluding more controls

126

641

2.10

12.39

3.7

2.6

166.44

245.63

ng/l

2.14

112

575

Other and unspecified immunodeficiencies with predominantly antibody defects

204

3.05

12.37

4.4

2.8

240.82

159.88

ng/l

0.40

187

Other general symptoms and signs

171

944

1.86

12.36

3.4

3.0

210.65

180.75

ng/l

0.41

150

857

Vitreous haemorrhage

452

3188

1.47

12.35

3.2

2.9

345.97

207.11

ng/l

3.47

420

2892

Pre-eclampsia or eclampsia

575

4198

1.39

12.33

2.4

2.5

143.67

123.08

ng/l

0.62

508

3801

Chronic myringitis

4.50

12.33

2.5

3.0

54.90

166.12

ng/l

2.66

Dementia, including avohilmo

2465

14585

1.18

12.32

3.0

228.28

253.44

ng/l

1.63

2249

13458

Astigmatism

227

1374

1.71

12.28

3.7

3.2

156.38

182.73

ng/l

0.56

209

1238

severe traumatic brain injury, does not include concussion

1067

8522

1.28

12.28

3.3

3.1

265.99

247.32

ng/l

0.61

957

7770

Cluster headache, strict, including avohilmo

159

870

1.90

12.25

2.0

2.9

91.25

135.70

ng/l

1.29

137

773

Abnormal findings in nipple discharge synovial fluid wound secretions

305

2.64

12.21

2.5

3.3

266.79

161.24

ng/l

0.66

274

Cardiomyopathy due to drugs and other external agents

7.14

12.18

4.0

2.8

416.86

165.53

ng/l

1.10

Pregnancy hypertension

1093

7802

1.27

12.13

2.4

125.06

118.90

ng/l

0.23

972

7025

Other specified/unspecified dorsopathies

152

828

1.93

12.09

2.5

2.8

164.76

213.53

ng/l

0.78

135

736

Hypertrophic scar

178

1013

1.82

12.07

3.1

2.8

171.95

161.87

ng/l

0.13

155

911

Other (seronegative) rheumatoid arthritis, wide

824

6389

1.32

12.07

3.2

2.9

212.59

197.41

ng/l

0.49

744

5816

Malignant neoplasm of oral cavity

174

994

1.87

12.06

2.1

3.0

276.87

208.88

ng/l

0.53

162

912

Hyperhidrosis

102

480

2.22

12.06

3.2

2.7

95.13

148.77

ng/l

2.09

428

Disorders of calcium metabolism

263

1666

1.64

12.04

3.7

2.7

258.76

190.36

ng/l

0.88

237

1513

Pre-eclampsia or poor fetal growth

724

5469

1.33

12.01

2.4

133.53

111.21

ng/l

0.89

638

4917

Other disorders of glucose regulation and pancreatic internal secretion

346

2329

1.54

11.96

3.5

3.0

385.23

220.22

ng/l

1.61

321

2104

Other/unspecified reactive arthropathies

246

1534

1.66

11.95

2.6

2.8

140.91

183.90

ng/l

1.41

220

1382

Primary coxarthrosis, bilateral

1415

11691

1.24

11.93

3.2

3.0

205.58

232.40

ng/l

1.67

1296

10736

Ganglion

712

5404

1.34

11.91

2.4

2.6

124.54

173.04

ng/l

4.37

652

4888

Dissociative [conversion] disorders

115

569

2.10

11.88

2.5

2.8

88.77

170.04

ng/l

3.22

101

510

Chylothorax

6.46

11.88

4.4

2.2

419.79

193.16

ng/l

0.79

Disorders of conjunctiva

3226

22740

1.15

11.88

3.0

2.8

171.07

186.88

ng/l

1.34

2870

20619

Acute nasopharyngitis (common cold)

387

2640

1.49

11.86

2.6

2.7

126.24

146.09

ng/l

0.71

357

2322

Viral haemorrhagic fevers, not elsewhere classified/unspecified

636

4763

1.37

11.85

2.3

3.0

207.37

190.30

ng/l

0.44

588

4324

Lichen planus

551

4047

1.40

11.83

2.8

170.22

189.96

ng/l

0.61

509

3695

Diseases of salivary glands

1227

9983

1.25

11.73

2.8

170.79

180.81

ng/l

0.35

1090

9056

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

222

2.91

11.72

4.4

2.8

205.00

178.52

ng/l

0.20

194

Migraine without aura and triptan purchases

382

2617

1.48

11.70

2.5

2.6

51.19

115.00

ng/l

17.29

331

2326

Other and unspecified disorders of white blood cells

182

1060

1.81

11.68

2.9

3.0

261.65

211.13

ng/l

0.67

161

970

Generalized anxiety disorder

386

2654

1.48

11.61

2.5

2.6

78.95

127.65

ng/l

4.35

329

2341

Cerebral cysts

210

1268

1.72

11.57

3.3

2.8

182.04

194.90

ng/l

0.19

186

1150

Ectropion of eyelid

242

1530

1.68

11.57

3.6

3.2

270.70

276.47

ng/l

0.05

227

1407

Other viral hepatitis

189

1107

1.76

11.54

3.2

2.8

171.33

140.43

ng/l

0.41

169

966

Disorders of parathyroid gland

980

7717

1.28

11.52

3.2

2.9

271.71

218.73

ng/l

2.14

896

7034

Acute pharyngitis

403

2779

1.46

11.44

3.2

2.7

140.67

136.76

ng/l

0.07

351

2433

Hyperkinetic disorders

231

1392

1.65

11.40

3.7

3.3

122.59

103.58

ng/l

0.26

189

1176

Hydrocele

536

3945

1.40

11.34

3.2

3.1

266.74

284.25

ng/l

0.23

503

3584

Visual field defects

379

2632

1.49

11.33

3.6

2.9

265.56

212.65

ng/l

1.26

343

2401

Thyrotoxicosis with diffuse goitre

495

3589

1.41

11.30

3.3

2.7

213.75

163.76

ng/l

0.71

443

3248

Other injuries of lower limb, level unspecified

182

3.12

11.28

2.5

3.0

193.57

170.20

ng/l

0.17

166

Arthropod-borne viral fevers and viral haemorrhagic fevers

714

5482

1.33

11.19

2.4

3.0

202.00

190.66

ng/l

0.30

654

4967

Chronic viral hepatitis

153

851

1.86

11.17

3.0

2.8

165.88

137.29

ng/l

0.33

137

730

Myopia

359

2460

1.49

11.12

2.8

132.46

149.05

ng/l

0.42

324

2178

Nummular dermatitis

353

2427

1.51

11.11

3.4

2.9

169.99

201.52

ng/l

1.04

334

2212

Oesophageal varices

191

1145

1.76

11.10

3.5

2.9

201.52

209.27

ng/l

0.12

175

1039

Pre-eclampsia

514

3752

1.39

11.09

2.5

134.86

121.00

ng/l

0.35

453

3405

Rheumatic fever incl heart disease

164

944

1.85

11.08

3.4

3.1

294.89

249.21

ng/l

0.56

150

857

Lichen simplex chronicus

148

824

1.90

11.07

2.8

152.79

191.03

ng/l

0.59

134

753

Other prurigo

255

2.73

10.95

3.2

305.55

192.58

ng/l

0.64

231

Use of pramipexole

987

7924

1.27

10.93

3.1

2.9

236.15

206.68

ng/l

0.65

895

7242

Other and unspecified urticaria

646

4902

1.34

10.91

3.5

2.8

165.67

164.48

ng/l

0.03

577

4430

Trigger finger

532

3928

1.38

10.90

3.3

2.7

183.70

184.68

ng/l

0.02

488

3567

Other follicular disorders

238

1504

1.63

10.89

3.2

2.7

206.95

158.22

ng/l

0.72

213

1339

Other/unspecified rheumatoid arthritis

569

4260

1.38

10.88

3.4

2.9

237.61

214.68

ng/l

0.59

516

3878

Thyrotoxicosis with toxic multinodular goitre

283

1874

1.58

10.86

3.2

2.9

257.54

208.27

ng/l

0.80

250

1711

Other specified/unspecified bacterial intestinal infections

285

1887

1.57

10.83

3.0

211.95

200.63

ng/l

0.15

258

1721

Other and unspecified primary disorders of muscles

143

3.38

10.80

3.3

3.4

136.16

194.29

ng/l

0.44

129

5-aminosalicylic acid

686

5253

1.33

10.80

2.9

2.5

181.16

164.86

ng/l

0.42

609

4729

Other diseases of pancreas

361

2509

1.49

10.79

3.1

2.9

222.36

203.85

ng/l

0.30

335

2283

Methotrexate

538

3986

1.38

10.79

2.6

2.5

170.78

175.23

ng/l

0.10

492

3634

Hypoglycaemia, other or unspecified

273

1789

1.58

10.78

3.6

3.1

426.95

226.47

ng/l

1.53

254

1625

Non-Hodgkin lymphoma, all, including Hilmo

619

4699

1.36

10.78

3.1

3.0

258.10

226.01

ng/l

0.90

577

4297

Other epidermal thickening

192

1160

1.74

10.77

3.9

2.9

242.63

199.04

ng/l

0.51

179

1062

Other misadventures during surgical and medical care

110

563

2.09

10.74

3.3

3.0

156.00

188.34

ng/l

0.73

103

514

Localized swelling, mass and lump of skin and subcutaneous tissue

1262

10399

1.23

10.73

3.0

2.9

195.05

201.40

ng/l

0.20

1146

9449

Ovarian dysfunction

155

873

1.81

10.72

2.6

2.5

77.68

96.30

ng/l

0.70

139

769

Dementia

2312

13777

1.17

10.72

3.1

3.0

231.25

254.62

ng/l

1.34

2115

12700

Glomerulonephritis

398

2815

1.46

10.70

3.9

3.0

399.27

203.84

ng/l

4.48

371

2559

Other secondary coxarthrosis

155

886

1.85

10.68

3.1

2.9

164.48

197.40

ng/l

0.63

141

805

Acute gastritis

332

2273

1.51

10.68

4.2

2.9

232.18

217.06

ng/l

0.26

311

2079

Certain zoonotic bacterial diseases

135

740

1.93

10.67

3.2

3.1

229.72

202.52

ng/l

0.37

125

677

Mixed hyperlipidaemia

180

1073

1.76

10.64

3.2

2.7

366.72

202.61

ng/l

1.92

163

973

Coxarthrosis, primary, with hip surgery

2289

18590

1.17

10.63

3.0

205.05

231.63

ng/l

2.50

2112

17059

Dependence on enabling machines and devices, not elsewhere classified

227

2.78

10.61

7.6

2.6

530.27

156.64

ng/l

2.12

208

Manic episode

111

568

2.05

10.61

2.7

2.9

147.19

164.49

ng/l

0.16

504

Other nonautoimmune haemolytic anaemias

6.58

10.60

4.1

2.2

248.19

238.14

ng/l

0.04

Superficial injury of ankle and foot

361

2502

1.47

10.60

2.8

3.0

136.40

156.39

ng/l

0.65

319

2236

Acute peritonitis

283

1881

1.57

10.59

3.8

3.0

438.81

227.16

ng/l

5.31

264

1713

Wet age-related macular degeneration

993

7785

1.27

10.58

3.4

3.1

260.85

260.98

ng/l

0.00

907

7127

Golimumab

106

533

2.07

10.57

2.0

2.7

62.93

126.95

ng/l

2.64

472

Alcohol dependence

1056

8560

1.25

10.55

2.9

3.0

226.38

209.89

ng/l

0.29

954

7766

Complications following infusion, transfusion and therapeutic injection

327

2.45

10.54

5.8

2.9

274.49

193.40

ng/l

0.70

296

Certain zoonotic bacterial diseases

431

2.25

10.53

3.6

3.0

232.68

196.83

ng/l

0.38

394

Disease of hard tissues of teeth, NOS

2473

11212

1.17

10.52

2.7

2.9

135.47

220.61

ng/l

30.71

2220

10259

Disorders of breast

1669

12804

1.20

10.50

2.4

2.7

151.67

161.97

ng/l

0.55

1480

11664

Brachial plexus disorders

273

1792

1.56

10.50

2.5

2.7

71.13

139.67

ng/l

6.81

244

1615

Cluster headache, wide,, including avohilmo

168

981

1.77

10.48

2.1

2.8

97.54

142.12

ng/l

1.38

144

871

Alzheimer disease

1790

11158

1.20

10.45

3.3

3.2

249.96

282.24

ng/l

1.98

1646

10258

Iridocyclitis

882

7020

1.28

10.41

3.3

2.9

184.61

186.58

ng/l

0.04

816

6359

Other and/or unspecified nontoxic goitre

347

2414

1.49

10.30

2.9

2.8

156.50

182.49

ng/l

1.09

313

2191

Hypertrophic disorders of skin

187

1130

1.71

10.28

3.1

2.8

167.06

164.17

ng/l

0.04

163

1008

Viral hepatitis

222

1399

1.63

10.27

3.2

2.7

172.48

154.44

ng/l

0.24

199

1234

Chronic hepatitis, not elsewhere classified

136

755

1.89

10.25

2.7

2.8

146.95

170.41

ng/l

0.43

127

684

Other eating disorders

103

515

2.04

10.25

2.3

3.5

59.49

106.02

ng/l

2.05

447

Myotonic dystrophy (Steinert)

5.52

10.24

1.6

2.1

135.71

105.80

ng/l

0.17

Excessive vomiting in pregnancy

194

1180

1.68

10.24

1.9

2.7

68.36

106.91

ng/l

3.17

167

1054

Other postsurgical states

242

1562

1.60

10.23

5.6

2.4

178.71

157.66

ng/l

0.41

225

1398

Eating disorder

170

996

1.73

10.18

2.3

3.0

57.18

100.15

ng/l

3.15

139

850

Diffuse large B-cell lymphoma

229

1472

1.64

10.18

4.1

3.2

272.70

216.56

ng/l

1.10

218

1364

Diffuse large B-cell lymphoma, including Hilmo

229

1472

1.64

10.18

4.1

3.2

272.70

216.56

ng/l

1.10

218

1364

Diffuse large B-cell lymphoma, helper endpoint

229

1472

1.64

10.18

4.1

3.2

272.70

216.56

ng/l

1.10

218

1364

Eating disorders

242

1552

1.58

10.16

2.4

3.0

138.37

142.18

ng/l

0.04

203

1367

Attention to artificial openings

185

1126

1.73

10.16

3.8

2.8

250.03

217.81

ng/l

0.41

167

1040

Other abnormal uterine and vaginal bleeding

880

5002

1.28

10.14

3.1

2.8

186.18

218.34

ng/l

1.31

798

4570

Disturbance of activity and attention

211

1284

1.63

10.11

3.7

3.0

126.45

97.65

ng/l

0.39

173

1083

Delayed milestone in childhood

233

2.58

10.11

10.2

7.0

193.70

233.67

ng/l

0.26

212

Other and unspecified abdominal hernia

195

1207

1.70

10.07

4.1

2.9

243.46

205.95

ng/l

0.43

177

1109

Postprocedural disorders of nervous system

190

1156

1.68

10.07

2.3

2.6

90.48

131.90

ng/l

0.91

167

1030

Gestational [pregnancy-induced] hypertension

598

4523

1.33

10.04

2.3

2.4

108.75

112.70

ng/l

0.11

534

4067

Conjunctivitis (acute, non atopic)

963

7735

1.26

10.04

3.7

2.9

157.53

175.42

ng/l

0.84

876

6979

Tinnitus

931

7492

1.27

10.03

2.6

2.8

131.13

189.61

ng/l

8.11

853

6796

Pneumonitis due to solids and liquids

404

2907

1.44

10.01

3.7

3.0

268.75

267.47

ng/l

0.02

365

2657

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

114

608

2.02

10.01

1.9

3.4

237.18

219.69

ng/l

0.13

105

567

Anxious personality disorder

244

2.58

10.01

2.1

2.5

98.98

119.41

ng/l

0.24

212

Cholangitis (primary sclerosing, PSC)

274

1832

1.55

9.99

2.9

223.19

222.69

ng/l

0.01

256

1659

Other bursitis of elbow

208

2.87

9.94

4.0

3.5

181.51

197.04

ng/l

0.14

187

Acquired haemolytic anaemia

123

673

1.96

9.93

3.9

3.0

373.41

208.41

ng/l

2.46

115

620

Other/unspecified disorders of vestibular function

190

1173

1.71

9.92

3.1

3.0

206.71

231.80

ng/l

0.19

177

1076

Vitamin deficiency, wide

197

1223

1.68

9.91

3.5

2.9

264.86

217.98

ng/l

0.39

176

1107

Vitamin deficiency

197

1223

1.68

9.91

3.5

2.9

264.86

217.98

ng/l

0.39

176

1107

Pain and other conditions associated with female genital organs and menstrual cycle

506

3441

1.37

9.91

2.3

2.5

106.25

146.38

ng/l

2.29

431

3092

Other/unspecified enthesopathies of lower limb, excluding foot

241

1563

1.59

9.91

3.0

2.7

129.75

177.99

ng/l

2.18

214

1398

L02BX Other hormone antagonists and related agents

293

2004

1.55

9.90

3.1

3.0

225.49

244.74

ng/l

0.26

275

1844

Right hemicolectomy

294

2005

1.53

9.89

3.7

3.0

239.83

239.95

ng/l

0.00

265

1833

Focal brain injury

259

1711

1.56

9.84

2.9

2.6

241.25

245.92

ng/l

0.05

228

1563

Unspecific neurodegenerative disorder

2292

13649

1.17

9.84

3.1

233.18

266.65

ng/l

2.86

2099

12576

Prurigo nodularis

120

653

1.96

9.83

2.7

3.0

325.80

212.24

ng/l

0.95

108

605

Type of accident

1108

9096

1.24

9.81

3.5

2.8

188.06

193.50

ng/l

0.20

1030

8197

Drug-induced osteoporosis

288

2.51

9.78

4.5

3.3

244.67

181.74

ng/l

0.30

262

Otitis externa

809

6424

1.28

9.74

3.1

2.8

174.74

183.50

ng/l

0.23

719

5811

Barrett oesophagus

227

1469

1.62

9.73

3.5

2.7

175.93

196.36

ng/l

0.46

214

1350

Injury of intra-abdominal organs

490

2.08

9.71

3.0

3.2

174.93

202.23

ng/l

0.33

440

Obsessive-compulsive disorder

149

856

1.78

9.70

2.6

96.38

124.93

ng/l

0.42

132

739

Budesonide

467

3442

1.38

9.68

3.0

2.5

148.42

169.64

ng/l

0.63

419

3117

Myotonic disorders

141

3.21

9.67

1.8

3.4

130.12

117.29

ng/l

0.11

127

Complications of other internal prosthetic devices, implants and grafts

191

1189

1.69

9.64

3.0

2.8

206.93

211.64

ng/l

0.05

169

1084

Schizophrenia

513

3837

1.36

9.64

2.9

2.8

121.23

157.02

ng/l

1.81

453

3410

Biological medication for rheuma

487

3611

1.37

9.64

2.4

2.8

114.75

138.24

ng/l

1.13

432

3210

Car occupant injured in other and unspecified transport accidents

603

4615

1.33

9.63

2.9

2.8

154.28

174.03

ng/l

0.74

537

4133

Other and unspecified diseases of blood and blood-forming organs

121

664

1.94

9.62

3.1

2.9

221.39

204.80

ng/l

0.17

111

611

Lichen planus, including avohilmo

769

6092

1.29

9.59

2.6

2.8

178.88

184.16

ng/l

0.11

704

5556

conjunctival haemorrhage

343

2419

1.47

9.58

3.8

2.9

239.08

213.65

ng/l

0.44

315

2220

Melanocytic naevi

1043

8530

1.24

9.57

3.1

2.8

162.62

177.65

ng/l

0.77

968

7723

Benign neoplasm: Oesophagus

279

2.52

9.53

3.1

3.2

215.33

201.94

ng/l

0.10

251

Secondary uncertain malignant neoplasm

599

4607

1.33

9.52

3.2

3.1

267.12

235.81

ng/l

0.74

558

4216

Rheumatic valve diseases

120

660

1.94

9.52

3.6

3.1

327.63

268.08

ng/l

0.55

110

599

Nonhereditary hypogammaglobulinemia

187

2.85

9.52

4.1

2.3

155.24

132.98

ng/l

0.14

167

Abnormal spermatozoa

316

4477

0.69

9.48

3.4

3.0

237.35

237.61

ng/l

0.00

299

4104

Respiratory conditions due to other external agents

110

591

2.01

9.48

4.4

3.0

279.62

217.80

ng/l

0.55

102

547

Hypothyroidism, strict autoimmune, 3 medication purchases required

3446

20798

1.13

9.47

3.0

2.8

186.75

206.31

ng/l

2.12

3137

18924

Diabetic retinopathy

1629

8640

1.20

9.47

3.8

3.3

310.20

234.72

ng/l

5.61

1511

7862

Disorders of oesophagus in diseases classified elsewhere

106

563

2.02

9.40

3.2

2.9

280.57

217.56

ng/l

0.47

525

Thyroiditis

248

1642

1.56

9.36

2.8

138.82

172.43

ng/l

1.04

228

1480

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

147

867

1.82

9.33

3.9

3.2

256.88

241.53

ng/l

0.15

134

801

Multiple myeloma

147

867

1.82

9.33

3.9

3.2

256.88

241.53

ng/l

0.15

134

801

Seronegative rheumatoid arthritis

457

3387

1.38

9.29

3.1

2.7

189.34

193.85

ng/l

0.10

413

3095

Hyperaldosteronism

130

738

1.87

9.28

2.7

3.0

277.14

188.29

ng/l

0.77

124

678

Thiazolidinediones

521

3949

1.36

9.28

3.3

2.7

251.61

210.45

ng/l

1.20

478

3639

Diseases of tongue

248

1648

1.56

9.26

2.8

2.9

165.94

208.28

ng/l

1.18

224

1497

Crushed, pushed or stepped on by crowd or human stampede

206

1308

1.61

9.24

2.9

3.0

154.72

164.80

ng/l

0.16

178

1159

Crohn's disease NAS

211

1351

1.61

9.22

2.7

2.8

165.29

176.58

ng/l

0.14

187

1211

Carcinoma in situ of skin of trunk

188

1189

1.69

9.21

2.9

3.1

310.44

252.71

ng/l

0.76

175

1091

Other benign neoplasms of connective and other soft tissue

381

2748

1.43

9.21

2.7

2.9

151.97

182.38

ng/l

1.14

350

2491

Background retinopathy and retinal vascular changes

106

567

2.00

9.21

4.0

3.2

375.35

224.14

ng/l

1.37

526

Nail disorders

293

2014

1.50

9.19

3.2

2.9

233.47

180.81

ng/l

0.84

271

1817

Adhesive capsulitis of shoulder

649

5060

1.31

9.16

3.0

2.8

167.71

200.99

ng/l

1.51

592

4610

Complications of labour and delivery

1408

9298

0.83

9.15

2.4

2.5

112.43

134.72

ng/l

2.17

1281

8432

Other specified and unspecified retinal disorders

164

997

1.73

9.14

3.0

225.63

218.27

ng/l

0.09

144

919

Cushing syndrome

215

2.67

9.13

2.2

2.5

199.25

159.94

ng/l

0.39

194

Use of other anti-dementia drugs

1527

10787

1.20

9.10

3.1

3.2

238.09

289.60

ng/l

4.90

1402

9922

Use of memantine

1527

10787

1.20

9.10

3.1

3.2

238.09

289.60

ng/l

4.90

1402

9922

Pedestrian injured in transport accident

264

1785

1.53

9.07

2.8

2.9

228.82

195.01

ng/l

0.58

240

1619

Other disorders of penis

386

2798

1.42

9.06

3.7

3.1

162.82

232.46

ng/l

4.11

351

2536

Other diseases of blood and blood-forming organs

288

1987

1.50

9.02

3.0

234.87

202.33

ng/l

0.70

262

1806

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

120

649

1.86

9.02

6.7

3.6

140.88

132.85

ng/l

0.10

108

558

In situ neoplasms

1668

14328

1.18

8.99

2.8

2.9

240.45

219.50

ng/l

1.11

1512

13115

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

176

1090

1.68

8.99

2.8

2.7

131.97

189.01

ng/l

1.76

169

988

Amputation of ankle bones

117

653

1.92

8.95

5.4

3.1

506.98

238.14

ng/l

4.70

109

600

Congenital malformations of the urinary system

200

1276

1.62

8.95

2.8

3.3

367.04

184.88

ng/l

4.06

190

1147

Other abnormalities of plasma proteins

413

2.18

8.94

4.7

3.2

254.73

217.63

ng/l

0.33

375

Exclusions for E4_PCOS_CONSORTIUM

2552

14067

1.14

8.92

2.7

2.8

166.38

172.62

ng/l

0.28

2284

12708

Other noninflammatory disorders of vulva and perineum

308

2147

1.47

8.92

2.8

2.7

149.58

190.38

ng/l

1.16

271

1951

Other superficial mycoses

389

2.17

8.91

4.1

2.9

195.03

174.10

ng/l

0.21

342

Spondylopathies (FG)

428

3156

1.38

8.86

2.6

2.7

146.53

159.18

ng/l

0.33

387

2847

Dislocation, sprain and strain of joints and ligaments at neck level

434

3207

1.38

8.84

2.3

2.7

103.51

153.11

ng/l

5.88

385

2850

Perforation of tympanic membrane

386

2810

1.41

8.84

3.2

2.9

171.05

197.83

ng/l

0.73

348

2544

Etanercept

200

1278

1.61

8.83

2.5

2.8

118.58

152.33

ng/l

1.07

177

1140

Benign neoplasm: Parathyroid gland

277

2.47

8.80

3.2

3.1

233.61

214.35

ng/l

0.11

253

Malignant neoplasm of other and unspecified parts of tongue

389

2.22

8.80

1.8

3.3

242.69

230.56

ng/l

0.06

358

Atypical facial pain

193

1229

1.63

8.76

2.7

2.9

105.53

184.46

ng/l

3.09

170

1102

Benign neoplasm: Sigmoid colon

847

6870

1.26

8.71

3.0

2.9

218.23

216.03

ng/l

0.05

770

6288

Injury of muscle and tendon at shoulder and upper arm level

1480

12631

1.19

8.68

2.8

2.9

158.37

203.06

ng/l

5.42

1341

11546

Erosion of teeth , including avohilmo

743

5919

1.27

8.66

2.6

2.8

149.70

155.00

ng/l

0.16

660

5295

Exposure to other and unspecified inanimate mechanical forces

254

1719

1.52

8.65

3.1

2.9

193.44

174.03

ng/l

0.29

230

1548

Other and unspecified erythematous conditions

135

790

1.80

8.64

2.2

3.0

176.95

191.09

ng/l

0.17

126

727

Viral haemorrhagic fevers, not elsewhere classified/unspecified

303

2126

1.47

8.64

2.6

2.9

149.74

182.92

ng/l

0.80

279

1930

Mild mental retardation

441

2.07

8.64

2.6

3.6

102.32

170.69

ng/l

1.44

399

Non-follicular lymphoma

441

3302

1.38

8.62

3.2

3.0

272.26

214.93

ng/l

1.53

409

3027

Hyperparathyroidism

849

6816

1.26

8.60

2.9

283.06

222.12

ng/l

2.19

772

6198

Family history of other conditions

166

2.79

8.59

2.3

1.9

54.14

91.26

ng/l

1.77

149

Psychotic depression

200

1286

1.60

8.58

3.0

2.8

119.55

177.12

ng/l

2.02

180

1148

Acute alcohol intoxication, ICD10

694

5501

1.28

8.53

2.9

250.87

190.26

ng/l

1.05

630

4923

Arthropod-borne viral fevers and viral haemorrhagic fevers

369

2685

1.41

8.52

2.7

2.9

150.77

185.64

ng/l

1.07

337

2439

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

643

5064

1.30

8.49

3.4

304.49

278.31

ng/l

0.60

586

4658

Localized scleroderma [morphea]

312

2.31

8.48

4.4

2.8

135.27

164.32

ng/l

0.31

288

Discitis, unspecified

442

2.10

8.47

5.1

3.0

317.51

231.71

ng/l

0.75

406

Periapical abscess

1668

14382

1.17

8.46

2.7

2.8

175.88

178.55

ng/l

0.09

1522

13028

Palmar fascial fibromatosis [Dupuytren]

695

5531

1.28

8.45

3.2

3.0

264.94

258.58

ng/l

0.07

646

5084

Vasomotor and allergic rhinitis

1163

9540

1.21

8.44

2.6

2.9

127.57

167.32

ng/l

4.10

1020

8625

Other disorders of bone

659

5197

1.29

8.44

3.0

2.8

161.97

164.39

ng/l

0.06

590

4666

Other disorders of bladder

526

4045

1.33

8.44

2.8

2.9

187.28

223.85

ng/l

1.33

484

3696

Seborrhoeic dermatitis

375

2740

1.41

8.44

3.9

2.8

188.44

199.78

ng/l

0.16

342

2495

Spondyloarthritis

669

5288

1.29

8.43

3.1

2.9

192.15

204.50

ng/l

0.34

613

4770

Biomechanical lesions, not elsewhere classified

210

1380

1.59

8.42

2.2

2.9

144.85

203.15

ng/l

2.16

193

1258

Additional codes for the location of defect, injury or illness

226

1506

1.55

8.41

3.6

3.0

162.29

199.68

ng/l

1.07

208

1364

Other congenital malformations of the digestive system

151

907

1.71

8.40

3.5

3.8

203.10

196.70

ng/l

0.07

137

826

Other maltreatment syndromes

479

1.99

8.40

1.9

2.6

99.63

117.56

ng/l

0.27

420

Injuries to the wrist and hand

4054

25495

1.11

8.36

3.0

2.8

177.94

192.72

ng/l

1.02

3647

23135

Alcohol-induced chronic pancreatitis

249

1696

1.52

8.34

3.1

2.9

233.82

183.54

ng/l

0.84

223

1541

Congenital malformations of the urinary system

212

1394

1.57

8.33

2.9

3.3

363.23

180.79

ng/l

4.35

201

1255

Inflammatory diseases of prostate (prostatitis)

534

4120

1.33

8.32

3.1

3.0

151.01

255.00

ng/l

10.29

493

3752

Ulcerative colitis

854

6947

1.25

8.32

3.1

2.8

208.98

179.87

ng/l

0.93

767

6256

Pleural plaque

485

3706

1.35

8.31

3.7

2.9

202.41

262.28

ng/l

3.48

454

3427

Sulfonylureas

1749

12065

1.17

8.29

3.8

2.9

321.73

252.80

ng/l

5.94

1604

11094

Other and unspecified injuries of abdomen, lower back and pelvis

295

2.32

8.26

5.7

2.9

221.22

202.16

ng/l

0.13

262

Injury of muscle and tendon at lower leg level

549

4249

1.32

8.26

2.8

2.9

154.49

185.88

ng/l

1.93

508

3826

Hepatocellular carcinoma, including Hilmo

153

943

1.72

8.24

2.9

3.2

219.48

266.69

ng/l

0.85

142

880

Other disorders of pigmentation

185

1189

1.62

8.19

3.2

2.9

155.89

201.01

ng/l

1.48

171

1096

Agranulocytosis

426

3191

1.37

8.18

3.0

2.9

195.97

182.56

ng/l

0.24

385

2902

Other strabismus

695

5518

1.27

8.14

3.4

2.9

160.24

168.26

ng/l

0.19

614

4960

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

499

3826

1.33

8.10

2.9

2.8

131.10

175.28

ng/l

3.17

449

3470

Superficial injury of wrist and hand

620

4876

1.29

8.10

3.1

2.9

152.12

164.65

ng/l

0.38

530

4361

Iron deficiency

334

2.17

8.09

4.7

2.7

235.36

149.02

ng/l

0.99

297

Hypermetropia

242

1644

1.51

8.08

3.3

3.2

154.54

189.98

ng/l

1.16

225

1482

Other benign neoplasms of skin

1584

13672

1.17

8.07

3.0

2.9

206.58

211.97

ng/l

0.13

1438

12479

Other specified and unspecified disorders of conjunctiva

198

2.64

8.05

4.9

2.8

262.83

176.81

ng/l

0.47

181

Single delivery by forceps and vacuum extractor

120

1239

0.58

8.03

2.1

2.4

39.58

93.96

ng/l

7.28

103

1072

Multiple myeloma, including Hilmo

225

1522

1.55

8.01

3.9

3.1

280.98

238.73

ng/l

0.62

205

1402

Dislocation, sprain and strain of joints and ligaments of thorax

132

783

1.76

8.01

2.6

2.9

168.38

206.12

ng/l

0.61

122

717

Delivery

1122

7076

0.83

8.00

2.8

160.21

188.55

ng/l

1.82

1024

6433

Melanocytic naevi of upper limb, including shoulder

491

1.97

7.97

3.0

195.05

193.77

ng/l

0.01

443

Mental disorders, not otherwise specified

220

1468

1.53

7.95

2.6

2.9

150.38

140.90

ng/l

0.13

190

1299

Paralytic ileus

179

1152

1.63

7.94

3.9

2.9

214.09

231.16

ng/l

0.23

164

1052

Open wound of forearm

361

2648

1.40

7.92

3.4

2.9

224.16

204.84

ng/l

0.27

320

2394

Tumor necrosis factor alpha inhibitors

423

3169

1.36

7.92

2.3

2.8

105.49

136.96

ng/l

1.69

371

2821

Tobacco use

179

1147

1.61

7.92

2.6

2.7

196.72

159.80

ng/l

0.51

167

1041

Temporomandibular joint disorders, including avohilmo

1274

10645

1.19

7.91

2.6

97.10

148.00

ng/l

7.58

1138

9550

Total colectomy operation

153

946

1.68

7.91

3.9

2.9

175.99

185.87

ng/l

0.12

132

857

Total colectomy

153

946

1.68

7.91

3.9

2.9

175.99

185.87

ng/l

0.12

132

857

Haemorrhagic disorder due to circulating anticoagulants

428

2.10

7.88

5.8

3.0

420.03

279.21

ng/l

1.73

395

Adalimumab

263

1823

1.47

7.87

2.2

2.8

104.19

135.15

ng/l

1.06

230

1616

Colorectal cancer

1093

8979

1.21

7.86

2.9

3.2

226.79

243.64

ng/l

0.66

994

8241

Lichen ruber planus, wide definition including periferal and oral lichen planus

873

7178

1.24

7.83

2.5

2.8

167.81

181.35

ng/l

0.39

793

6543

Conjunctivitis

2742

20465

1.13

7.82

2.9

2.8

159.71

178.40

ng/l

1.63

2426

18525

Vasculitis limited to skin, not elsewhere classified

122

717

1.80

7.80

3.9

3.0

237.33

217.25

ng/l

0.23

112

661

Adult respiratory distress syndrome

338

2.21

7.80

4.1

2.9

286.81

201.78

ng/l

0.48

306

Myositis

115

665

1.82

7.74

2.8

3.0

146.09

214.84

ng/l

1.72

101

608

Benign neoplasm: Kidney

158

995

1.67

7.74

2.9

147.92

213.31

ng/l

1.42

145

914

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

361

2664

1.39

7.73

2.4

2.9

219.73

187.55

ng/l

0.64

330

2422

Contusion of other and unspecified parts of foot

142

863

1.69

7.72

2.4

2.9

107.85

153.07

ng/l

1.55

123

767

Other bursitis of hip

513

1.94

7.68

3.1

159.42

216.66

ng/l

1.13

465

Ulcerative colitis, NAS

462

3527

1.33

7.68

3.5

2.9

201.14

176.77

ng/l

0.47

415

3163

Other congenital malformations of the digestive system

174

1108

1.61

7.66

3.3

3.7

197.32

194.09

ng/l

0.04

158

1005

Benign neoplasm: Skin of upper limb, including shoulder

442

2.01

7.65

2.3

3.0

169.27

194.22

ng/l

0.21

400

Anterior Iridocyclitis

755

6128

1.25

7.64

3.4

2.9

186.05

185.85

ng/l

0.00

697

5541

Corns and callosities

271

1910

1.46

7.63

3.3

2.9

214.25

192.15

ng/l

0.38

246

1731

Maternal care for other conditions predominantly related to pregnancy

393

2865

1.36

7.62

2.1

2.4

79.78

89.27

ng/l

0.31

337

2550

Herpesviral [herpes simplex] infections

406

3050

1.36

7.61

3.7

2.8

168.50

182.63

ng/l

0.30

362

2763

Malignant neoplasm of tongue, including Hilmo

127

761

1.77

7.61

1.9

3.1

247.44

215.49

ng/l

0.27

118

702

Carcinoma in situ of skin of scalp and neck

150

945

1.71

7.60

2.8

3.1

284.81

259.88

ng/l

0.21

139

873

Car occupant injured in noncollision transport accident

117

680

1.78

7.58

2.7

2.9

188.47

170.81

ng/l

0.13

107

614

Sacrococcygeal disorders, not elsewhere classified

103

577

1.85

7.58

2.2

3.0

97.60

205.87

ng/l

3.85

507

Allergic conjunctivitis

1905

16273

1.15

7.57

2.5

2.7

156.08

161.66

ng/l

0.24

1663

14693

Intentional self-harm by sharp object

290

2.21

7.55

2.5

2.7

85.70

126.36

ng/l

0.75

252

Other disorders of nervous system

265

1865

1.47

7.53

3.7

2.7

145.01

195.82

ng/l

1.95

251

1696

Papillary adenocarcinoma of thyroid gland

181

1179

1.59

7.51

4.2

3.0

172.67

166.96

ng/l

0.07

166

1067

Injury of nerves at lower leg level

162

2.72

7.47

2.5

2.2

120.19

164.60

ng/l

0.61

141

Dermatitis due to substances taken internally

198

1316

1.55

7.47

3.7

2.7

178.43

196.94

ng/l

0.27

178

1196

Plantar fascial fibromatosis

334

2442

1.40

7.47

2.5

2.7

115.61

177.07

ng/l

3.75

304

2194

Otitis externa, unspecified

369

2741

1.37

7.44

3.6

2.9

176.90

173.77

ng/l

0.04

330

2465

Bursitis of shoulder

101

569

1.86

7.40

2.6

2.9

124.99

190.87

ng/l

1.55

517

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1826

15542

1.15

7.40

2.5

2.7

155.61

161.85

ng/l

0.27

1592

14030

Convalescence

178

1158

1.58

7.38

4.1

2.4

226.53

164.66

ng/l

0.79

156

1039

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

205

2.48

7.38

2.3

2.9

183.74

136.31

ng/l

0.26

187

Other and unspecified intracranial injuries

130

788

1.73

7.36

3.0

2.8

243.43

229.37

ng/l

0.12

119

712

Disorder of external ear, unspecified

132

804

1.72

7.33

3.1

2.9

229.02

196.92

ng/l

0.31

122

737

Other disorders of conjunctiva

597

4754

1.28

7.31

3.7

2.9

233.34

207.35

ng/l

0.67

546

4349

Diseases of external ear

1334

11456

1.18

7.28

3.2

2.9

203.84

203.68

ng/l

0.00

1198

10411

Other disorders starting during childhood or adolescence

101

560

1.82

7.28

7.6

4.2

131.85

157.93

ng/l

0.39

475

Single spontaneous delivery

1126

7062

0.84

7.28

2.8

158.73

188.75

ng/l

2.01

1031

6421

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1060

8873

1.20

7.26

2.7

155.01

149.95

ng/l

0.16

933

7910

Other erythematous conditions

143

892

1.67

7.24

2.3

2.9

171.91

196.36

ng/l

0.35

134

816

Oesophagitis

227

1565

1.50

7.24

3.2

2.9

198.78

212.41

ng/l

0.15

210

1429

Salpingitis and oophoritis

563

4446

1.29

7.24

2.7

2.6

149.55

150.05

ng/l

0.01

520

4034

Unspecified event, undetermined intent

470

1.93

7.24

3.0

2.9

140.76

162.17

ng/l

0.36

423

Chronic lymphocytic leukaemia

146

921

1.68

7.23

2.6

3.2

225.91

240.55

ng/l

0.17

130

852

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

146

921

1.68

7.23

2.6

3.2

225.91

240.55

ng/l

0.17

130

852

Chronic lymphocytic leukaemia, helper endpoint

146

921

1.68

7.23

2.6

3.2

225.91

240.55

ng/l

0.17

130

852

Benign neoplasm of middle ear and respiratory system

325

2387

1.40

7.21

3.0

2.9

289.00

207.46

ng/l

0.59

299

2171

Benign neoplasm of eye and adnexa

417

3179

1.35

7.21

3.6

3.0

196.29

200.34

ng/l

0.06

379

2900

Dextrocardia

14.28

7.20

6.7

3.7

272.83

235.25

ng/l

0.09

Nonsuppurative otitis media

621

4278

1.27

7.18

3.3

2.8

159.82

172.68

ng/l

0.37

547

3785

Nasal polyp

743

6066

1.24

7.16

2.8

3.0

140.75

211.73

ng/l

9.54

675

5532

Pedal cyclist injured in transport accident

751

6131

1.24

7.16

2.9

160.67

172.21

ng/l

0.40

697

5507

Neuroendocrine tumor and carcinoma of pancreas

144

2.89

7.16

3.6

3.3

131.30

221.02

ng/l

1.02

134

Carcinoma in situ of skin of other and unspecified parts of face

458

3558

1.33

7.12

2.8

3.1

314.57

253.57

ng/l

1.55

416

3248

Acute generalized exanthematous pustulosis

167

1083

1.60

7.12

3.7

2.9

163.02

210.34

ng/l

0.92

150

989

Other neurotic disorders

192

1284

1.55

7.12

2.9

2.8

213.55

211.18

ng/l

0.02

173

1168

Abscess of anal and rectal regions

282

2021

1.43

7.12

2.8

2.6

193.78

160.96

ng/l

0.62

248

1818

Mandibular prognathia

240

2.32

7.11

3.0

3.1

128.94

143.79

ng/l

0.11

219

Allergic urticaria

255

1796

1.45

7.10

4.0

3.0

144.79

178.90

ng/l

1.08

225

1613

Atrophic disorders of skin

530

4171

1.29

7.08

2.8

153.69

169.35

ng/l

0.60

475

3776

Other specified/unspecified inflammatory spondylopathies

135

830

1.67

7.06

2.3

2.8

78.91

174.87

ng/l

5.98

126

733

Lateral epicondylitis

417

3177

1.33

7.06

2.6

2.7

128.57

155.09

ng/l

0.76

375

2869

Acute appendicitis, no complications

1886

16540

1.14

7.03

2.8

2.7

159.43

173.60

ng/l

0.82

1678

14931

Problems related to social environment

116

690

1.75

7.02

4.5

3.0

201.67

226.51

ng/l

0.35

105

629

Superficial injury of shoulder and upper arm

410

3125

1.34

7.00

3.0

2.9

202.94

199.81

ng/l

0.05

371

2830

Late syphilis

372

2.06

6.99

2.9

3.2

318.12

171.32

ng/l

1.52

333

Inflammatory bowel disease

1073

9080

1.19

6.97

3.0

2.8

195.41

177.88

ng/l

0.59

963

8166

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

100

571

1.82

6.96

2.5

2.9

87.29

170.26

ng/l

4.12

509

Polyarthritis, unspecified

141

885

1.66

6.93

3.6

2.9

276.35

193.29

ng/l

0.86

126

809

Oxicams

1059

5056

1.20

6.93

3.0

3.3

199.20

308.10

ng/l

12.01

960

4662

Contusion of toe(s) without damage to nail

399

1.98

6.87

2.6

2.8

138.70

144.36

ng/l

0.05

356

Hypocalcemia

532

1.86

6.87

4.4

3.0

393.19

195.66

ng/l

1.09

481

Unspecified/other endometriosis

216

1481

1.48

6.85

2.3

2.7

94.25

161.13

ng/l

2.57

197

1337

Bruxism

270

2.20

6.84

2.6

2.8

72.86

128.23

ng/l

1.57

243

Status epilepticus

145

920

1.64

6.83

4.6

2.7

197.36

234.60

ng/l

0.52

135

839

Malignant neoplasm of endocrine gland

256

1823

1.44

6.81

3.6

3.0

173.03

177.49

ng/l

0.06

233

1657

Other diseases of spinal cord

119

720

1.73

6.80

3.3

2.8

158.33

203.07

ng/l

0.76

109

655

Other/unspecified synovitis and tenosynovitis

401

3060

1.34

6.78

3.0

2.8

267.29

194.50

ng/l

0.62

361

2763

Unspecified abortion

132

816

1.66

6.77

2.5

2.9

65.29

100.18

ng/l

1.99

118

727

Other specified disorders of muscle

116

698

1.73

6.76

3.2

3.1

234.42

218.60

ng/l

0.13

111

634

Viral warts

665

5394

1.25

6.75

3.1

2.8

161.61

163.28

ng/l

0.04

607

4844

Myeloid leukaemia

124

763

1.71

6.75

3.9

3.0

227.76

230.98

ng/l

0.04

116

702

Granulomatous disorders of skin and subcutaneous tissue

533

1.84

6.74

3.4

2.8

134.54

166.99

ng/l

0.62

486

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

156

1002

1.58

6.74

2.2

2.5

94.74

79.74

ng/l

0.19

137

895

Benign lipomatous neoplasm

1166

9979

1.18

6.72

2.8

182.51

194.10

ng/l

0.41

1047

9070

Colonic or urogenital fistula

1012

8558

1.20

6.72

2.6

2.9

191.11

192.86

ng/l

0.04

910

7745

Other and unspecified rosacea

302

2215

1.40

6.72

3.1

2.8

162.81

180.03

ng/l

0.36

271

2008

Emotional disorders starting during childhood or adolecense, excluding more controls

375

1.96

6.71

3.2

2.8

69.75

111.18

ng/l

0.79

326

Hypothyroidism due to medicaments and other exogenous substances

255

2.28

6.71

3.2

2.8

184.56

191.87

ng/l

0.07

225

Carcinoma in situ of skin of upper limb, including shoulder

141

903

1.67

6.70

3.0

3.1

274.46

259.20

ng/l

0.14

125

828

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

221

1531

1.47

6.70

2.2

2.8

110.57

147.14

ng/l

1.57

192

1365

Algoneurodystrophy

100

577

1.79

6.69

2.5

2.6

74.81

131.26

ng/l

3.08

518

Restless leg syndrome

506

3993

1.29

6.69

2.7

2.9

167.96

190.31

ng/l

0.83

458

3627

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

258

2.32

6.67

2.9

3.5

320.46

248.04

ng/l

0.41

238

Haemorrhage in early pregnancy

680

5380

1.24

6.66

2.4

2.5

103.01

122.85

ng/l

0.80

615

4851

Post-traumatic wound infection, not elsewhere classified

105

618

1.78

6.66

3.4

2.9

337.79

193.26

ng/l

1.41

561

Impetigo

127

782

1.67

6.64

3.3

110.31

160.85

ng/l

1.70

112

701

Other noninfective disorders of lymphatic vessels and lymph nodes

139

880

1.64

6.62

4.0

2.8

195.32

185.54

ng/l

0.11

124

796

Other/unspecified soft tissue disorders related to use, overuse and pressure

100

580

1.79

6.62

3.9

2.8

144.22

170.08

ng/l

0.48

527

Coeliac disease

409

3141

1.33

6.61

3.3

2.9

146.79

176.63

ng/l

1.54

366

2840

Malignant neoplasm of colon, including Hilmo

875

7325

1.22

6.60

3.0

3.2

214.92

247.46

ng/l

1.60

792

6723

Nonspecific lymphadenitis

182

1220

1.53

6.59

2.8

2.9

195.64

145.78

ng/l

0.43

169

1093

Lesion of radial nerve

146

937

1.62

6.57

3.2

2.9

198.65

214.37

ng/l

0.16

132

860

!Aliquae complicationes praecoces traumatis

165

1088

1.57

6.56

3.6

2.8

307.65

208.01

ng/l

1.34

154

986

Early complications of trauma

165

1088

1.57

6.56

3.6

2.8

307.65

208.01

ng/l

1.34

154

986

Other diseases of peritoneum

179

1203

1.54

6.55

2.9

2.8

176.29

202.33

ng/l

0.48

164

1101

Open wound of abdomen, lower back and pelvis

103

604

1.77

6.54

2.9

3.0

364.50

181.47

ng/l

0.98

539

Focal epilepsy

808

6713

1.22

6.53

3.0

168.65

211.02

ng/l

3.13

735

6073

Early lumbar disc prolapse, operated

213

1471

1.47

6.51

2.5

2.7

75.76

102.13

ng/l

0.76

183

1280

Primary biliary cholangitis (PBC)

512

1.85

6.47

2.7

2.9

255.06

173.04

ng/l

0.75

465

Small fibre neuropathy

125

779

1.69

6.46

3.8

2.9

202.66

192.81

ng/l

0.09

113

710

Dermatophytosis

519

4128

1.28

6.46

3.5

2.9

208.22

205.47

ng/l

0.06

481

3742

Malignant neoplasm of thyroid gland

237

1682

1.45

6.45

3.7

2.9

170.76

174.14

ng/l

0.05

217

1528

Other endocrine disorders

157

980

1.58

6.45

5.1

3.8

217.34

181.15

ng/l

0.30

146

883

Achilles tendinitis

355

2684

1.35

6.45

2.9

2.7

152.66

192.73

ng/l

1.50

326

2429

Anomalies of pupillary function

381

1.97

6.43

2.7

2.8

97.70

165.68

ng/l

1.91

345

Acute and subacute iridocyclitis

697

5720

1.24

6.43

3.3

2.8

188.53

184.19

ng/l

0.08

641

5170

Ethmoidectomy

425

3296

1.31

6.40

2.9

2.8

113.70

162.56

ng/l

3.18

390

2968

Congenital malformations of the musculoskeletal system, not elsewhere classified

199

2.37

6.40

1.8

2.6

90.31

108.70

ng/l

0.23

178

Sequelae of intentional self-harm, assault and events of undetermined intent

3.27

6.39

2.6

2.4

62.26

91.06

ng/l

0.60

Nephrotic syndrome

123

764

1.68

6.39

4.6

3.3

605.69

198.69

ng/l

2.68

114

698

Monoplegia

342

2.05

6.38

5.6

3.0

237.93

195.06

ng/l

0.24

311

Pulmonary eosinophilia, not elsewhere classified

316

2.12

6.37

3.2

3.1

239.39

208.18

ng/l

0.18

289

Effects of foreign body entering through natural orifice

842

7039

1.21

6.36

3.2

2.9

159.36

184.78

ng/l

1.00

748

6338

Other disorders of Eustachian tube

107

641

1.74

6.35

2.9

150.89

168.12

ng/l

0.18

102

585

Endometriosis

1112

5544

1.19

6.35

2.6

2.7

118.10

196.62

ng/l

13.88

1011

5042

Acute and transient psychotic disorders

356

2696

1.34

6.35

2.6

2.8

147.14

162.13

ng/l

0.29

307

2398

Trigeminal neuralgia

219

1538

1.47

6.34

3.3

2.9

146.60

199.81

ng/l

1.39

189

1391

Giant cell arteritis

199

1381

1.51

6.33

3.3

2.9

235.33

227.10

ng/l

0.09

182

1263

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

253

1819

1.42

6.32

2.1

2.6

158.19

134.75

ng/l

0.33

223

1645

Delivery, wide proxy

989

6203

0.84

6.30

2.8

2.9

173.02

196.62

ng/l

1.21

916

5638

Inflammatory diseases of the central nervous system

292

2154

1.39

6.29

2.7

2.9

182.57

189.17

ng/l

0.09

260

1936

Malignant neoplasm of retroperitoneum and peritoneum

198

2.46

6.28

2.0

3.4

112.97

240.58

ng/l

2.51

183

Intracerebral haemorrhage

587

4754

1.26

6.28

3.6

3.0

251.43

258.60

ng/l

0.15

527

4342

Hypothermia

474

1.88

6.26

3.8

3.2

234.09

251.51

ng/l

0.15

430

Caught, crushed, jammed or pinched in or between objects

161

1065

1.55

6.26

2.9

3.0

136.07

162.54

ng/l

0.51

150

963

Other disorders of patella

493

3900

1.28

6.25

2.6

2.7

136.82

155.85

ng/l

0.39

444

3528

Secondary parkinsonism+Parkinsonism in other disease

130

826

1.65

6.24

3.7

3.1

163.77

251.91

ng/l

2.76

116

754

Noise effects on inner ear

167

1119

1.55

6.23

2.8

196.01

209.77

ng/l

0.16

150

1015

Use of disulfiram, acamprosate or naltrexone

270

1968

1.40

6.23

2.8

2.7

153.56

145.91

ng/l

0.12

242

1751

Other and unspecified injuries of thorax

372

1.98

6.23

4.1

3.1

202.47

220.56

ng/l

0.10

337

Radial styloid tenosynovitis [de Quervain]

164

1089

1.54

6.22

3.2

2.8

163.92

155.59

ng/l

0.09

147

967

Sub-endpoint used in defining T1D endpoints

1086

9141

1.18

6.22

3.6

3.0

320.63

224.64

ng/l

5.48

1009

8188

Cerebral palsy

234

2.23

6.21

2.9

2.7

138.52

135.34

ng/l

0.02

209

Polycystic ovarian syndrome

535

1.77

6.18

2.5

2.6

80.23

77.22

ng/l

0.06

462

Malignant neoplasm of thyroid gland, including Hilmo

266

1941

1.41

6.16

3.5

2.9

162.93

174.15

ng/l

0.19

242

1758

Otalgia

261

1897

1.41

6.16

3.3

3.0

136.57

191.49

ng/l

2.20

237

1709

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

876

7366

1.20

6.16

2.9

2.7

153.90

160.07

ng/l

0.18

791

6605

Benign neoplasm: Rectosigmoid junction

186

1282

1.51

6.12

2.9

3.0

232.24

221.21

ng/l

0.12

172

1177

Monoamine oxidase A inhibitors

421

3284

1.31

6.11

2.5

2.8

149.48

181.90

ng/l

1.10

384

2991

Haemangioma, any site

301

2244

1.37

6.09

2.8

2.9

154.25

189.18

ng/l

0.91

271

2037

Sleep disorders, other/unspecified

555

1.76

6.09

2.4

3.1

153.41

157.70

ng/l

0.04

488

Mixed conductive and sensorineural hearing loss

522

4189

1.27

6.08

2.9

177.74

215.14

ng/l

1.59

478

3818

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

110

670

1.69

6.08

2.2

2.9

122.90

152.79

ng/l

0.78

598

Acne

191

1308

1.48

6.06

3.4

2.8

116.25

106.58

ng/l

0.16

162

1112

Prepatellar bursitis

172

1165

1.52

6.05

3.4

2.9

216.53

197.41

ng/l

0.23

156

1054

Contact with sharp object, undetermined intent

440

1.87

6.03

2.0

2.9

130.56

169.10

ng/l

0.68

393

Certain conditions originating in the perinatal period

160

937

1.54

6.03

3.2

4.0

99.18

139.17

ng/l

1.54

142

805

Ulcerative proctitis

190

1310

1.49

6.02

2.9

2.7

230.15

164.06

ng/l

0.78

168

1181

Intentional self-harm by unspecified means

154

2.51

6.02

2.4

2.5

116.72

124.85

ng/l

0.07

134

Herpesviral [herpes simplex] infections

751

6243

1.22

6.02

2.9

2.7

146.98

162.18

ng/l

0.58

664

5643

Ankylosing spondylitis

283

2091

1.38

6.00

2.6

2.8

148.11

197.84

ng/l

1.64

256

1884

Spondylopathies in diseases classified elsewhere

309

2.09

5.99

2.7

2.9

153.88

220.17

ng/l

1.16

282

Anti-inflammatory and antirheumatic products, non-steroids

1256

5439

1.17

5.99

3.0

3.4

218.92

296.80

ng/l

6.98

1132

4987

Alcoholic liver disease

394

3062

1.32

5.98

2.9

296.47

206.21

ng/l

0.96

366

2772

Other encephalitis

103

622

1.73

5.97

2.3

3.0

184.58

207.85

ng/l

0.18

562

Haemangioma and lymphangioma, any site

317

2390

1.36

5.94

2.7

3.0

150.80

190.34

ng/l

1.17

287

2168

Secondary parkinsonism

126

805

1.64

5.94

3.7

3.1

166.44

243.53

ng/l

2.18

112

736

Other and unspecified disorders of skin and subcutaneous tissue

113

1781

0.62

5.92

4.9

3.0

207.08

200.02

ng/l

0.08

103

1613

Other specified/unspecified soft tissue disorders

195

1360

1.48

5.92

3.6

3.0

215.30

227.73

ng/l

0.14

177

1226

Generalized skin eruption due to drugs and medicaments

143

937

1.58

5.90

4.0

3.0

165.11

215.22

ng/l

0.84

129

854

Erythema intertrigo

100

603

1.74

5.90

3.7

2.9

238.42

215.72

ng/l

0.25

554

Dislocation, sprain and strain of joint and ligaments of hip

162

1094

1.54

5.89

2.5

3.1

198.14

229.79

ng/l

0.41

155

998

Strabismus

888

7493

1.20

5.89

3.4

2.9

176.44

177.69

ng/l

0.03

789

6759

Vitamin D deficiency

322

2.01

5.88

2.9

2.8

136.86

151.43

ng/l

0.19

294

L02BB Anti-androgens

455

3618

1.29

5.87

2.9

3.1

231.63

278.14

ng/l

1.52

428

3353

Crohn disease

392

3043

1.31

5.86

2.9

2.8

159.62

162.80

ng/l

0.06

346

2717

Carcinoma in situ of skin

412

3240

1.31

5.85

3.1

3.0

250.93

233.00

ng/l

0.32

380

2964

Postmenopausal bleeding

1090

4976

1.18

5.85

2.8

173.32

218.40

ng/l

3.29

969

4553

Inguinal hernia, unilateral

118

745

1.66

5.81

3.1

3.0

193.97

205.23

ng/l

0.15

105

688

Inguinal of femoral hernia, unilateral

118

745

1.66

5.81

3.1

3.0

193.97

205.23

ng/l

0.15

105

688

Femoral hernia, unilateral

118

745

1.66

5.81

3.1

3.0

193.97

205.23

ng/l

0.15

105

688

Hypertrophy of breast in women and men

572

4646

1.25

5.80

2.3

2.6

122.30

146.63

ng/l

1.01

508

4216

Autonomic disorders

529

1.78

5.80

2.4

2.7

159.68

209.36

ng/l

0.41

484

Bulimia nervosa (incl. atypical)

321

1.97

5.80

2.8

58.40

79.69

ng/l

0.65

272

Infection due to other mycobacteria

405

1.91

5.79

3.4

3.0

139.85

199.24

ng/l

1.44

365

Carcinoma in situ of skin of ear and external auricular canal

513

1.83

5.79

3.0

3.1

348.00

266.80

ng/l

0.74

467

Multiple myeloma and malignant plasma cell neoplasms

223

1607

1.44

5.78

3.9

3.0

281.39

236.19

ng/l

0.70

204

1473

Malignant neoplasm of head and neck

345

2649

1.34

5.77

2.4

3.2

298.22

234.08

ng/l

0.91

312

2440

Recurrent dislocation of patella

105

638

1.68

5.76

1.8

2.7

66.78

115.96

ng/l

2.78

565

Other congenital malformations of skin

122

774

1.62

5.75

2.9

3.1

126.19

177.47

ng/l

1.46

107

699

Injury of other and unspecified intrathoracic organs

253

1857

1.40

5.74

2.8

2.9

252.35

216.14

ng/l

0.45

232

1688

Hepatocellular carcinoma

112

704

1.69

5.73

2.9

3.2

238.89

272.86

ng/l

0.41

102

658

Chronic iridocyclitis

178

1228

1.49

5.72

3.2

2.8

154.15

198.55

ng/l

1.08

161

1110

Intercostal neuropathy

173

2.45

5.71

4.0

3.0

99.24

218.73

ng/l

3.59

160

Temporal arteritis

175

1212

1.51

5.69

3.3

2.9

209.12

226.68

ng/l

0.22

158

1112

Syndactyly

4.00

5.69

2.3

2.1

69.83

84.02

ng/l

0.18

Benign neoplasm: Transverse colon

463

3700

1.28

5.69

3.1

3.0

237.77

211.08

ng/l

0.71

425

3391

Other specified/unspecified necrotizing vasculopathies

336

2.00

5.67

3.1

3.3

240.41

229.27

ng/l

0.07

302

Normotensive glaucoma

411

3245

1.30

5.66

3.4

3.0

209.39

227.04

ng/l

0.54

379

2976

Viral agents as the cause of diseases classified to other chapters

458

1.83

5.64

4.4

3.1

250.02

172.20

ng/l

0.54

414

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1049

9032

1.17

5.64

2.7

2.9

202.05

188.01

ng/l

0.26

937

8143

Wegener granulomatosis

365

1.95

5.63

3.3

106.98

210.93

ng/l

2.94

332

Vascular dementia (undefined)

221

1579

1.43

5.63

4.1

3.5

397.32

382.02

ng/l

0.15

196

1431

Dermatographic urticaria

183

1270

1.47

5.61

2.9

2.7

128.28

159.81

ng/l

0.65

162

1133

Encephalitis

107

664

1.67

5.60

2.3

2.9

180.85

207.47

ng/l

0.22

601

Unspecified jaundice

214

1536

1.44

5.59

3.2

2.8

323.39

231.94

ng/l

1.43

197

1395

Burn and corrosion of trunk

109

680

1.67

5.59

3.1

3.0

154.50

193.98

ng/l

0.65

617

Intracranial and intraspinal abscess and granuloma

275

2.11

5.57

2.6

2.9

235.82

228.42

ng/l

0.05

243

Leisure time condition

665

5517

1.22

5.57

3.6

2.9

179.07

198.88

ng/l

0.85

611

4977

Other specified/unspecified spondylopathies

115

731

1.65

5.55

3.6

2.9

314.55

249.06

ng/l

0.34

105

664

Other and specified injuries of hip and thigh

100

614

1.71

5.54

3.5

3.3

224.73

239.17

ng/l

0.12

561

Acute alcohol intoxication

947

8102

1.18

5.54

3.0

2.9

236.46

217.38

ng/l

0.32

863

7340

Anuria and oliguria

163

2.49

5.53

5.9

4.8

303.06

227.57

ng/l

0.27

147

Malignant neoplasm of colon

687

5733

1.22

5.53

3.2

222.07

238.98

ng/l

0.52

629

5259

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

101

617

1.68

5.52

3.2

2.6

370.27

98.73

ng/l

3.46

541

Malignant neoplasm of rectosigmoid junction, including Hilmo

141

941

1.57

5.52

2.9

3.1

241.00

257.48

ng/l

0.15

126

873

Sequelae of injuries of head

180

1253

1.48

5.51

2.7

176.79

181.49

ng/l

0.06

164

1133

Melanocytic naevi of trunk

398

3126

1.30

5.51

3.5

2.9

179.15

181.85

ng/l

0.06

364

2822

Calcific tendinitis of shoulder

187

1311

1.46

5.49

3.5

2.6

109.16

171.15

ng/l

3.39

174

1177

Pedal cyclist injured in noncollision transport accidents

360

2792

1.31

5.48

2.9

2.8

170.15

169.77

ng/l

0.01

338

2494

Generalized epilepsy, mode (most common among epilepsy diagnosis)

535

1.73

5.48

2.4

3.0

92.87

151.60

ng/l

1.79

479

Other ulcerative colitis

177

1228

1.48

5.48

3.4

2.8

278.17

169.15

ng/l

1.37

164

1102

Hypermobility syndrome

112

702

1.63

5.48

1.9

2.5

111.98

97.08

ng/l

0.11

613

Benign neoplasm: Choroid

257

1910

1.39

5.47

4.0

2.9

193.11

200.59

ng/l

0.09

231

1741

Other and unspecified glaucoma

337

2606

1.33

5.46

2.8

3.1

252.00

241.08

ng/l

0.20

308

2379

Heterophoria

233

1696

1.40

5.46

4.6

3.0

149.49

174.02

ng/l

0.51

209

1516

Viral agents as the cause of diseases classified to other chapters

530

1.75

5.46

4.2

3.0

237.42

169.33

ng/l

0.52

478

Open wound of shoulder and upper arm

396

1.87

5.46

2.9

3.0

192.98

182.88

ng/l

0.10

353

Other and unspecified iridocyclitis

156

1059

1.52

5.45

3.0

3.1

149.72

177.92

ng/l

0.71

145

957

Tongue abnormality

240

1764

1.40

5.45

2.8

2.9

161.63

195.79

ng/l

0.88

217

1607

Other diseases of gallbladder

187

1318

1.47

5.44

2.7

2.9

212.62

212.69

ng/l

0.00

170

1199

All dysplastic lesions of the vulva

134

881

1.57

5.44

2.3

2.9

207.25

156.47

ng/l

0.57

119

788

Corneal scars and opacities

112

710

1.65

5.44

4.3

3.0

364.62

195.53

ng/l

1.14

104

646

Exposure to other and unspecified animate mechanical forces

491

1.76

5.43

2.9

200.48

154.29

ng/l

0.32

438

Scar conditions and fibrosis of skin

127

825

1.58

5.43

3.3

2.8

134.27

157.37

ng/l

0.43

114

743

Benign neoplasm of urinary organs

199

1420

1.45

5.43

2.9

185.30

212.73

ng/l

0.31

182

1299

Squamous cell neoplasms and carcinomas of the skin

414

3286

1.29

5.42

3.5

3.3

340.25

272.00

ng/l

1.51

379

3033

Other specified and unspecified disorders of lens

302

2.08

5.42

6.3

2.9

346.71

226.12

ng/l

0.44

281

Malignant neoplasm of mesothelium and soft tissue

176

1230

1.49

5.42

2.3

3.1

206.32

225.57

ng/l

0.27

154

1129

Cutaneous lupus erythematosus

563

1.73

5.41

2.6

2.8

232.24

195.16

ng/l

0.26

520

Thyroiditis, unspecified

305

2.00

5.38

3.0

2.8

147.32

152.96

ng/l

0.05

280

Unspecified chronic bronchitis

149

1007

1.53

5.37

3.7

2.9

170.62

258.77

ng/l

2.11

132

915

Hypopituitarism

216

1559

1.42

5.35

3.6

3.2

137.86

170.67

ng/l

0.65

186

1396

Other superficial mycoses

285

2146

1.35

5.35

2.7

2.9

164.83

159.37

ng/l

0.10

249

1915

Portal vein thrombosis

364

1.92

5.34

2.9

3.1

211.35

196.23

ng/l

0.10

322

Colorectal adenocarcinoma

896

7652

1.19

5.34

2.8

3.2

239.36

247.88

ng/l

0.23

814

7022

Generalized epilepsy

120

772

1.59

5.33

2.6

3.0

107.59

162.19

ng/l

1.59

110

690

Congenital malformations of the musculoskeletal system, not elsewhere classified

236

2.11

5.29

1.8

2.6

87.08

107.76

ng/l

0.30

211

Corneal ulcer

619

5125

1.22

5.29

3.0

2.9

171.91

177.65

ng/l

0.11

559

4618

Crossbite

165

1047

1.48

5.28

4.2

3.6

158.27

147.33

ng/l

0.10

146

926

Giant cell arteritis with polymyalgia rheumatica

175

1231

1.48

5.27

3.3

2.9

209.12

230.79

ng/l

0.29

158

1130

Ehlers-Danlos syndrome

103

2.75

5.27

1.7

2.2

40.32

89.42

ng/l

1.69

Dysplastic lesion of unknown severity of the cervix uteri

127

2.57

5.27

2.5

2.3

93.69

122.38

ng/l

0.21

117

Other and unspecified vasculitis limited to skin

102

638

1.68

5.27

4.1

3.1

254.64

219.07

ng/l

0.38

590

Insulin, fast-acting (human)

431

3433

1.27

5.27

3.1

2.8

364.81

184.74

ng/l

4.90

399

3032

Rash and other nonspecific skin eruption

345

2681

1.31

5.25

2.6

3.1

225.21

198.77

ng/l

0.45

312

2428

Effects of other external causes

481

1.76

5.25

2.5

3.7

101.25

147.81

ng/l

1.26

418

Chronic laryngitis and laryngotracheitis

513

4178

1.25

5.22

3.0

2.9

155.67

195.87

ng/l

1.66

466

3818

Abnormality of white blood cells, not elsewhere classified

180

2.33

5.20

4.6

2.8

223.33

177.81

ng/l

0.31

161

Benign neoplasm: Liver

439

1.80

5.20

2.0

2.8

132.57

166.36

ng/l

0.45

399

Lymphoid leukaemia

243

1807

1.39

5.19

2.7

3.2

240.58

238.37

ng/l

0.03

216

1654

Injury of blood vessels at hip and thigh level

3.53

5.19

2.9

3.4

226.00

177.37

ng/l

0.26

Other injuries of upper limb, level unspecified

240

2.12

5.17

2.0

2.7

291.32

175.13

ng/l

0.30

215

Graves disease, strict definition

285

2159

1.34

5.17

3.2

2.8

140.24

154.21

ng/l

0.41

250

1939

Malignant neoplasm of tongue

542

1.73

5.16

1.8

3.3

259.79

219.71

ng/l

0.25

495

Disorders of orbit

149

1015

1.51

5.14

2.4

3.0

181.11

165.90

ng/l

0.19

129

928

Acne vulgaris

141

943

1.51

5.14

3.6

2.8

94.96

87.32

ng/l

0.11

121

790

Other peripheral vertigo

363

2852

1.30

5.14

3.0

2.9

137.32

200.83

ng/l

5.83

340

2597

212

2881

0.72

5.12

2.8

3.0

436.58

242.82

ng/l

1.17

193

2632

Habit and impulse disorders

219

2.13

5.11

2.1

2.6

69.49

106.63

ng/l

0.84

187

Benign neoplasm of meninges

414

3308

1.28

5.10

2.6

2.9

165.66

192.52

ng/l

1.02

376

3017

Seropositive rheumatoid arthritis, strict definition

557

4589

1.23

5.09

2.7

2.8

212.01

178.20

ng/l

1.02

509

4174

Disorders of lacrimal system and orbit in diseases classified elsewhere

488

1.74

5.06

2.7

146.93

157.71

ng/l

0.12

449

Propionic acid derivatives

1240

5439

1.16

5.05

3.0

3.4

210.72

296.80

ng/l

8.35

1122

4987

Antenatal screening

249

1879

0.74

5.03

2.2

74.64

78.68

ng/l

0.12

213

1652

Bell's palsy

420

3364

1.27

5.00

3.0

2.9

181.54

200.27

ng/l

0.47

372

3053

Fasciculation

209

2.17

4.99

2.6

2.5

83.69

166.50

ng/l

2.08

186

Speech disturbances, not elsewhere classified

373

2954

1.29

4.98

4.3

2.9

217.08

230.02

ng/l

0.24

350

2681

FESS (DNB20)

395

3141

1.28

4.97

2.7

2.8

104.49

161.34

ng/l

4.26

362

2824

Infections with a predominantly sexual mode of transmission

735

6198

1.19

4.97

2.5

2.6

176.00

132.78

ng/l

1.55

634

5490

Left hemicolectomy

108

697

1.63

4.97

4.0

3.1

248.78

243.72

ng/l

0.04

643

Inflammatory disorders of breast

157

1085

1.47

4.95

2.2

2.9

137.54

139.99

ng/l

0.03

134

973

Peptic ulcer

224

2.14

4.95

3.3

2.8

269.71

240.65

ng/l

0.11

205

False labour

540

2744

1.23

4.94

2.0

2.4

45.65

83.75

ng/l

9.20

468

2424

Sequelae of injuries of neck and trunk

105

670

1.62

4.94

3.1

2.7

122.89

168.63

ng/l

1.57

606

Central retinal artery occlusion

113

739

1.61

4.94

3.2

3.1

266.23

253.20

ng/l

0.13

107

682

Benign neoplasm: Caecum

464

3774

1.26

4.94

3.2

3.0

235.15

210.83

ng/l

0.55

426

3458

Secondary polycythaemia

578

1.68

4.93

3.4

3.0

293.67

190.67

ng/l

1.49

522

Benign neoplasm: Rectum, anus and anal canal

864

7428

1.18

4.93

2.7

2.9

242.41

213.23

ng/l

1.00

783

6808

Other/unspecified enthesopathies, not elsewhere classified

310

2398

1.32

4.92

3.0

2.9

222.47

208.19

ng/l

0.18

273

2166

Type 1 diabetes, wide definition, subgroup 2

471

0.35

4.91

4.5

3.1

836.21

309.90

ng/l

1.49

433

Unspecified nephritic syndrome

548

1.70

4.90

3.3

3.0

299.11

212.65

ng/l

0.80

497

Congenital iodine-deficiency syndrome/hypothyroidism

122

809

1.57

4.90

3.4

2.9

213.75

220.76

ng/l

0.07

112

739

Contact with lifting and transmission devices, not elsewhere classified

389

1.83

4.89

2.4

2.9

170.53

165.90

ng/l

0.03

350

Benign neoplasm: Cerebral meninges

375

2979

1.29

4.88

2.5

2.9

160.16

194.84

ng/l

1.56

339

2719

Campylobacter enteritis

618

1.65

4.87

2.8

3.0

222.92

202.70

ng/l

0.15

563

Hemiplegia

185

1327

1.43

4.86

3.1

2.9

226.88

219.85

ng/l

0.07

159

1205

Nontraumatic intracranial haemmorrhage

883

7607

1.18

4.86

3.4

3.0

259.03

246.31

ng/l

0.36

791

6935

Thrombocytopenia, unspecified

277

2118

1.34

4.85

3.4

2.9

303.97

206.16

ng/l

2.53

256

1938

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

475

1.76

4.84

2.1

3.1

121.80

202.49

ng/l

2.59

432

Combined immunodeficiencies

226

2.12

4.83

3.1

2.6

154.42

190.50

ng/l

0.35

206

Mixed disorders of conduct and emotions, excluding more controls

163

2.25

4.83

1.9

3.0

25.00

88.16

ng/l

1.94

138

Fluid overload

3.37

4.83

5.4

3.7

193.92

220.82

ng/l

0.14

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

154

1073

1.48

4.82

2.9

211.74

200.89

ng/l

0.11

142

977

Other degenerative diseases of the basal ganglia

547

1.71

4.81

3.1

3.2

129.38

229.86

ng/l

3.97

498

Spontaneous rupture of synovium and tendon

308

2391

1.32

4.79

3.2

2.8

157.70

206.89

ng/l

1.51

282

2172

Ménière disease

378

3013

1.28

4.79

3.1

2.9

210.08

211.50

ng/l

0.02

354

2748

Chronic tubulo-interstitial nephritis

139

950

1.51

4.76

2.8

2.7

238.15

202.09

ng/l

0.44

126

851

Psoriatic and enteropathic arthropathies

360

2846

1.28

4.76

3.0

2.7

200.74

162.40

ng/l

0.71

310

2583

Foreign body in respiratory tract

173

1231

1.44

4.76

4.2

2.9

132.11

189.77

ng/l

1.69

153

1116

Postzoster neuralgia

486

1.75

4.76

3.7

3.1

314.80

247.55

ng/l

0.46

454

Retinal detachment with retinal break

539

4466

1.23

4.74

2.9

212.87

206.56

ng/l

0.12

502

4071

Assault by sharp object

254

2.00

4.72

2.7

2.6

70.55

112.63

ng/l

1.39

214

Emotional disorders and disorders of social functioning with onset specific to childhood

470

1.70

4.72

3.0

3.4

50.49

121.94

ng/l

2.74

404

Nail dystrophy

123

2.55

4.72

2.6

77.34

135.58

ng/l

1.32

110

Vulvovaginal ulceration/inflammation in other diseases

136

923

1.50

4.71

2.1

2.8

112.91

126.89

ng/l

0.25

115

821

Other congenital malformations of integument

3.32

4.71

3.8

2.2

372.37

184.30

ng/l

1.19

Anorexia (incl.atypical)

135

914

1.50

4.71

2.2

3.1

191.27

163.94

ng/l

0.17

112

811

Ulcer of vagina/vulva

498

1.70

4.71

2.9

2.7

96.52

190.89

ng/l

3.80

455

Focal epilepsy, strict definition

740

6299

1.19

4.71

3.0

176.96

212.83

ng/l

2.11

673

5709

Immunodeficiency associated with other major defects

3.85

4.68

4.3

2.0

150.80

180.63

ng/l

0.17

Ehlers-Danlos syndrome

128

2.43

4.68

1.7

2.4

41.55

92.30

ng/l

2.14

111

Acute lymphadenitis

167

1183

1.44

4.67

2.9

2.8

198.00

169.06

ng/l

0.31

147

1060

Benign neoplasm: Liver/bile ducts

515

1.69

4.66

2.1

2.9

127.20

166.15

ng/l

0.61

468

Bacterial, viral and other infectious agents

271

2073

1.33

4.65

3.6

3.0

232.59

161.83

ng/l

1.47

240

1843

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

194

2.16

4.65

2.6

2.4

91.74

136.59

ng/l

0.52

176

Foreign body in ear

372

1.82

4.64

3.3

3.2

141.93

153.07

ng/l

0.14

334

Other and unspecified corneal deformities and disorders

112

737

1.57

4.63

3.3

2.8

187.84

189.41

ng/l

0.01

105

669

Injury of nerves and spinal cord at neck level

549

1.67

4.63

2.9

164.44

210.31

ng/l

0.62

499

Pyogenic granuloma

358

1.84

4.63

4.0

2.9

175.56

204.55

ng/l

0.23

324

LSIL lesion of the vulva

539

1.67

4.62

2.2

2.7

200.22

145.56

ng/l

0.48

483

Diabetic neuropathy

501

4118

1.24

4.62

3.8

3.5

279.02

252.88

ng/l

0.47

466

3747

Other and unspecified epidermal thickening

635

1.62

4.61

3.6

2.8

190.48

188.04

ng/l

0.02

582

Colon adenocarcinoma

536

4455

1.23

4.61

3.2

3.1

242.50

237.90

ng/l

0.09

491

4095

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

271

1.96

4.60

2.4

3.3

118.44

165.11

ng/l

0.59

248

Convergent concomitant strabismus

152

1061

1.46

4.60

3.0

197.73

153.80

ng/l

0.35

131

943

Senility

286

1.95

4.59

2.2

3.3

347.83

268.83

ng/l

0.52

260

Atypical mycobacterium lung infection

310

1.93

4.58

3.8

3.0

179.16

183.70

ng/l

0.04

279

Amputation of thigh

148

1038

1.49

4.57

5.6

3.2

509.45

279.97

ng/l

3.46

138

950

L04AC Interleukin inhibitors

156

1096

1.45

4.57

2.3

2.7

133.54

147.81

ng/l

0.21

143

967

Disorders of synovium and tendon in diseases classified elsewhere

512

1.69

4.56

2.8

2.9

108.58

182.60

ng/l

2.42

462

Crohn's disease of large intestine

144

998

1.47

4.55

2.8

177.05

163.18

ng/l

0.15

129

893

Polypectomy (DHB20)

246

1868

1.35

4.55

2.4

2.8

124.48

188.13

ng/l

3.83

223

1696

Paraplegia, diplegia of upper limbs

536

1.67

4.54

3.0

2.9

181.91

207.79

ng/l

0.24

495

Malignant neoplasm of liver and intrahepatic bile ducts

135

932

1.51

4.53

2.8

3.2

234.44

277.65

ng/l

0.65

124

865

Graves ophthalmopathy, strict

435

1.74

4.53

2.7

2.8

157.30

165.39

ng/l

0.08

402

Perineal laceration during delivery

151

1793

0.70

4.53

1.8

2.3

49.98

81.03

ng/l

3.02

126

1578

Other diseases of biliary tract

364

2910

1.28

4.53

3.0

2.9

241.77

226.53

ng/l

0.23

345

2652

Psoriasis

1016

8885

1.15

4.52

3.0

2.9

205.18

182.38

ng/l

0.78

910

8044

Complications of genitourinary prosthetic devices, implants and grafts

591

1.63

4.51

2.8

2.9

163.09

192.21

ng/l

0.41

540

IgA nephropathy (IgA glomerulonephritis)

505

1.69

4.51

2.9

494.89

167.65

ng/l

2.63

451

Metabolic disorder, other/unspecified

3.69

4.50

8.8

2.6

410.87

155.35

ng/l

0.53

Viral infections of the central nervous system

245

1859

1.34

4.49

3.0

3.1

178.61

182.45

ng/l

0.04

220

1682

Herpesviral keratitis and keratoconjunctivitis

161

1146

1.45

4.49

3.9

2.9

167.51

196.60

ng/l

0.56

143

1043

Erythema multiforme

498

1.69

4.48

2.6

3.0

164.86

188.33

ng/l

0.25

451

Hypoparathyroidism

147

1033

1.47

4.46

4.5

2.9

166.80

196.22

ng/l

0.75

137

944

Intestinal malabsorption

157

1113

1.45

4.45

3.5

2.9

255.31

182.55

ng/l

0.86

136

1006

Dislocation of lens

479

1.72

4.45

2.2

2.9

219.75

266.53

ng/l

0.52

439

Chronic mastoiditis

113

755

1.56

4.45

3.6

3.0

205.10

227.44

ng/l

0.25

102

691

Abnormal findings on examination of urine, without diagnosis

163

1165

1.44

4.45

3.1

3.0

254.46

206.20

ng/l

0.89

155

1061

Rosacea

371

2972

1.27

4.45

3.0

2.7

150.40

171.91

ng/l

0.62

332

2697

Open wound of thorax

304

1.89

4.44

2.2

3.0

242.65

182.35

ng/l

0.25

268

Atopic conjunctivitis

121

815

1.52

4.42

3.2

2.8

154.57

161.74

ng/l

0.08

106

735

Other, unspecified and serous retinal detachments

129

886

1.51

4.42

3.5

3.0

186.71

217.25

ng/l

0.44

119

826

Dependent personality disorder

378

1.79

4.41

2.1

2.9

187.45

163.89

ng/l

0.16

346

Other congenital malformations of intestine

234

2.03

4.41

3.3

3.0

288.72

158.54

ng/l

0.99

210

Vasomotor rhinitis (mode)

249

1902

1.34

4.40

2.7

2.9

196.01

186.15

ng/l

0.13

229

1725

Pseudomembranous colitis

159

2.27

4.40

4.4

2.4

234.95

169.06

ng/l

0.36

141

Postmenopausal atrophic vaginitis

749

4832

0.85

4.40

2.4

2.7

132.69

203.73

ng/l

7.35

679

4434

Dermatophytosis

2315

21192

1.10

4.39

2.7

2.8

196.91

191.30

ng/l

0.25

2090

19268

Other keratitis

353

2815

1.27

4.39

2.8

2.9

209.76

176.46

ng/l

0.51

311

2539

Femoral hernia

182

1330

1.41

4.39

3.7

2.9

189.16

216.12

ng/l

0.58

162

1224

Other and unspecified mononeuropathies of upper limb

103

674

1.58

4.38

3.6

2.7

159.56

195.34

ng/l

0.42

614

Urethral stricture

248

1900

1.34

4.37

3.0

2.9

256.68

235.62

ng/l

0.25

227

1737

Acute appendicitis

2496

21442

1.09

4.35

2.8

172.05

184.53

ng/l

0.50

2222

19402

Polyarteritis nodosa and related conditions

307

1.88

4.34

3.7

3.3

231.58

197.45

ng/l

0.21

276

Chronic Coagulation defects

417

1.73

4.33

2.9

3.0

182.91

146.24

ng/l

0.32

382

Compression of brain

6.97

4.29

2.9

1.7

114.90

272.56

ng/l

—

Other and unspecified acne

166

2.18

4.29

3.4

2.7

142.07

92.59

ng/l

0.45

145

Anoxic brain damage

369

1.81

4.28

5.1

2.9

226.54

241.85

ng/l

0.13

334

Fenamates

585

3326

1.21

4.28

2.6

3.3

182.67

272.51

ng/l

5.79

515

3070

Synovial cyst of popliteal space [Baker]

276

2148

1.31

4.27

2.9

2.8

200.69

214.49

ng/l

0.22

250

1941

Calculus of kidney and ureter

1204

10695

1.14

4.27

3.0

190.23

224.61

ng/l

2.10

1095

9760

Acute myeloid leukaemia and myelodysplastic syndromes

101

667

1.59

4.26

3.2

274.58

278.79

ng/l

0.04

617

Postpartum haemorrhage

315

3354

0.79

4.26

2.0

2.3

83.54

90.33

ng/l

0.18

278

2996

Persistent delusional disorders

278

2166

1.31

4.26

3.1

3.0

195.57

200.19

ng/l

0.06

259

1954

Ingrowing nail

166

1197

1.42

4.26

3.0

2.8

251.84

180.53

ng/l

1.09

153

1087

Graves ophthalmopathy

505

1.66

4.25

2.7

2.8

148.67

159.45

ng/l

0.12

466

Melanocytic naevi of ear and external auricular canal

104

2.59

4.24

3.5

2.9

173.36

247.87

ng/l

0.53

Juvenile arthritis (FINNGEN)

100

652

1.56

4.23

3.0

188.51

150.93

ng/l

0.40

579

Normal-pressure hydrocephalus

130

1841

0.68

4.23

2.4

3.1

171.91

257.87

ng/l

2.41

112

1689

Viral meningitis

614

1.59

4.22

3.5

2.8

194.49

139.45

ng/l

0.28

543

Pedestrian injured in collision with pedal cycle

109

729

1.54

4.22

2.9

197.35

206.10

ng/l

0.08

664

Other disorders of cornea

348

2790

1.27

4.21

2.9

225.17

194.81

ng/l

0.35

316

2534

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1292

8681

1.13

4.21

2.6

2.5

143.19

129.59

ng/l

0.65

1165

7815

Chronic drug-induced interstitial lung disorders

4.65

4.21

2.4

2.1

267.43

122.63

ng/l

0.52

Other Crohn's disease

185

1359

1.38

4.20

2.3

2.7

160.99

159.27

ng/l

0.02

157

1219

Pediculosis, acariasis and other infestations

439

3600

1.23

4.19

2.9

178.56

157.00

ng/l

0.35

392

3213

Bacterial, viral and other infectious agents

252

1939

1.32

4.19

3.6

3.0

241.07

161.96

ng/l

1.56

222

1726

Cerebral aneurysm, nonruptured

306

2418

1.29

4.19

2.7

2.8

174.69

183.96

ng/l

0.17

281

2199

Use of rotigotine

261

1.96

4.17

2.1

3.2

144.49

183.31

ng/l

0.43

234

Posteruptive colour changes of dental hard tissues

3.20

4.17

3.5

2.0

51.47

100.02

ng/l

1.13

Bullous disorders

241

1853

1.34

4.16

4.0

2.9

188.49

219.38

ng/l

0.69

223

1695

Kela-code for behavioural disturbances in mental retardation

198

2.11

4.15

2.0

3.4

85.85

188.86

ng/l

2.17

180

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

522

1.62

4.13

3.2

3.9

95.65

161.73

ng/l

2.27

459

Crowding of teeth, including avohilmo

160

945

1.41

4.12

3.4

119.95

122.23

ng/l

0.03

148

810

Myelodysplastic syndrome, including Hilmo

146

1044

1.46

4.12

3.2

277.72

270.32

ng/l

0.08

128

966

Benign neoplasm: Skin of scalp and neck

589

1.60

4.11

2.8

3.1

229.46

209.76

ng/l

0.13

537

Maxillary retrognathism

238

1.95

4.11

1.9

3.0

48.82

89.96

ng/l

2.53

212

Idiopathic urticaria

333

1.80

4.10

2.6

2.9

170.06

149.15

ng/l

0.14

297

Other and unspecified disorders of vitreous body

1678

15003

1.11

4.10

2.8

152.55

191.28

ng/l

4.69

1530

13771

Other otitis externa (chronic)

225

1714

1.34

4.09

2.5

2.9

138.20

196.68

ng/l

3.20

207

1553

Hordeolum and other deep inflammation of eyelid

177

1301

1.39

4.06

3.1

2.9

181.26

178.06

ng/l

0.04

161

1176

Other specified and unspecified disorders of eyelid

345

1.80

4.03

3.0

3.1

187.06

186.99

ng/l

0.00

315

Necrobiosis lipoidica, not elsewhere classified

2.80

4.02

3.6

2.3

157.07

123.44

ng/l

0.14

Recurrent dislocation and subluxation of joint

175

1283

1.38

4.02

2.2

2.8

108.02

141.90

ng/l

1.20

150

1148

Exposure to smoke, fire and flames

545

1.61

4.00

2.9

3.0

232.33

207.59

ng/l

0.14

493

Hypertrophy of breast

450

3720

1.22

3.99

2.0

2.6

74.26

129.61

ng/l

11.08

395

3382

Myeloproliferative diseases

334

2688

1.27

3.98

3.5

3.0

218.44

219.49

ng/l

0.02

309

2447

Hypersomnia

249

1.93

3.98

2.2

2.8

114.33

165.35

ng/l

0.73

222

Burns and corrosions of external body surface, specified by site

333

2671

1.26

3.98

2.7

2.9

201.22

180.82

ng/l

0.35

300

2393

UC patients in KELA-register (code 208), prior to 1994

153

1107

1.42

3.93

2.6

2.8

237.40

190.18

ng/l

0.49

136

1006

Anomalies of dental arch relationship, including avohilmo

487

3656

1.21

3.93

3.3

2.9

107.06

145.74

ng/l

1.96

438

3239

Gonococcal infection

610

1.57

3.92

2.3

3.1

260.40

137.57

ng/l

0.61

547

Achalasia of cardia

463

1.67

3.92

2.9

210.72

223.56

ng/l

0.09

426

Acute suppurative otitis media

578

4561

1.19

3.91

3.2

2.7

169.88

136.74

ng/l

1.00

510

3964

Onycholysis

108

2.47

3.91

2.7

2.3

281.21

107.34

ng/l

0.95

Viral infections of the central nervous system

226

1733

1.33

3.91

3.0

182.35

183.69

ng/l

0.01

202

1569

Hyperfunction of pituitary gland

127

887

1.46

3.90

3.0

2.9

145.07

163.55

ng/l

0.27

114

793

Other specified disorders of kidney and ureter

120

834

1.49

3.88

4.2

3.0

292.10

217.32

ng/l

0.91

110

765

Nontoxic multinodular goitre

793

6907

1.16

3.88

2.6

2.8

176.49

194.79

ng/l

0.78

727

6322

Allergic rhinitis

786

6745

1.16

3.87

2.6

2.9

103.14

147.53

ng/l

4.93

679

6040

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

239

1853

1.32

3.87

2.7

2.9

189.53

190.26

ng/l

0.01

218

1685

Other and unspecified follicular disorders

127

891

1.46

3.86

3.5

2.8

257.06

179.99

ng/l

0.71

115

802

Chronic diseases of tonsils and adenoids

2720

15909

1.08

3.86

2.7

2.8

133.98

174.14

ng/l

7.60

2411

14404

Pyoderma gangrenosum

148

2.23

3.86

2.6

3.0

361.38

167.47

ng/l

0.65

135

Acquired pure red cell aplasia [erythroblastopenia]

2.65

3.84

2.8

3.3

271.09

176.27

ng/l

0.33

Contact with other and unspecified heat and hot substances

122

2.36

3.83

2.6

2.2

327.86

139.25

ng/l

0.51

Exophthalmic conditions

232

1.96

3.82

1.8

2.9

206.53

175.04

ng/l

0.19

213

Other and unspecified psoriasis

236

1830

1.32

3.81

3.0

2.9

258.25

189.87

ng/l

0.99

204

1655

Personal history of malignant neoplasm

195

1471

1.35

3.79

1.9

2.3

134.73

144.22

ng/l

0.19

171

1325

Persons with potential health hazards related to communicable diseases

954

8329

1.14

3.79

3.2

2.8

209.30

145.14

ng/l

2.34

858

7399

Clear cell adenocarcinoma of kidney

192

1453

1.36

3.78

2.9

3.0

275.11

201.32

ng/l

0.83

180

1342

Other congenital malformations of skin

224

1724

1.32

3.76

2.6

3.1

148.56

173.41

ng/l

0.51

195

1547

Benign neoplasm of mouth and pharynx

396

3264

1.23

3.75

2.9

213.62

198.35

ng/l

0.26

351

2978

Pedal cyclist injured in other and unspecified transport accidents

358

2918

1.24

3.74

3.1

2.9

157.98

182.51

ng/l

0.64

328

2621

Struck by thrown, projected or falling objec

155

1132

1.40

3.74

2.9

120.05

174.14

ng/l

2.46

134

1015

Mental and behavioural disorders due to cannabinoids

319

1.76

3.73

3.2

3.1

75.54

102.49

ng/l

0.49

268

Volvulus

112

776

1.49

3.72

2.8

212.08

210.39

ng/l

0.02

102

713

Psoriasis vulgaris

642

5519

1.18

3.72

3.0

2.9

220.75

184.14

ng/l

1.06

576

5009

Late syphilis

308

1.81

3.72

3.3

3.0

372.73

171.15

ng/l

1.66

274

Cysts of oral region, not elsewhere classified

194

1469

1.35

3.72

3.2

2.9

228.77

189.96

ng/l

0.35

182

1329

Other juvenile arthritis

544

1.57

3.71

3.1

3.2

193.49

149.49

ng/l

0.40

489

Mandibular retrognathia

148

1068

1.40

3.71

2.5

2.9

76.83

132.58

ng/l

2.89

135

943

Oesophageal obstruction

148

1079

1.42

3.71

3.1

2.9

188.38

225.75

ng/l

0.63

137

990

Noninflammatory disorders of female genital tract

1291

5791

1.13

3.70

2.9

2.7

147.85

199.74

ng/l

5.58

1163

5253

Idiopathic thrombocytopenic purpura

111

768

1.49

3.70

3.2

3.4

205.58

201.74

ng/l

0.04

100

701

Inflammatory disorders of male genital organs, not elsewhere classified

339

1.76

3.69

2.8

3.1

189.18

217.88

ng/l

0.32

299

Superficial injury of forearm

293

2339

1.27

3.68

2.5

2.9

260.85

183.41

ng/l

0.63

252

2101

Malnutrition

542

1.59

3.68

6.2

3.8

249.01

238.09

ng/l

0.09

501

Excessive earwax

2311

20846

1.09

3.68

2.9

3.0

170.84

213.64

ng/l

7.50

2123

19053

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

282

2251

1.28

3.67

3.3

3.1

199.60

248.63

ng/l

1.77

263

2074

Use of ropinirole

146

1065

1.42

3.67

3.0

2.9

163.18

208.51

ng/l

1.19

136

976

Other infective otitis externa

201

1534

1.34

3.65

3.3

2.9

176.70

191.63

ng/l

0.27

176

1391

Hydrocephalus

204

2641

0.76

3.64

2.7

2.9

152.87

232.88

ng/l

3.94

182

2403

Emotional disorders starting during childhood or adolescence

470

1.60

3.64

3.2

3.7

69.08

117.57

ng/l

1.06

399

Whooping cough

178

2.03

3.62

1.9

3.1

164.83

134.28

ng/l

0.21

158

Alzheimer’s disease (Atypical or mixed)

529

4470

1.20

3.61

3.8

3.3

247.07

315.96

ng/l

3.30

496

4068

Other benign neoplasm of uterus: Other parts/unspecified

113

1588

0.69

3.61

2.3

3.1

209.52

242.39

ng/l

0.55

106

1442

Autoimmune hepatitis

173

2.08

3.59

3.3

2.3

118.45

159.39

ng/l

0.64

161

Follow-up care involving plastic surgery

754

0.56

3.59

1.9

2.4

103.84

168.16

ng/l

1.64

676

Urolithiasis

1298

11708

1.12

3.58

2.9

3.0

196.00

229.96

ng/l

2.01

1181

10699

Pregnancy, childbirth and the puerperium

947

5599

0.88

3.58

3.1

3.0

205.58

216.37

ng/l

0.34

870

5078

Contact with and exposure to communicable diseases

499

5874

0.84

3.57

3.4

2.7

109.11

132.12

ng/l

1.21

452

5159

Injury of nerves at shoulder and upper arm level

216

1.94

3.55

3.3

2.8

277.09

177.89

ng/l

0.43

192

Entropion and trichiasis of eyelid

391

3245

1.23

3.55

3.4

3.1

278.76

256.13

ng/l

0.37

362

2977

Benign neoplasm: Ascending colon

579

4969

1.18

3.54

3.4

2.9

255.98

205.37

ng/l

1.61

530

4563

Open bite

103

705

1.48

3.52

5.1

3.1

146.21

118.91

ng/l

0.21

616

Burns and corrosions

420

3500

1.21

3.51

2.7

2.9

195.05

178.04

ng/l

0.34

372

3131

Gonococcal infection

634

1.52

3.51

2.3

3.2

257.38

139.60

ng/l

0.59

568

Pseudopolyposis of colon

3.38

3.50

4.5

2.1

91.03

176.40

ng/l

0.53

Gestational diabetes (for exclusion)

469

3882

0.84

3.48

2.0

2.3

64.96

83.66

ng/l

1.41

407

3423

Postpartum haemorrhage due to anatomy

1100

0.64

3.48

3.1

2.1

138.53

54.87

ng/l

0.87

957

Chronic conjunctivitis

653

1.51

3.48

2.4

3.0

164.83

185.77

ng/l

0.27

598

Malignant neoplasm of other connective and soft tissue, including Hilmo

167

1254

1.37

3.48

2.4

3.1

224.13

213.15

ng/l

0.13

149

1150

Other and unspecified pemphigus

2.88

3.48

3.0

2.9

126.06

159.63

ng/l

0.27

Benign neoplasm: Rectum

748

6550

1.16

3.46

2.7

2.9

242.31

209.71

ng/l

1.03

682

5994

Abscess of lung

376

1.69

3.46

4.4

3.0

331.65

194.13

ng/l

0.88

335

Other renal tubulo-interstitial diseases

484

1.60

3.46

2.7

2.6

239.99

173.24

ng/l

0.83

438

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

3.21

3.45

11.9

2.0

194.00

121.62

ng/l

0.40

Dystonia

176

1331

1.35

3.43

2.6

3.0

149.94

184.47

ng/l

0.49

158

1192

Divergent concomitant strabismus

222

1731

1.30

3.43

2.8

2.9

118.57

180.91

ng/l

3.19

197

1553

Diabetes insipidus

169

2.06

3.43

2.3

2.9

85.39

145.52

ng/l

1.14

151

Chorioretinal inflammation

664

1.50

3.43

4.2

2.9

113.37

197.46

ng/l

3.10

609

Suppurative otitis media, unspecified

501

1.58

3.42

4.5

3.0

153.83

189.58

ng/l

0.45

457

Other bullous disorders

100

690

1.50

3.42

4.3

3.1

179.78

207.76

ng/l

0.28

635

Other menopausal disorders

694

4503

0.86

3.41

2.2

2.7

103.33

188.06

ng/l

12.90

622

4127

Certolizumab pegol

232

1.86

3.41

1.9

2.6

39.50

111.18

ng/l

4.84

204

Congenital malformations of eye, ear, face and neck

160

1191

1.36

3.41

3.2

3.5

157.08

174.29

ng/l

0.26

142

1060

Psoriatic arthropathies

309

2506

1.25

3.41

3.0

2.8

201.01

169.55

ng/l

0.49

267

2276

Foreign body or object entering through skin

183

1392

1.34

3.40

2.5

2.8

146.53

165.31

ng/l

0.29

166

1254

Drug-induced fever

3.84

3.40

4.4

2.3

145.92

151.51

ng/l

0.04

Alcohol abuse counselling and surveillance

297

0.33

3.39

9.3

2.9

148.80

156.52

ng/l

—

264

Injury of eye and orbit

430

3604

1.21

3.39

2.7

2.9

167.97

176.19

ng/l

0.20

388

3202

Early lumbar disc prolapse operation

219

1704

1.30

3.38

2.5

2.7

75.89

87.16

ng/l

0.27

189

1467

Suppurative and unspecified otitis media

943

7412

1.13

3.37

3.4

2.8

167.86

159.84

ng/l

0.24

838

6541

Postviral fatigue syndrome

2.56

3.36

1.7

2.3

232.21

71.88

ng/l

0.46

Simple and mucopurulent chronic bronchitis

159

1190

1.37

3.36

3.2

220.47

274.35

ng/l

0.76

150

1082

Other complications of labour and delivery, not elsewhere classified

1167

0.67

3.36

1.9

2.2

46.75

68.40

ng/l

1.33

1018

Other and unspecified injuries of wrist and hand

108

756

1.46

3.36

2.8

2.7

140.52

162.90

ng/l

0.37

689

Parapsoriasis

402

1.65

3.35

2.7

184.53

162.98

ng/l

0.16

366

Hyperprolactinaemia

527

1.55

3.33

2.9

2.8

115.58

119.27

ng/l

0.04

467

Primary hyperparathyroidism

426

3584

1.21

3.33

2.7

2.9

154.86

196.35

ng/l

2.05

390

3262

Malignant neoplasm of renal pelvis, including Hilmo

351

1.72

3.32

3.9

3.5

369.16

249.22

ng/l

0.75

327

Fracture of neck

243

1931

1.29

3.32

3.0

321.65

223.09

ng/l

0.53

221

1761

Duodenal ulcer

461

3905

1.20

3.31

3.6

2.9

296.47

246.14

ng/l

1.01

409

3586

Other meningitis

310

1.74

3.31

2.4

3.1

169.61

173.86

ng/l

0.03

275

Ankylosing spondylitis, ICD10

265

2122

1.27

3.31

2.7

147.61

173.69

ng/l

0.61

240

1904

Stenosis and insufficiency of lacrimal passages

351

2901

1.23

3.30

3.6

2.9

218.61

209.77

ng/l

0.13

324

2646

Erythema nodosum

678

1.49

3.29

2.8

208.75

179.42

ng/l

0.24

617

Urethritis and urethral syndrome

483

1.58

3.28

3.3

3.1

109.45

190.50

ng/l

2.90

434

Other vitreous opacities

148

1102

1.38

3.27

3.5

2.9

155.65

200.31

ng/l

0.80

142

1010

Postpartum hemorraghe, parous women as controls

315

3281

0.81

3.26

2.0

2.2

83.54

84.55

ng/l

0.02

278

2920

Malignant neoplasm of urinary organs

407

3419

1.21

3.25

3.1

333.17

231.95

ng/l

1.98

381

3144

Autoimmune thyroiditis

319

1.71

3.25

3.1

2.6

103.13

134.76

ng/l

0.52

289

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

144

2.09

3.24

2.2

3.0

60.46

99.20

ng/l

1.16

131

Arnold-Chiari syndrome

104

2.30

3.23

3.1

117.94

129.28

ng/l

0.08

Maltreatment syndromes

106

743

1.45

3.23

2.5

2.7

147.50

117.75

ng/l

0.28

644

Infective bursitis

106

748

1.46

3.23

3.4

3.0

189.93

205.84

ng/l

0.15

101

679

Marginal zone B-cell lymphoma, including Hilmo

448

1.61

3.22

2.1

3.3

302.09

214.78

ng/l

0.53

414

Maxillary prognathism

2.76

3.22

2.7

2.5

39.38

94.46

ng/l

1.34

Pemphigus

139

2.14

3.20

2.8

2.5

137.80

206.11

ng/l

0.75

124

Injury of muscle and tendon at ankle and foot level

478

1.57

3.19

2.2

3.0

123.55

145.95

ng/l

0.22

430

Nontoxic goitre/thyroid nodule

1158

10458

1.12

3.19

2.8

179.55

195.33

ng/l

0.81

1063

9552

Alzheimer’s disease (Early onset)

119

1628

0.71

3.18

2.5

3.3

236.77

320.97

ng/l

1.45

1470

Benign neoplasm: Descending colon

282

2292

1.26

3.18

3.3

3.0

226.48

207.12

ng/l

0.38

262

2098

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

113

2.31

3.18

3.6

3.4

471.62

186.44

ng/l

1.15

101

Beningn neoplasm: Meninges, unspecified

393

1.65

3.18

2.5

3.2

167.99

217.71

ng/l

0.41

362

Other disorders of iris and ciliary body

103

726

1.46

3.18

3.6

3.1

259.51

234.57

ng/l

0.26

667

Exclusion endpoint for supernumerary teeth

145

2.06

3.17

2.7

3.0

67.38

110.04

ng/l

1.08

134

Long labour

324

3371

0.82

3.16

1.9

2.4

91.69

97.24

ng/l

0.11

278

3024

Other acquired deformities of musculoskeletal system and connective tissue

152

1142

1.36

3.15

2.9

2.8

123.98

186.96

ng/l

2.62

138

1037

Monosomies and deletions from the autosomes, not elsewhere classified

3.63

3.14

6.1

3.2

205.25

147.25

ng/l

0.26

Mucosal proctocolitis

358

2974

1.22

3.13

3.0

2.8

174.47

164.31

ng/l

0.16

318

2654

Other deformities of toe(s)

117

844

1.42

3.13

2.6

3.0

192.72

197.70

ng/l

0.05

109

769

Deep bite

277

1962

1.25

3.12

3.3

3.1

114.49

146.40

ng/l

1.21

251

1739

Cerebral atherosclerosis

387

1.65

3.12

3.7

3.1

232.46

274.44

ng/l

0.34

357

Injury of muscle and tendon at hip and thigh level

308

2526

1.24

3.12

3.0

2.8

172.07

174.75

ng/l

0.04

279

2280

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

215

1700

1.30

3.11

3.4

3.3

207.36

261.54

ng/l

1.62

198

1571

Other and unspecified aplastic anaemias

287

1.76

3.11

3.4

3.2

304.54

184.32

ng/l

0.56

257

Wide developmental disorders, excluding more controls

301

1.69

3.11

3.0

3.5

68.81

129.93

ng/l

1.51

259

malignant neoplasm of male genital organs

1275

7039

1.11

3.10

2.7

3.2

235.90

255.98

ng/l

0.68

1159

6453

Injury of muscle and tendon at wrist and hand level

439

3722

1.19

3.10

2.9

190.24

180.47

ng/l

0.07

396

3342

Chondropathies

458

3898

1.19

3.07

3.1

2.8

167.75

169.54

ng/l

0.04

408

3507

Other lesions of median nerve

114

825

1.43

3.06

3.5

2.9

211.56

252.22

ng/l

0.43

102

759

Benign leiomyoma with endometriosis

414

4882

0.84

3.05

2.6

2.7

128.66

174.70

ng/l

3.32

385

4458

Open wound of hip and thigh

630

1.48

3.04

2.6

2.9

144.28

176.20

ng/l

0.69

553

Other bursitis, not elsewhere classified

206

1.88

3.04

2.9

3.2

361.24

189.44

ng/l

0.96

182

Autism spe, excluding more controls

211

1.83

3.03

2.8

3.1

74.12

106.17

ng/l

0.48

180

Anogenital herpesviral [herpes simplex] infection

127

931

1.38

3.02

2.4

2.8

103.14

119.98

ng/l

0.44

112

814

Alcohol induced polyneuropathy

252

1.80

3.01

4.0

2.9

287.17

183.63

ng/l

0.60

226

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

423

3592

1.20

3.01

3.0

3.1

319.10

230.32

ng/l

1.76

395

3301

Other and unspecified localized connective tissue disorders

2.92

3.01

2.1

1.8

183.07

133.77

ng/l

0.23

Mental and behavioural disorders due to tobacco

266

2158

1.25

3.00

3.0

2.8

302.76

169.24

ng/l

0.84

234

1952

Smoking dependency

266

2158

1.25

3.00

3.0

2.8

302.76

170.37

ng/l

0.83

234

1948

Intermittent heterotropia

142

1060

1.36

3.00

4.6

3.3

155.36

174.88

ng/l

0.23

126

953

Other congenital malformations of nervous system

121

2.14

3.00

3.0

2.9

116.65

124.75

ng/l

0.06

110

Oral leukoplakia, including avohilmo

693

1.46

2.99

2.6

2.9

193.74

202.77

ng/l

0.10

633

Malignant neoplasm of other connective and soft tissue

703

1.46

2.98

2.5

3.2

250.27

221.60

ng/l

0.26

643

Collagenous colitis

317

2623

1.23

2.98

3.3

2.9

207.03

195.41

ng/l

0.14

282

2381

Congenital deformities of feet

649

1.46

2.97

2.4

2.9

162.30

153.73

ng/l

0.06

581

Benign neoplasm: Spinal cord

298

1.71

2.96

2.9

2.8

148.26

161.70

ng/l

0.13

266

Malignant neoplasm of breast

1434

8542

1.10

2.95

2.4

2.7

163.98

166.26

ng/l

0.08

1311

7748

Benign neoplasm: Larynx

120

881

1.40

2.95

3.2

3.0

399.80

221.00

ng/l

0.46

108

798

Pleural plaque with presence of asbestos

342

2863

1.22

2.94

3.9

3.1

214.00

267.11

ng/l

1.95

319

2649

Varicella [chickenpox]

119

869

1.39

2.94

3.6

2.9

199.33

136.20

ng/l

1.00

107

769

Retinal haemorrhage

107

773

1.43

2.94

3.3

3.0

193.16

227.55

ng/l

0.77

720

Injuries involving multiple body regions

114

829

1.40

2.92

3.8

3.0

186.88

202.97

ng/l

0.11

743

Benign neoplasm: Skin of eyelid, including canthus

603

5272

1.16

2.92

2.8

2.9

225.69

200.47

ng/l

0.33

553

4812

Premenstrual syndrome

129

2.07

2.92

2.4

2.8

104.29

92.84

ng/l

0.16

108

Other condition

452

3863

1.18

2.92

3.4

2.9

195.67

180.45

ng/l

0.37

430

3470

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

143

1057

1.35

2.91

3.0

3.8

114.78

157.97

ng/l

1.41

128

932

Injury of nerves at wrist and hand level

111

804

1.41

2.91

2.5

2.9

131.38

168.18

ng/l

0.75

727

HSIL lesion of the vulva

362

1.63

2.91

2.4

3.0

195.45

186.32

ng/l

0.05

336

Monoarthritis, not elsewhere classified

133

992

1.37

2.90

2.6

2.9

240.19

199.33

ng/l

0.34

120

896

Benign neoplasm: Lip

565

1.50

2.90

3.0

3.1

122.59

207.65

ng/l

3.50

517

Lens-induced iridocyclitis

3.47

2.90

3.7

1.8

717.75

188.69

ng/l

0.40

Arthropathy in Crohn disease

158

1.98

2.89

2.6

3.5

90.57

85.19

ng/l

0.08

144

Alcohol withdrawal state with delirium

241

1946

1.26

2.89

3.1

2.9

250.27

188.47

ng/l

0.92

213

1761

Assault by unspecified means

314

1.66

2.89

3.8

2.6

133.20

105.51

ng/l

0.36

272

Deficiency of other B group vitamins

549

1.51

2.88

2.4

2.9

264.08

246.99

ng/l

0.09

500

Benign neoplasm: Mediastinum

2.58

2.87

2.8

2.4

183.59

175.07

ng/l

0.03

Diffuse brain injury

108

780

1.41

2.87

2.5

170.58

227.45

ng/l

0.92

710

Use of biperiden

168

1299

1.32

2.87

3.3

2.8

128.87

186.19

ng/l

1.81

146

1179

Crushing injury of wrist and hand

356

1.64

2.86

3.5

2.6

103.88

167.89

ng/l

1.74

318

Paranoid personality disorder

347

1.63

2.86

2.3

2.8

187.21

168.85

ng/l

0.13

306

Conductive hearing loss, unspecified

279

2290

1.24

2.85

3.1

2.8

147.89

201.18

ng/l

2.67

252

2077

Burn and corrosion of shoulder and upper limb, except wrist and hand

411

1.58

2.84

2.4

3.0

187.90

175.12

ng/l

0.07

366

Appendicitis, broad definition

2653

22510

1.07

2.84

2.8

173.89

185.43

ng/l

0.48

2360

20375

Chronic suppurative otitis media

224

1797

1.27

2.83

4.1

3.1

190.98

214.15

ng/l

0.45

200

1631

Other melanin hyperpigmentation

644

1.47

2.82

4.0

3.0

174.09

210.63

ng/l

0.62

597

Aneurysms, operations, SAH

614

5387

1.15

2.82

2.9

221.66

203.07

ng/l

0.50

551

4919

Poor fetal growth

183

1428

1.29

2.81

2.2

111.56

76.96

ng/l

0.60

158

1256

Mixed disorders of conduct and emotions

202

1.81

2.80

1.9

3.5

25.00

108.37

ng/l

2.81

167

Carcinoma in situ of vulva

168

1.94

2.80

2.2

3.2

195.00

211.21

ng/l

0.08

154

Sacroiliitis, not elsewhere classified

706

1.42

2.80

3.0

2.7

166.09

153.26

ng/l

0.12

612

Asymmetry of jaw

181

1.87

2.80

1.7

2.7

56.79

102.65

ng/l

1.59

162

Contact with machinery

384

3255

1.20

2.79

2.6

2.9

165.96

191.72

ng/l

0.70

352

2944

Oral lichen planus

627

1.46

2.79

2.1

3.1

99.49

182.39

ng/l

1.57

571

Non-Hodgkin lymphoma, all

188

1486

1.30

2.78

3.6

3.2

289.79

249.01

ng/l

0.67

176

1368

Malignant neoplasm of breast, HER2-negative

1418

8496

1.10

2.78

2.4

2.7

166.37

166.88

ng/l

0.02

1295

7706

IBD patients in KELA-register

662

5834

1.14

2.78

2.9

2.8

182.47

164.11

ng/l

0.45

592

5221

Lichen sclerosus et atrophicus

352

2963

1.20

2.77

2.7

2.8

156.95

173.85

ng/l

0.55

316

2690

Other salmonella infections

120

889

1.38

2.77

2.3

2.7

372.81

195.44

ng/l

0.65

112

808

Benign neoplasm: salivary glands, exclude unknown (D119)

318

2657

1.22

2.74

2.5

2.9

207.15

205.48

ng/l

0.03

276

2421

Preterm labour and delivery

614

5387

1.15

2.74

2.5

2.4

120.74

119.94

ng/l

0.02

547

4859

Amblyopia ex anopsia

113

830

1.39

2.73

3.2

2.9

168.54

180.69

ng/l

0.12

101

751

Malignant neoplasm of rectosigmoid junction

483

1.53

2.73

2.9

3.2

276.52

259.48

ng/l

0.09

447

Leiomyosarcoma

178

1.91

2.71

1.9

3.9

158.68

248.11

ng/l

0.76

161

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

5.28

2.71

2.9

227.14

173.73

ng/l

—

Appendectomy

2194

19599

1.07

2.68

2.8

2.7

166.78

173.85

ng/l

0.23

1960

17712

Benign neoplasm of major salivary glands

363

3076

1.20

2.68

2.6

2.9

232.26

206.09

ng/l

0.50

316

2801

Varicella [chickenpox]

133

1004

1.34

2.67

3.5

3.0

212.72

142.35

ng/l

1.08

121

890

Outcome of delivery

176

1389

0.78

2.66

2.0

2.2

60.93

74.26

ng/l

0.52

143

1225

Malignant neoplasm of kidney, except renal pelvis

364

3090

1.20

2.66

2.9

3.2

321.05

227.01

ng/l

1.60

342

2843

Third [oculomotor] nerve palsy

477

1.52

2.65

3.7

3.1

216.68

232.03

ng/l

0.12

437

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

128

964

1.35

2.64

2.2

2.9

124.92

181.72

ng/l

1.44

112

862

Cystic kidney disease

101

735

1.41

2.63

2.8

3.0

492.05

174.27

ng/l

4.20

668

Synovial hypertrophy, not elsewhere classified

142

1.97

2.63

2.0

2.9

108.32

115.82

ng/l

0.07

129

Other and unspecified mononeuropathies of lower limb

702

1.42

2.63

3.1

2.8

124.73

199.59

ng/l

2.51

648

Juvenile osteochondrosis

499

1.49

2.63

2.8

3.0

110.97

167.76

ng/l

1.33

437

Undefined dementia

444

4731

0.85

2.62

3.3

337.84

328.40

ng/l

0.07

400

4284

Benign neoplasm: Parotid gland

286

2378

1.22

2.62

2.5

2.9

210.85

200.57

ng/l

0.17

250

2165

Superficial injury of neck

315

1.63

2.62

2.2

2.9

201.88

161.05

ng/l

0.30

277

Malignant neoplasm of breast, HER2-negative, including Hilmo

1448

8620

1.09

2.61

2.5

2.7

159.02

166.05

ng/l

0.30

1324

7816

Malignant neoplasm of breast, including Hilmo

1448

8620

1.09

2.61

2.5

2.7

159.02

166.05

ng/l

0.30

1324

7816

Disturbances of smell and taste

130

985

1.35

2.60

2.3

2.7

120.25

187.95

ng/l

3.01

118

883

Fibrothorax

3.00

2.60

3.7

3.1

121.02

212.99

ng/l

0.54

Hypercalcemia

164

1287

1.31

2.58

3.7

3.0

205.00

223.65

ng/l

0.23

148

1183

Other benign neoplasms of uterus

151

1928

0.77

2.58

2.3

3.1

183.71

222.40

ng/l

0.94

140

1754

Acute hepatitis B

2.46

2.58

2.4

167.62

84.28

ng/l

0.52

Contusion of ankle

719

1.40

2.58

3.5

2.9

161.25

157.70

ng/l

0.04

652

Acute alcohol intoxication ICD-9

126

954

1.35

2.57

3.9

2.9

220.73

212.39

ng/l

0.07

119

870

Endometriosis of pelvic peritoneum

381

3091

1.18

2.57

2.4

2.5

80.11

147.18

ng/l

11.21

343

2810

Glycogen storage disease

6.19

2.57

2.0

4.8

323.17

88.17

ng/l

—

Other and unspecified haemorrhagic conditions

366

1.58

2.57

2.4

3.2

338.98

226.28

ng/l

0.85

339

Medial epicondylitis

105

772

1.39

2.55

2.6

2.8

116.06

162.34

ng/l

1.33

699

Motor neuron disease (with DMD)

497

1.49

2.54

3.3

2.7

153.23

228.10

ng/l

1.15

451

Other combined immunodeficiencies

3.84

2.54

3.4

1.7

102.11

113.05

ng/l

—

LeFortI or BSSO operation

602

1.43

2.54

1.8

2.7

62.53

127.47

ng/l

3.94

521

L01XX Other antineoplastic agents

239

1963

1.24

2.54

3.4

2.9

206.13

221.59

ng/l

0.27

223

1790

Other abnormal auditory perceptions

203

1.79

2.54

2.8

3.2

66.81

193.49

ng/l

4.09

187

Other obstetric trauma

661

0.61

2.53

2.0

2.4

71.25

67.82

ng/l

0.06

581

Diseases of appendix

2672

22693

1.06

2.53

2.8

173.60

185.90

ng/l

0.52

2376

20548

Macular hole

240

1974

1.24

2.53

3.0

2.9

191.82

209.32

ng/l

0.30

223

1816

Tibial collateral bursitis [Pellegrini-Stieda]

211

1.77

2.52

1.8

3.2

129.27

186.86

ng/l

0.68

190

Spirochaetal infections, other/unspecified

203

2505

0.80

2.51

2.2

2.9

162.53

186.60

ng/l

0.50

179

2284

Benign neoplasm of ovary

593

5237

1.14

2.50

2.7

2.8

165.36

173.43

ng/l

0.24

539

4774

Covid-19 suspected case

587

5173

1.14

2.50

3.1

2.6

192.32

165.70

ng/l

0.81

526

4615

Pleural plaque without asbestos

174

1386

1.29

2.49

3.4

3.1

191.55

265.71

ng/l

2.22

162

1273

Autoimmune polyglandular failure

5.49

2.47

2.3

191.67

143.58

ng/l

—

Oral lichen planus, including avohilmo , including avohilmo

208

1685

1.26

2.47

1.9

2.8

96.21

166.27

ng/l

3.54

184

1525

Ankylosing spondylitis, strict definition

105

776

1.37

2.46

2.3

2.7

98.93

142.49

ng/l

1.24

683

Labour and delivery complicated by fetal stress [distress]

258

2047

0.82

2.45

2.1

2.2

88.51

68.20

ng/l

0.39

227

1810

Traumatic cerebral oedema

2.68

2.45

3.6

2.1

86.92

227.59

ng/l

1.74

Postpartum hemorraghe, all women as controls

315

3673

0.84

2.44

2.0

2.3

83.54

90.41

ng/l

0.18

278

3259

Crohn's disease of small intestine

178

1417

1.27

2.43

2.9

2.7

171.13

160.56

ng/l

0.13

155

1274

Disorders of iron metabolism

299

1.62

2.42

3.2

2.9

179.74

157.47

ng/l

0.23

269

Benign neoplasm of other and unspecified sites

113

851

1.36

2.41

3.2

3.0

126.18

197.50

ng/l

2.81

102

776

Syphilis

569

1.44

2.41

2.9

338.09

176.71

ng/l

1.45

507

Syphilis

569

1.44

2.41

2.9

338.09

176.71

ng/l

1.45

507

Inflammatory bowel disease, strict (require KELA)

662

5895

1.13

2.41

2.9

2.8

182.47

163.86

ng/l

0.46

592

5268

Toxic effect of ethanol

101

746

1.38

2.39

2.5

2.7

167.34

163.02

ng/l

0.05

660

Muscle strain

670

1.40

2.39

4.1

3.1

152.72

176.74

ng/l

0.35

605

Disorders of purine and pyrimidine metabolism

134

1.99

2.39

3.6

3.4

459.44

196.34

ng/l

1.08

121

Abnormalities of forces of labour

123

1607

0.76

2.39

2.1

2.5

132.92

91.33

ng/l

0.52

106

1444

Episcleritis

137

1059

1.31

2.38

2.7

2.8

138.94

151.07

ng/l

0.15

124

948

Frostbite

192

1.78

2.38

3.4

2.8

160.36

170.80

ng/l

0.04

166

Glaucoma secondary to other eye disorders

154

1213

1.30

2.37

2.9

3.2

316.15

240.87

ng/l

0.85

141

1107

Fitting and adjustment of external prosthetic device

2.47

2.36

3.9

2.0

302.09

192.95

ng/l

0.50

Atopic dermatitis, strict definition with reimbursement

703

6069

1.12

2.35

2.7

2.8

147.92

137.10

ng/l

0.28

624

5386

Visual impairment including blindness (binocular or monocular)

265

2215

1.22

2.34

3.6

3.0

276.38

246.13

ng/l

0.40

241

2009

Failure of sterile precautions during surgical operation

2.54

2.33

3.5

2.4

248.57

193.17

ng/l

0.25

Inguinal hernia, bilateral

421

3657

1.17

2.33

3.0

262.26

225.49

ng/l

0.38

388

3359

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

195

1582

1.26

2.33

2.3

2.8

181.72

177.31

ng/l

0.05

180

1442

Benign neoplasm: Connective and other soft tissue of head, face and neck

383

1.54

2.32

2.5

2.9

149.59

185.18

ng/l

0.28

346

Other bursitis of knee

335

1.58

2.32

4.7

3.2

230.55

199.95

ng/l

0.19

304

Congenital vesicoureteral reflux

2.53

2.32

2.5

2.8

110.62

118.31

ng/l

0.05

Inguinal or femoral hernia, bilateral

428

3725

1.16

2.31

3.0

261.11

226.79

ng/l

0.36

395

3423

Primary open-angle glaucoma

1492

13399

1.08

2.31

3.3

3.0

221.41

247.81

ng/l

1.50

1370

12321

Peritonsillar abscess

546

4818

1.14

2.31

2.5

2.8

143.38

166.90

ng/l

0.89

483

4341

Intestinal helminthiases, other/unspecified

2.45

2.31

2.9

1.9

530.40

126.46

ng/l

0.68

Multifocal fibrosclerosis

158

1.88

2.30

2.8

2.9

177.86

265.49

ng/l

0.66

141

Tuberculosis, IBD comorbidity

297

2514

1.20

2.30

3.8

3.1

209.60

269.13

ng/l

2.22

275

2290

Burn and corrosion of head and neck

416

1.50

2.30

2.0

2.8

83.32

167.13

ng/l

2.88

371

Open wound of wrist and hand

1477

13389

1.08

2.30

2.7

2.9

178.13

189.65

ng/l

0.48

1323

12093

Essential (haemorrhagic) thrombocythaemia

144

1131

1.30

2.30

3.2

3.1

168.78

212.06

ng/l

1.40

137

1041

Neovascular glaucoma

153

1210

1.29

2.29

2.9

3.0

315.62

234.54

ng/l

0.94

140

1104

Blood alcohol or alcohol intoxication level

424

1.49

2.29

5.0

2.6

195.71

151.76

ng/l

0.49

377

Myeloproliferative diseases (CML excluded)

292

2470

1.20

2.28

3.3

3.0

223.31

221.65

ng/l

0.02

268

2245

Abscess of mediastinum

2.95

2.28

7.5

1.9

207.45

211.08

ng/l

0.01

Persons encountering health services in circumstances related to reproduction

1674

10490

1.08

2.27

3.2

2.7

120.47

138.03

ng/l

1.33

1511

9339

Focal epilepsy, mode (most common among epilepsy diagnosis)

658

5885

1.13

2.27

3.0

178.14

213.31

ng/l

1.82

597

5328

Carcinoma in situ of skin of lower limb, including hip

100

752

1.38

2.26

2.7

3.1

263.23

244.93

ng/l

0.12

693

Calculus of urinary tract in diseases classified elsewhere

4.95

2.26

2.7

1.6

270.17

36.89

ng/l

—

Periodontal disease, other/unspecified

585

1.42

2.25

3.3

2.8

118.49

170.99

ng/l

1.75

523

Dislocations, sprains and strains involving multiple body regions

4.11

2.24

3.3

2.4

69.57

178.16

ng/l

—

258

1.65

2.24

2.4

2.8

369.52

216.98

ng/l

0.60

228

Schizoid personality disorder

329

1.56

2.24

2.2

2.9

146.79

144.81

ng/l

0.01

289

Cystic kidney disease

107

810

1.35

2.22

3.0

473.17

180.59

ng/l

4.02

102

738

Other and unspecified degenerative diseases of nervous system

112

857

1.35

2.22

2.5

3.0

148.69

263.34

ng/l

5.38

102

792

Pilonidal cyst

197

1604

1.24

2.21

2.4

2.6

157.49

124.91

ng/l

0.51

173

1400

Other endophthalmitis

116

2.01

2.21

2.9

2.6

228.32

209.29

ng/l

0.06

Other disorders of optic disc

243

1.66

2.20

4.2

3.1

138.87

156.85

ng/l

0.11

219

Ectopic pregnancy

408

3544

1.16

2.20

2.1

2.5

104.76

121.48

ng/l

0.77

366

3193

Bicipital tendinitis

149

1181

1.28

2.18

2.6

2.8

170.62

179.72

ng/l

0.10

133

1067

Scabies

323

2759

1.18

2.17

2.8

195.95

144.30

ng/l

0.74

281

2439

Diseases of middle ear and mastoid

1806

13820

1.07

2.17

3.1

2.8

170.70

181.04

ng/l

0.45

1620

12404

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

2.42

2.17

3.1

2.9

88.43

105.11

ng/l

0.16

Ulcerative enterocolitis

623

1.39

2.16

2.6

2.9

174.85

170.26

ng/l

0.03

559

Malignant neoplasm of prostate

1248

6892

1.09

2.15

2.7

3.2

238.88

259.03

ng/l

0.67

1134

6332

Benign neoplasm: Skin of lower limb, including hip

668

1.38

2.15

4.3

3.0

176.99

198.57

ng/l

0.27

610

Toxic effects of substances chiefly nonmedicinal as to source

327

2802

1.18

2.15

2.8

2.9

173.39

178.85

ng/l

0.08

290

2505

Crohn disease (strict definition, require KELA)

152

1208

1.27

2.15

2.2

2.8

151.11

153.82

ng/l

0.03

133

1075

Enteropathic arthropathies

439

1.47

2.14

2.9

2.7

165.45

155.12

ng/l

0.06

398

Congenital malformations of genital organs

184

1484

1.24

2.14

2.9

3.1

164.42

129.73

ng/l

0.47

164

1303

Occlusion and stenosis of arteries, not leading to stroke

400

1.50

2.13

3.7

3.3

269.38

281.20

ng/l

0.05

366

Papilloedema, unspecified

415

1.48

2.12

2.3

3.0

108.21

162.39

ng/l

1.35

375

Other and unspecified nail disorders

474

1.45

2.12

4.3

2.9

144.88

160.32

ng/l

0.22

428

Degenerative macular diseases

527

4685

1.14

2.11

3.2

3.0

243.61

228.40

ng/l

0.34

484

4289

Tooth agenesis EXCLUDE clefts and syndromes

430

1.46

2.11

4.2

3.0

157.07

130.40

ng/l

0.13

376

Injury of heart

2.74

2.11

4.7

1.9

168.82

181.97

ng/l

0.08

Leiomyosarcoma, including Hilmo

240

1.66

2.10

2.2

3.7

165.13

236.67

ng/l

0.76

220

Other and unspecified types of non-Hodgkin lymphoma, hilmo

159

1280

1.27

2.09

3.3

3.1

324.01

229.24

ng/l

1.31

148

1170

Contact with sharp glass

660

1.37

2.09

3.0

2.9

273.99

143.57

ng/l

0.92

580

Mental and behavioural disorders due to use of other stimulants, including caffeine

325

1.53

2.09

2.4

2.9

118.76

105.43

ng/l

0.15

270

Pollen allergy

368

3143

1.16

2.09

2.6

3.0

93.84

128.40

ng/l

2.05

314

2773

Hypertrophy of tongue papillae

263

1.61

2.08

2.3

3.5

114.73

195.48

ng/l

1.40

236

Malignant neoplasm of corpus uteri, including Hilmo

282

3303

0.84

2.08

2.6

3.1

188.22

201.25

ng/l

0.23

254

3010

Antepartum haemorrhage, not elsewhere classified

135

1060

1.28

2.08

1.9

2.4

44.13

83.63

ng/l

4.50

119

944

Benign neoplasm: Anus and anal canal

105

803

1.34

2.08

2.8

3.1

275.93

228.26

ng/l

0.47

741

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

373

3235

1.16

2.07

2.8

2.6

130.68

142.76

ng/l

0.26

338

2906

Sclerosis of liver

5.58

2.06

9.6

1.6

207.00

118.45

ng/l

—

Scleritis and episcleritis

162

1305

1.26

2.06

2.6

2.9

136.65

157.80

ng/l

0.34

147

1171

Alcoholic gastritis

353

1.52

2.06

3.2

3.0

219.37

196.81

ng/l

0.13

321

Crohn disease (strict definition, require KELA, min 2 HDR)

149

1188

1.27

2.06

2.2

2.8

148.39

152.65

ng/l

0.05

131

1057

Other and unspecified mononeuropathies, also in other diseases

103

786

1.34

2.06

2.8

2.9

171.96

218.96

ng/l

0.66

728

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

156

1.81

2.05

1.5

3.2

119.00

174.21

ng/l

0.74

139

Disorders of optic nerve, not elsewhere classified

564

1.41

2.04

3.7

3.2

272.04

217.04

ng/l

0.34

519

Atopic dermatitis, strict definition

660

5815

1.12

2.03

2.7

2.8

145.82

137.16

ng/l

0.20

584

5167

Autism

247

1.60

2.03

2.8

3.0

72.00

107.49

ng/l

0.61

202

Assault by other and unspecified firearm discharge

3.62

2.03

7.9

1.9

117.43

113.75

ng/l

—

289

1.54

2.02

5.9

6.8

195.00

214.35

ng/l

0.09

263

Burns and corrosions confined to eye and internal organs

512

1.41

2.01

3.1

2.8

123.22

154.54

ng/l

0.51

455

Other disorders of male genital organs

114

884

1.31

2.01

3.0

2.9

202.09

220.83

ng/l

0.22

108

793

Prolapse and hernia of ovary and fallopian tube

186

1518

1.24

2.01

3.4

3.3

242.35

297.50

ng/l

0.45

171

1376

Infections with a predominantly sexual mode of transmission

890

7576

1.10

1.99

2.5

2.6

167.83

127.89

ng/l

1.70

772

6705

Unspecified transport accident

2.22

1.99

2.6

3.2

88.13

148.20

ng/l

0.51

Use of levodopa decarboxylase inhibitor

602

5417

1.12

1.98

3.3

3.1

205.90

248.36

ng/l

1.91

548

4994

Alcohol-induced acute pancreatitis

114

887

1.31

1.98

2.9

2.8

273.05

184.05

ng/l

0.99

104

800

Right side

139

0.34

1.98

2.2

2.7

46.80

182.93

ng/l

—

123

Non-small cell lung cancer, adenocarcinoma

247

2091

1.20

1.98

2.7

3.1

226.71

238.73

ng/l

0.14

222

1928

Major anomalies of jaw size

480

1.42

1.97

2.7

2.9

109.09

129.87

ng/l

0.39

438

Sequelae of other and unspecified effects of external causes

2.05

1.97

5.2

2.9

145.46

171.46

ng/l

0.19

Contact with heat and hot substances

151

1215

1.26

1.97

2.7

3.2

246.16

187.01

ng/l

0.71

131

1103

Maternal care for known or suspected malpresentation of fetus

192

1688

0.82

1.96

2.0

2.3

46.03

72.26

ng/l

2.53

158

1502

Circumscribed brain atrophy

664

1.37

1.96

2.4

3.0

121.86

258.55

ng/l

6.71

609

Other orthopaedic follow-up care

162

1315

1.25

1.95

2.4

271.95

183.30

ng/l

0.90

147

1178

Meningitis

142

1136

1.27

1.95

2.8

2.9

164.36

189.08

ng/l

0.34

122

1031

Fall on and from ladder

277

2369

1.19

1.95

3.2

2.9

210.29

206.33

ng/l

0.05

253

2168

Malignant neoplasm of corpus uteri

246

2894

0.84

1.95

2.6

3.0

198.82

203.74

ng/l

0.07

224

2634

Endometriosis ASRM stages 1,2

391

3421

1.15

1.94

2.4

2.5

83.67

122.70

ng/l

4.85

351

3083

Alzheimer’s disease, strict definition

1275

9772

1.08

1.94

3.1

3.2

247.02

290.30

ng/l

2.75

1165

8971

Alzheimer’s disease (Late onset)

1191

9301

1.09

1.93

3.2

3.3

247.26

296.04

ng/l

3.17

1093

8532

Upper arm

2.85

1.93

7.7

1.6

256.72

101.93

ng/l

—

Polycystic ovarian syndrome, broad definition

149

1196

1.25

1.93

2.3

2.2

66.18

71.70

ng/l

0.18

134

1040

Respiratory tuberculosis, confirmed

502

1.41

1.91

3.9

3.2

261.25

241.81

ng/l

0.13

455

Benign neoplasm: Floor of mouth

2.33

1.91

2.4

2.2

146.82

231.28

ng/l

0.52

Other predominantly sexually transmitted diseases, not elsewhere classified

343

2978

1.16

1.90

2.6

128.23

124.43

ng/l

0.08

291

2620

Oligomenorrhoea

568

1.37

1.90

2.7

2.8

121.93

159.39

ng/l

0.67

511

Schizotypal disorder

358

1.48

1.90

1.8

2.8

220.86

140.48

ng/l

0.45

313

Dementia due to Parkinsons disease, excluding more controls

728

1.34

1.90

2.7

232.28

293.32

ng/l

0.62

667

Polyp of the female genital tract

1012

5349

1.09

1.88

2.5

2.7

162.63

206.51

ng/l

2.92

919

4877

Anogenital herpesviral [herpes simplex] infection

195

1616

1.21

1.88

2.4

2.6

102.09

118.00

ng/l

0.51

173

1412

Other acute skin changes due to ultraviolet radiation

118

930

1.29

1.88

3.9

2.9

182.06

208.20

ng/l

0.43

111

855

Primary open-angle glaucoma, strict

1202

11158

1.08

1.87

3.3

3.0

213.43

243.44

ng/l

2.00

1100

10271

Deficiency of other/unspecified vitamins

3.36

1.87

3.3

1.8

195.00

124.89

ng/l

—

Polyp of middle ear

3.03

1.87

2.5

2.2

96.75

127.08

ng/l

—

Allergic purpura

640

1.35

1.87

3.1

2.9

238.59

184.54

ng/l

0.65

581

Other salmonella infections

127

1009

1.28

1.87

2.3

2.7

363.00

192.21

ng/l

0.65

117

912

Contact with other hot fluids

588

1.37

1.87

2.2

3.5

209.66

174.34

ng/l

0.23

531

Single delivery by caesarean section

228

1557

0.84

1.86

1.9

2.4

72.76

100.09

ng/l

1.25

199

1354

Female infertility, associated with anovulation

759

1.31

1.86

1.9

2.4

49.78

96.32

ng/l

2.36

668

269

1.54

1.86

6.1

7.2

203.49

226.49

ng/l

0.10

246

Contact with other hot metals

320

1.51

1.85

3.4

3.0

240.72

161.00

ng/l

1.02

285

Other congenital malformations of circulatory system

547

1.38

1.85

2.0

2.8

170.95

162.89

ng/l

0.07

497

Carcinoma in situ of skin of eyelid, including canthus

2.36

1.84

2.5

2.1

308.62

213.66

ng/l

0.30

Other surgical follow-up care

685

1.34

1.84

2.8

2.5

278.99

179.50

ng/l

0.54

616

Other congenital malformations of face and neck

504

1.39

1.83

2.8

2.9

167.60

158.61

ng/l

0.07

447

Subacute thyroiditis

100

773

1.32

1.83

2.1

2.5

103.55

161.46

ng/l

1.18

693

Benign neoplasm: Skin of other and unspecified parts of face

401

3540

1.15

1.83

3.1

3.0

207.44

219.69

ng/l

0.20

362

3225

Impacted cerumen

307

3532

0.86

1.83

3.3

3.0

204.59

227.38

ng/l

0.44

277

3220

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

2.15

1.82

2.6

3.9

98.53

175.27

ng/l

0.85

Other obstructive and reflux uropathy

121

959

1.28

1.82

3.0

2.7

290.54

186.49

ng/l

1.20

101

858

Myasthenia gravis

414

1.44

1.81

3.4

3.1

141.56

196.94

ng/l

1.03

377

Chronic suppurative otitis media, including avohilmo

252

2152

1.18

1.81

4.0

3.1

190.47

209.30

ng/l

0.37

221

1947

Other disorders of breast

349

3052

1.15

1.80

2.5

2.8

189.91

151.06

ng/l

0.84

312

2767

Other disorders of optic [2nd] nerve and visual pathways

198

1657

1.21

1.80

3.3

2.9

199.78

196.91

ng/l

0.03

179

1506

Polyhydramnios

530

1.37

1.80

1.9

2.5

74.61

82.73

ng/l

0.17

465

Use of rivastigmine

741

6761

1.10

1.79

2.9

3.2

189.63

283.12

ng/l

12.07

675

6201

Injury of nerves at ankle and foot level

1.99

1.79

1.9

3.0

223.92

185.85

ng/l

0.08

Benign neoplasm: Other and unspecified parts of mouth

111

876

1.29

1.77

3.0

2.9

203.36

187.45

ng/l

0.20

799

Macular pucker

652

5933

1.11

1.77

2.7

2.9

223.33

207.06

ng/l

0.40

600

5458

Use of selegiline

118

1473

0.79

1.76

3.5

3.0

192.06

241.16

ng/l

0.65

106

1351

Foreign body in alimentary tract

174

1443

1.22

1.75

3.0

3.1

185.12

207.78

ng/l

0.32

155

1321

Evidence of alcohol involvement determined by level of intoxication

148

1.73

1.74

3.4

2.2

178.91

140.24

ng/l

0.19

126

Drug-induced myopathy

2.26

1.74

2.8

219.00

155.91

ng/l

0.36

Lesion of sciatic nerve

180

1502

1.22

1.74

3.6

3.0

223.54

253.08

ng/l

0.45

162

1376

Other specific arthropathies, wide

459

1.40

1.73

2.5

2.8

173.02

187.63

ng/l

0.10

421

Hypertrichosis

250

1.54

1.73

3.3

2.4

60.39

102.74

ng/l

1.34

221

Congenital malformations of the nervous system

324

1.48

1.73

2.7

3.7

92.87

152.19

ng/l

1.17

293

Myelodysplastic syndrome

378

1.46

1.72

2.8

3.2

297.32

290.96

ng/l

0.03

350

Tuberculosis

256

2202

1.18

1.72

4.1

3.1

233.56

284.75

ng/l

1.39

234

2012

Parkinson's disease, strict definition

611

5551

1.11

1.72

3.1

215.71

244.35

ng/l

1.04

555

5116

Pyoderma

435

1.41

1.71

2.6

3.4

213.78

193.29

ng/l

0.16

400

Other and unspecified myoneural disorders

2.15

1.71

3.5

2.7

83.57

98.05

ng/l

0.21

Keratoconus

477

1.39

1.71

2.5

2.8

268.54

147.56

ng/l

0.43

426

Lactose intolerance

563

1.35

1.70

2.3

2.9

167.66

167.81

ng/l

0.00

512

Disorders of optic nerve and visual pathways

267

2303

1.17

1.69

3.1

2.9

191.15

187.79

ng/l

0.04

243

2079

Respiratory tuberculosis

215

1828

1.19

1.68

3.9

3.1

225.63

271.40

ng/l

1.04

197

1680

Respiratory tuberculosis, confirmed and not-confirmed

215

1828

1.19

1.68

3.9

3.1

225.63

271.40

ng/l

1.04

197

1680

Bullous pemphigoid

726

1.32

1.68

4.0

3.2

241.87

248.15

ng/l

0.06

666

Varicose veins of other sites

201

1697

1.20

1.68

3.1

2.9

105.89

181.85

ng/l

5.85

180

1532

Spermatocele

292

2544

1.16

1.66

3.4

2.9

181.24

260.01

ng/l

3.56

272

2329

Supervision of normal pregnancy

276

1827

0.86

1.66

2.0

2.2

58.60

78.07

ng/l

1.36

253

1604

Pediculosis, acariasis and other infestations

158

1305

1.22

1.66

3.6

2.7

150.68

164.45

ng/l

0.21

143

1175

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

158

1303

1.22

1.65

2.3

2.6

71.74

104.03

ng/l

2.27

138

1156

All dysplastic lesions of the cervix uteri, vagina or vulva

591

5277

1.11

1.65

2.3

2.4

153.87

115.05

ng/l

1.36

522

4737

Malignant neoplasm of rectum, including Hilmo

491

4420

1.12

1.65

2.4

3.1

226.58

234.58

ng/l

0.15

444

4059

Sequelae of transport accidents

2.03

1.64

3.1

2.9

128.80

132.01

ng/l

0.02

Hirsutism, drug-induced

3.77

1.64

2.2

1.4

60.20

103.64

ng/l

—

Female infertility

548

3688

0.90

1.64

2.2

2.5

99.53

143.12

ng/l

3.84

500

3342

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

296

1.49

1.64

2.6

3.1

108.27

187.42

ng/l

1.88

265

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

440

3933

1.13

1.63

3.1

2.9

196.19

168.22

ng/l

0.55

394

3509

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

388

3449

1.14

1.63

2.4

3.1

234.47

229.45

ng/l

0.08

347

3172

Dermatitis herpetiformis

432

1.40

1.61

5.3

2.9

134.87

177.39

ng/l

0.53

398

Wide developmental disorders

361

1.42

1.61

3.0

3.8

68.81

132.11

ng/l

1.83

304

Separation of retinal layers (serosa)

126

1022

1.25

1.60

3.3

2.8

213.70

173.90

ng/l

0.40

113

935

Lesion of femoral nerve

145

1.72

1.60

1.9

2.7

91.06

172.58

ng/l

1.87

133

Autism spe

255

1.51

1.60

2.8

3.8

74.13

101.98

ng/l

0.49

213

Progressive external ophthalmoplegia

3.79

1.59

2.0

34.00

138.87

ng/l

—

Malignant neoplasm of thymus, including Hilmo

1.93

1.59

2.6

3.1

206.71

135.89

ng/l

0.67

Adenocarcinoma and papilloma adenocarcinoma of rectum

370

3286

1.14

1.59

2.3

3.1

233.08

226.44

ng/l

0.10

331

3022

Burn and corrosion of hip and lower limb, except ankle and foot

484

1.37

1.59

3.1

2.9

210.32

195.29

ng/l

0.08

428

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

158

1311

1.22

1.58

2.3

2.8

147.04

153.97

ng/l

0.09

138

1166

Respiratory tuberculosis, bacteriologically and histologically confirmed

520

1.36

1.58

3.9

3.2

261.25

240.49

ng/l

0.14

473

Cholesteatoma of middle ear

188

1592

1.20

1.56

4.0

3.0

233.13

221.12

ng/l

0.09

177

1454

Other drug-induced secondary parkinsonism

226

1.56

4.0

3.1

175.55

170.26

ng/l

0.03

203

Measles

161

1.65

1.56

3.0

2.3

250.89

79.17

ng/l

1.02

136

Disorders of puberty

153

1.66

1.55

6.3

2.9

201.50

125.53

ng/l

0.34

134

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

158

1313

1.21

1.55

2.3

2.5

71.74

100.20

ng/l

1.93

138

1185

Benign neoplasm: Tongue

697

1.30

1.55

2.7

2.9

262.04

188.97

ng/l

0.46

636

Melanoma of uvea

260

1.52

1.53

2.2

3.0

265.84

203.85

ng/l

0.29

232

Calcium deposit in bursa

2.30

1.53

2.9

1.9

117.45

137.98

ng/l

0.15

Malignant neoplasm of bronchus and lung, including Hilmo

933

7261

1.08

1.51

3.0

3.2

225.95

251.38

ng/l

1.01

872

6678

Pemphigoid

113

916

1.26

1.51

3.9

3.1

220.84

245.57

ng/l

0.32

102

844

Excessive attrition of teeth

1760

16695

1.06

1.50

2.7

2.8

144.47

167.12

ng/l

2.14

1571

15110

Medicines for HER+ breast cancer

1141

11535

0.93

1.50

2.4

2.8

159.13

176.71

ng/l

1.06

1042

10550

Idiopathic hypoparathyroidism

2.16

1.50

19.4

3.1

141.92

226.96

ng/l

0.63

Other abnormal products of conception

559

3356

1.11

1.49

2.1

2.3

54.67

87.76

ng/l

6.81

485

2985

HSIL lesion of the cervix uteri, vagina or vulva

377

3358

1.13

1.49

2.3

2.5

146.94

117.99

ng/l

0.69

332

3010

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

2.08

1.49

5.2

3.3

300.92

156.02

ng/l

0.75

Melanocytic naevi, other sites/unspecified

228

1967

1.17

1.49

3.1

2.9

176.28

186.68

ng/l

0.16

216

1777

Failed induction of labour

618

1.30

1.49

2.0

2.4

25.26

74.14

ng/l

7.48

533

Other predominantly sexually transmitted diseases, not elsewhere classified

389

3473

1.12

1.48

2.7

2.6

137.05

118.15

ng/l

0.50

332

3035

Blepharospasm

221

1.55

1.47

2.5

3.1

118.71

206.38

ng/l

1.93

202

Rheumatic heart disease, other

2.43

1.47

1.6

2.1

267.67

247.41

ng/l

—

Melanocytic naevi of lower limb, including hip

120

980

1.24

1.45

2.9

2.8

123.06

166.48

ng/l

1.65

111

891

Other facial nerve disorders

632

1.30

1.45

2.9

2.8

155.14

207.92

ng/l

0.91

582

Residual foreign body in soft tissue

136

1125

1.22

1.45

3.4

2.8

146.83

184.59

ng/l

0.69

122

1016

Presbyopia

174

1473

1.19

1.44

2.7

166.76

146.69

ng/l

0.24

153

1327

Scabies

115

935

1.24

1.44

3.9

2.8

161.39

153.56

ng/l

0.08

103

847

Aphakia

389

1.39

1.44

3.0

2.9

272.25

206.42

ng/l

0.67

360

Malignant neoplasm of anus and anal canal, including Hilmo

348

1.42

1.44

2.6

3.3

129.56

216.65

ng/l

2.26

322

Melanocytic naevi of other and unspecified parts of face

165

1391

1.20

1.44

2.7

101.26

181.70

ng/l

6.79

149

1256

6-mercaptopurine

491

1.34

1.44

3.0

2.8

92.52

137.52

ng/l

1.14

431

Puerperal sepsis

318

2814

1.14

1.44

2.2

2.6

113.56

132.68

ng/l

0.52

300

2568

Malignant neoplasm of prostate, including Hilmo

1262

7051

1.07

1.44

2.7

3.2

227.05

255.70

ng/l

1.25

1147

6475

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

120

983

1.24

1.44

3.8

3.0

179.12

209.45

ng/l

0.41

106

893

Follicular lymphoma, hilmo

154

1294

1.21

1.43

2.5

2.8

261.71

203.44

ng/l

0.79

140

1178

Perioral dermatitis

338

1.41

1.43

3.3

2.7

101.13

130.09

ng/l

0.49

306

Tuberculosis, wide

298

2634

1.14

1.42

3.8

3.1

208.97

274.04

ng/l

2.59

276

2403

Disorder of the sleep-wake schedule

288

1.45

1.42

2.5

3.0

91.46

156.29

ng/l

1.46

258

Sequelae of infectious and parasitic diseases

233

2023

1.16

1.42

3.2

2.9

198.87

219.41

ng/l

0.36

207

1817

Parkinson's disease, including avohilmo

673

6207

1.09

1.42

3.0

3.1

213.13

242.71

ng/l

1.21

613

5708

120

980

1.23

1.41

2.0

2.2

144.41

61.41

ng/l

0.82

858

Malignant neoplasm of anus and anal canal

136

1.71

1.41

2.8

3.1

168.41

197.75

ng/l

0.21

122

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

495

4497

1.11

1.40

3.0

2.8

195.69

168.92

ng/l

0.56

443

4025

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

103

829

1.25

1.40

1.8

2.1

54.91

68.59

ng/l

0.62

736

Arthropathic psoriasis

331

2946

1.13

1.39

2.9

2.8

197.27

171.81

ng/l

0.41

288

2674

Carcinoma in situ of other and unspecified digestive organs

122

1007

1.24

1.38

2.9

3.1

260.83

215.29

ng/l

0.52

115

927

Traumatic amputation of wrist and hand

145

1216

1.21

1.38

3.3

2.8

228.24

205.85

ng/l

0.23

133

1106

Toxic effect of alcohol

453

1.35

1.38

2.9

3.1

175.25

185.98

ng/l

0.09

407

Crushing injury of ankle and foot

2.06

1.37

4.2

3.5

138.25

223.05

ng/l

0.51

Other disorders of the genitourinary system

461

4185

1.11

1.37

2.8

2.9

193.33

197.74

ng/l

0.09

428

3815

Patellar tendinitis

240

1.48

1.37

1.6

2.8

83.89

169.80

ng/l

1.62

205

Benign neoplasm of bone and articular cartilage

227

1973

1.16

1.37

2.5

2.8

180.48

175.53

ng/l

0.04

204

1780

Ulcerative colitis (strict definition, require KELA)

454

4115

1.11

1.36

3.0

2.9

202.96

167.41

ng/l

0.74

406

3674

Benign neoplasm: Conjunctiva

102

827

1.25

1.36

2.7

3.0

199.95

207.83

ng/l

0.05

757

Use of antiglaucoma preparations and miotics

346

3099

1.13

1.35

3.2

291.47

250.69

ng/l

0.77

311

2835

Parkinson's disease

641

5916

1.09

1.34

3.0

3.1

215.88

243.00

ng/l

1.00

582

5442

Malignant neoplasm of stomach, including Hilmo

236

2064

1.16

1.34

2.7

3.2

262.41

253.20

ng/l

0.07

219

1898

Bilateral sagittal split ramus osteotomy operation

489

1.32

1.33

1.8

2.6

67.85

117.22

ng/l

2.16

424

Disorders of aromatic amino-acid metabolism

2.18

1.33

6.6

3.5

316.56

159.95

ng/l

—

Female infertility, cervical, vaginal, other or unspecified origin

504

3600

0.91

1.33

2.2

2.5

101.29

140.62

ng/l

2.95

460

3271

Other articular cartilage disorders

588

1.30

1.33

2.4

2.7

99.97

189.82

ng/l

3.05

535

Other or unspecified common variable immunodeficiency

2.04

1.33

5.9

1.9

72.92

120.02

ng/l

0.78

Disorders of eyelid in diseases classified elsewhere

757

1.26

1.33

3.9

3.0

200.62

210.25

ng/l

0.07

690

Hyperchylomicronaemia

2.44

1.31

2.6

1.9

94.88

119.60

ng/l

—

Malignant neoplasm of nasal cavity and middle ear

115

1.74

1.31

2.8

3.7

107.21

180.60

ng/l

0.99

102

Guttate psoriasis

260

1.45

1.31

2.5

3.0

169.70

177.89

ng/l

0.03

229

Polycythaemia vera

134

1125

1.21

1.30

3.8

3.2

273.37

234.17

ng/l

0.38

123

1028

L02BG Aromatase inhibitors

952

10132

0.93

1.29

2.4

2.7

165.84

174.51

ng/l

0.34

866

9286

Inflammatory disease of cervix uteri

142

1678

0.84

1.28

2.4

2.9

227.74

183.37

ng/l

0.51

126

1526

Panhypopituitarism

416

1.35

1.28

3.3

3.0

137.77

201.32

ng/l

0.80

375

Multiple delivery

128

1528

0.83

1.27

2.1

2.5

88.57

126.92

ng/l

2.02

118

1378

Testicular hypofunction

672

1.27

1.26

3.0

2.8

185.62

158.24

ng/l

0.20

593

Use of donepezil

890

9083

0.93

1.25

2.9

3.3

221.35

283.66

ng/l

4.08

809

8351

Secondary malignant neoplasm of respiratory and digestive organs

533

1.31

1.25

2.8

3.4

163.56

238.24

ng/l

1.36

499

Maternal care related to the fetus and amniotic cavity and possible delivery problems

810

5105

0.93

1.25

2.2

2.4

78.26

108.90

ng/l

4.57

719

4593

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

252

2225

1.14

1.25

2.6

2.9

152.36

179.65

ng/l

0.56

217

2022

Sleepwalking [somnambulism]

2.25

1.24

2.3

2.2

206.63

122.53

ng/l

—

Other and unspecified diseases of spleen

1.82

1.24

4.6

3.4

199.07

120.97

ng/l

0.36

Behavioural syndromes associated with physiological disturbances and physical factors

3381

23164

1.04

1.24

2.5

2.9

162.18

188.01

ng/l

2.99

3055

20977

Cachexia

109

1.72

1.24

3.2

2.5

607.58

173.93

ng/l

1.27

100

Maternal care for known or suspected fetal abnormality and damage

224

1682

1.15

1.23

2.3

66.57

74.97

ng/l

0.34

190

1503

Other and unspecified injuries of shoulder and upper arm

738

1.25

1.23

2.7

115.54

199.08

ng/l

1.73

670

Congenital absence, atresia and stenosis of small intestine

2.50

1.23

2.8

2.5

430.83

141.65

ng/l

—

Glaucoma, exfoliation

496

4553

1.10

1.22

3.7

3.1

239.89

260.42

ng/l

0.38

459

4163

Use of galantamine

308

3428

0.89

1.22

2.5

3.2

197.46

285.39

ng/l

5.52

278

3126

IBD (strict) with PSC

133

1.61

1.20

3.0

2.7

81.57

105.94

ng/l

0.32

118

Other proliferative retinopathy

1.79

1.19

3.1

2.0

456.33

243.33

ng/l

0.32

Testicular dysfunction

777

1.24

1.19

2.9

2.8

196.91

157.00

ng/l

0.34

681

Other effects of reduced temperature

2.16

1.19

4.4

2.3

216.50

121.35

ng/l

—

Retinal breaks without detachment

558

5151

1.09

1.18

2.6

2.8

141.31

182.99

ng/l

2.49

504

4709

Special screening examination for infectious and parasitic diseases

468

3146

1.10

1.18

2.0

2.3

138.08

120.84

ng/l

0.47

371

2769

Other demyelinating diseases of the central nervous system

579

1.27

1.18

2.1

2.9

80.03

144.04

ng/l

2.34

512

Malignant neoplasm of eye and adnexa, including Hilmo

458

1.32

1.17

2.7

3.9

328.08

234.65

ng/l

0.66

425

Other abortion

126

1.62

1.17

2.3

2.8

103.40

148.33

ng/l

0.34

109

Endometriosis of ovary

457

4078

1.10

1.17

2.6

2.7

119.05

179.27

ng/l

5.13

426

3714

Carcinoma in situ of penis

2.15

1.17

2.0

2.3

99.13

230.03

ng/l

—

Other maternal disorders predominantly related to pregnancy

1382

8222

1.06

1.16

2.2

2.4

94.03

122.47

ng/l

3.30

1242

7419

Sequelae of tuberculosis

610

1.27

1.16

4.8

3.3

270.64

309.16

ng/l

0.41

558

Other superficial injuries of ankle and foot

1.80

1.15

4.3

6.2

161.57

200.53

ng/l

0.18

Spasmodic torticollis

690

1.25

1.15

2.5

3.0

105.32

174.09

ng/l

1.98

626

Laparoscopic right hemicolectomy

224

1981

1.15

1.14

2.5

2.9

196.79

223.00

ng/l

0.53

205

1810

Biological medicines for asthma

319

1.37

1.14

2.8

2.6

89.46

122.49

ng/l

0.33

286

Non-small cell lung cancer, adenocarcinoma, helper endpoint

247

2198

1.14

1.13

2.7

3.0

226.71

233.90

ng/l

0.08

222

2011

Pregnancy examination and test

232

1267

1.14

1.13

1.9

2.1

83.17

72.56

ng/l

0.18

192

1116

Disorders of puberty, all

184

1.49

1.12

6.0

3.2

194.27

131.12

ng/l

0.30

166

Other rupture of muscle

120

1.63

1.12

3.3

3.1

138.05

161.97

ng/l

0.23

103

Medical treatment for female infertility

250

2794

0.89

1.12

1.9

2.2

59.72

76.93

ng/l

1.13

229

2460

Congenital lens malformations

1.88

1.12

7.1

3.2

211.42

197.30

ng/l

0.05

Cerebral arteritis

2.03

1.11

2.9

2.1

71.37

99.97

ng/l

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

186

1.50

1.11

2.5

3.4

198.41

212.67

ng/l

0.05

168

Complications associated with artificial fertilization

168

1.50

1.11

1.6

2.5

39.37

87.87

ng/l

1.88

139

Degenerative myopia

153

1.55

1.10

3.0

3.1

263.22

184.15

ng/l

0.42

136

HSIL lesion of the cervix uteri

311

2800

1.11

1.10

2.2

2.4

135.12

108.30

ng/l

0.56

274

2492

Retinoschisis and retinal cysts

697

1.24

1.09

3.3

3.0

156.87

222.94

ng/l

1.40

645

Sequelae of other accidents

384

1.33

1.08

3.1

2.8

186.12

200.62

ng/l

0.12

344

Intentional self-harm by hanging, strangulation and suffocation

121

0.48

1.08

7.3

3.3

98.50

146.30

ng/l

—

Childhood allergy (age < 16)

168

1198

1.16

1.08

3.9

3.6

80.36

117.27

ng/l

0.99

135

1003

Mesial bite

129

1.58

1.08

2.8

2.4

90.53

104.95

ng/l

0.13

122

Malignant neoplasm of rectum

364

3318

1.11

1.07

2.3

3.1

229.94

228.05

ng/l

0.03

330

3048

Other specified/unspecified disorders of bone/cartilage

607

1.25

1.06

2.2

2.9

137.05

180.06

ng/l

0.54

544

Use of glatiramer acetate

195

1.46

1.06

1.7

2.4

67.76

74.91

ng/l

0.15

172

Malignant neoplasm of bladder, including Hilmo

501

4603

1.09

1.06

3.3

259.02

283.22

ng/l

0.60

462

4246

Carcinoma in situ of oesophagus

2.43

1.06

1.2

2.1

169.00

120.29

ng/l

—

Chronic nephritic syndrome

121

1028

1.19

1.06

3.5

2.9

452.31

196.48

ng/l

3.58

111

937

Foreign body on external eye

420

3853

1.10

1.05

2.9

2.8

158.48

170.96

ng/l

0.21

369

3438

Pregnancy with abortive outcome

2137

10717

1.04

1.05

2.5

2.7

148.79

168.49

ng/l

1.68

1942

9750

Ovarian hyperstimulation (induction)

146

1.52

1.04

1.6

2.5

41.19

68.87

ng/l

0.71

121

Psoriatic arthropathies, ICD10

297

2682

1.12

1.04

3.0

2.8

208.73

167.81

ng/l

0.67

255

2432

Diabetes mellitus in pregnancy

488

2877

1.09

1.03

1.9

2.3

81.51

79.85

ng/l

0.04

425

2535

Chalazion

327

2970

1.11

1.02

2.4

2.9

174.05

178.15

ng/l

0.07

294

2692

Placenta praevia

530

0.75

1.02

2.5

97.69

72.78

ng/l

0.34

466

Aggressive periodontitis

485

1.28

1.02

2.7

3.0

160.03

199.88

ng/l

0.54

443

malignant neoplasm of female genital organs

485

5206

0.92

1.02

2.5

2.9

205.14

197.15

ng/l

0.15

443

4749

Acne varioliformis

1.92

1.02

1.6

2.3

303.89

201.26

ng/l

—

Bitten or struck by other mammals

265

2380

1.12

1.02

2.6

2.8

177.41

157.64

ng/l

0.25

241

2124

Complications predominantly related to the puerperium

529

4905

1.08

1.01

2.2

2.4

102.60

117.04

ng/l

0.49

486

4413

Intrahepatic Cholestasis of Pregnancy (ICP)

103

864

1.20

1.01

1.8

2.4

54.91

69.86

ng/l

0.84

754

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

467

1.28

1.01

2.5

2.8

119.38

156.91

ng/l

0.41

414

Contact with hot air and gases

132

1.56

1.00

2.3

3.2

409.69

150.13

ng/l

0.70

115

Personality and behavioural disorders due to brain disease, damage and dysfunction

362

1.32

1.00

1.6

3.2

221.87

226.89

ng/l

0.02

327

Other psoriatic arthropathies

288

2603

1.11

1.00

3.0

2.9

206.43

164.96

ng/l

0.66

246

2360

Pustular psoriasis

131

1126

1.18

1.00

4.0

3.2

165.77

179.88

ng/l

0.22

122

1021

Other specified/unspecified disorders of middle ear and mastoid

1.89

1.00

2.9

2.4

95.22

278.94

ng/l

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

542

1.26

0.99

2.3

3.2

180.37

270.91

ng/l

1.92

502

Benign neoplasm: Peripheral nerves and autonomic nervous system

372

1.32

0.99

3.4

3.2

130.60

173.95

ng/l

0.65

340

Disorders of muscle in diseases classified elsewhere

2.40

0.97

6.2

1.8

646.83

164.45

ng/l

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.84

0.97

3.5

2.4

185.91

132.13

ng/l

0.32

Tic and related disorders

149

1.50

0.97

3.6

3.3

87.33

148.51

ng/l

0.86

131

Abnormal findings on diagnostic imaging of central nervous system

123

1055

1.18

0.97

3.3

2.7

137.28

187.40

ng/l

1.05

111

954

Unspecified dementia

441

4287

0.92

0.97

3.3

334.04

328.51

ng/l

0.04

397

3904

Persons encountering health services in other circumstances

1202

12537

0.95

0.96

2.9

2.8

227.04

188.09

ng/l

1.52

1067

11416

Malignant neoplasm of vagina, including Hilmo

1.68

0.96

2.1

3.8

395.20

203.92

ng/l

0.33

Ulcerative rectosigmoiditis

215

1918

1.13

0.96

2.5

2.7

178.01

174.13

ng/l

0.05

190

1727

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

110

938

1.19

0.95

4.2

3.1

230.96

261.95

ng/l

0.43

102

864

Other leukaemias of specified cell type

1.81

0.95

1.8

2.7

296.89

266.51

ng/l

—

Loose body in joint

562

1.25

0.95

2.3

2.8

231.49

185.84

ng/l

0.29

517

Dislocation, sprain and strain of joints and ligaments of elbow

143

1242

1.16

0.95

3.1

2.9

159.06

160.26

ng/l

0.01

131

1111

Benign neoplasm: other/unspecified salivary gland

755

1.21

0.94

2.8

3.0

288.57

228.42

ng/l

0.40

693

Lactose intolerance, other/unspecified

508

1.25

0.94

2.2

2.9

162.83

174.06

ng/l

0.10

461

Malignant neoplasm of vagina

1.92

0.93

2.3

3.5

425.20

155.31

ng/l

—

Other and unspecified disorders of globe

2.02

0.92

3.1

1.9

109.13

142.64

ng/l

—

Obstructed labour due to malposition and malpresentation of fetus

316

3228

0.91

2.1

2.3

83.09

83.48

ng/l

0.01

279

2877

Other abnormal findings of blood chemistry

133

1156

1.16

0.90

3.1

2.9

272.57

186.44

ng/l

1.16

126

1057

Rare circulating lymphoid malignancy, including Hilmo

100

851

1.19

0.90

2.7

3.5

215.52

238.02

ng/l

0.20

792

Gastrointestinal stromal tumor and sarcoma

317

1.33

0.90

2.0

3.4

202.46

199.10

ng/l

0.02

293

Intentional self-harm by other and unspecified firearm discharge

2.11

0.90

3.5

2.2

534.50

163.56

ng/l

—

Infectious mononucleosis

123

1061

1.16

0.89

3.4

2.7

102.62

116.56

ng/l

0.31

915

Other and unspecified water transport accidents

1.79

0.89

3.1

3.9

147.00

123.66

ng/l

0.15

Gluteal tendinitis

101

860

1.19

0.89

2.7

2.8

94.71

184.18

ng/l

5.74

758

Rickettsioses

1.90

0.89

4.0

3.9

150.00

170.46

ng/l

—

Crushing injury of lower leg

2.07

0.88

1.2

2.0

42.17

152.04

ng/l

—

Malignant neoplasm of pancreas, including Hilmo

329

3021

1.10

0.88

3.2

192.96

239.14

ng/l

1.39

304

2776

Non-small cell lung cancer

407

3740

1.09

0.88

2.8

3.3

202.31

266.41

ng/l

2.34

372

3442

Mandibular retrognathia AND surgery (BSSO)

361

1.29

0.87

1.9

2.6

63.32

121.27

ng/l

2.27

318

Congenital varicose veins

1.80

0.85

3.2

2.8

280.70

100.71

ng/l

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

801

1.19

0.85

1.9

3.1

159.46

184.05

ng/l

0.44

728

Benign neoplasm: Ribs, sternum and clavicle

1.82

0.85

2.4

124.25

130.43

ng/l

—

Torsion of testis

274

1.33

0.85

3.2

3.6

137.25

152.72

ng/l

0.09

227

Cleft lip, lip and palate or palate

205

1.38

0.84

2.3

3.1

79.10

104.12

ng/l

0.37

183

Postpartum care and examination

191

1077

1.13

0.83

2.2

2.1

74.14

69.85

ng/l

0.05

166

940

Glaucoma-related operations

228

2066

1.12

0.83

2.6

3.1

203.54

230.24

ng/l

0.79

207

1901

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.82

0.0

5.6

—

166.96

—

Non-small cell lung cancer, squamous, helper endpoint

148

1670

0.88

0.81

2.9

3.1

167.75

302.81

ng/l

7.68

139

1533

Other specified disorders of external ear

128

1122

1.16

0.81

3.3

2.9

296.42

217.29

ng/l

0.53

117

1020

Fistulae involving female genital tract

375

1.27

0.81

2.5

3.0

154.51

190.25

ng/l

0.22

340

Other helminthiases

0.00

0.81

0.0

1.8

—

131.90

—

Dental pulpitis, including avohilmo

3001

18946

1.03

0.81

2.6

2.8

131.14

168.36

ng/l

6.56

2629

17145

Caries in Clefts patients

114

1.51

0.81

2.8

3.0

72.50

126.80

ng/l

0.63

103

Other papulosquamous disorders

225

1.36

0.80

2.6

2.7

82.80

190.21

ng/l

2.46

206

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

584

1.22

0.80

2.7

3.0

135.19

202.48

ng/l

1.15

536

Superficial injuries involving multiple body regions

547

1.22

0.80

4.3

3.1

245.47

203.26

ng/l

0.20

493

Congenital malformations of ovaries, fallopian tubes and broad ligaments

841

1.17

0.79

2.4

2.8

119.94

113.89

ng/l

0.05

739

Malignant neoplasm of stomach

191

1719

1.12

0.79

2.7

3.2

281.85

260.76

ng/l

0.15

178

1584

Drug-induced neutropenia

216

1957

1.11

0.78

3.0

2.8

158.53

180.09

ng/l

0.44

199

1769

Other contact dermatitis

215

1946

1.11

0.78

3.3

2.9

167.93

179.08

ng/l

0.16

197

1745

Absence of one kidney

1.76

0.77

1.3

2.4

296.56

212.26

ng/l

—

L02BA Anti-estrogens

446

4767

0.93

0.77

2.2

2.8

151.87

169.21

ng/l

0.63

407

4340

Other disorders of prostate

1099

0.85

0.77

3.0

2.9

261.94

263.46

ng/l

0.01

1010

Sleep disorders

3188

22452

1.03

0.77

2.5

2.9

160.22

185.43

ng/l

2.87

2886

20328

Contact with other sharp object(s)

141

1247

1.14

0.76

2.3

2.9

144.05

150.57

ng/l

0.06

126

1107

Contact with nonpowered hand tool

114

995

1.16

0.76

2.9

123.00

179.83

ng/l

1.13

103

896

Rickettsioses

1.94

0.76

3.7

4.1

157.86

180.95

ng/l

—

Transient global amnesia

340

3152

1.09

0.76

3.2

3.0

144.10

212.04

ng/l

3.14

320

2879

Impacted maxillary molar

582

0.80

0.76

2.6

2.7

208.43

93.89

ng/l

0.71

487

Triptan medication for migraine, min. 3 purchases

1385

10169

1.04

0.75

2.3

2.5

86.90

126.70

ng/l

6.93

1214

9082

Pervasive developmental disorders excl. Autism + Asperger

148

1.42

0.75

3.0

3.7

52.75

171.06

ng/l

2.71

126

Benign neoplasm: Eye, unspecified

1.57

0.75

3.5

5.7

440.00

290.88

ng/l

0.33

Other osteochondropathies

177

1591

1.12

0.75

3.1

2.8

209.05

162.84

ng/l

0.68

155

1442

Other intracranial haemorrhages

121

1065

1.15

0.74

4.4

3.0

327.03

246.61

ng/l

0.60

113

975

Labour and delivery complicated by umbilical cord complications

776

0.83

0.74

1.9

2.7

87.33

99.99

ng/l

0.22

689

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

2.07

0.74

1.6

1.9

13.60

190.53

ng/l

—

Malignant neoplasm of heart, mediastinum and pleura

381

1.26

0.74

2.0

3.3

183.33

240.00

ng/l

0.73

353

Pustulosis palmaris et plantaris

110

961

1.15

0.74

3.1

3.0

162.32

166.57

ng/l

0.05

103

876

Other disorders of carbohydrate metabolism

1.62

0.74

2.2

3.6

187.83

132.51

ng/l

0.22

Ophthalmic devices associated with adverse incidents

1.81

0.73

1.7

2.0

79.86

192.58

ng/l

—

Unattended death

240

0.69

0.73

2.8

3.0

278.06

236.68

ng/l

0.28

215

Use of bromocriptine

2.01

0.72

2.0

2.5

213.60

117.05

ng/l

—

Severe bullous disorders, KELA reimbursement

1.78

0.72

2.7

2.0

209.43

107.60

ng/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

141

1255

1.13

0.72

2.8

125.41

188.09

ng/l

2.17

127

1132

Pedal cyclist injured in collision with motor vehicle

628

1.19

0.72

2.5

2.9

138.96

160.94

ng/l

0.20

561

Exposure to other specified electric current

390

1.24

0.72

3.1

3.6

92.92

129.12

ng/l

0.93

342

Congenital ovarian cysts

600

1.19

0.71

2.3

2.7

90.24

101.90

ng/l

0.13

529

Spinal enthesopathy

105

917

1.15

0.70

3.3

3.1

206.60

339.24

ng/l

2.92

100

827

Respiratory tuberculosis, not confirmed

152

1363

1.13

0.70

3.7

3.1

205.64

269.56

ng/l

1.70

142

1250

Subarachnoid haemorrhage

361

3367

1.08

0.70

2.9

2.8

259.77

221.06

ng/l

0.84

318

3053

Burns and corrosions of multiple and unspecified body regions

474

1.22

0.70

2.2

2.8

345.53

182.88

ng/l

0.97

426

Tic disorders

161

1.38

0.69

3.6

3.1

87.33

145.19

ng/l

0.82

141

Psoriasis (vulgaris), strict definition

681

0.83

0.68

2.3

2.8

113.08

168.73

ng/l

1.34

614

Absence of one kidney

1.68

0.68

1.4

2.5

115.00

240.32

ng/l

—

Benign neoplasm: Skin, unspecified

111

978

1.15

0.68

3.0

2.8

193.21

194.17

ng/l

0.01

895

Complications of anaesthesia during labour and delivery

1.81

0.67

1.0

1.6

95.80

53.83

ng/l

—

Benign neoplasm: Long bones of lower limb

624

1.18

0.66

2.5

2.7

164.14

154.11

ng/l

0.08

558

Twin gestation

131

1167

1.13

0.66

2.0

2.3

55.16

88.15

ng/l

2.06

115

1042

Obstructed labour due to maternal pelvic abnormality

327

3508

0.93

0.65

2.3

2.6

123.71

134.29

ng/l

0.22

292

3204

Narcolepsy and cataplexy

1.50

0.65

3.8

2.6

127.71

176.83

ng/l

0.33

Benign neoplasm: Skin of trunk

117

1038

1.14

0.65

3.3

3.0

178.42

194.11

ng/l

0.17

106

951

Left side

103

0.56

0.65

7.0

3.0

175.67

213.52

ng/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

252

1.29

0.64

2.7

2.8

218.22

200.75

ng/l

0.13

229

Other symptoms and signs involving the digestive system and abdomen

512

4844

1.06

0.64

3.3

2.6

186.71

189.63

ng/l

0.04

466

4396

Allergic contact dermatitis

340

3175

1.07

0.64

2.7

151.37

151.62

ng/l

0.00

310

2868

Malignant melanoma

534

5063

1.06

0.64

2.3

3.0

233.43

224.45

ng/l

0.16

476

4633

Impacted teeth

246

2373

0.92

0.63

3.0

2.7

152.14

116.14

ng/l

0.65

227

2017

Colorectal neuroendocrine tumor and carcinoma

316

1.25

0.63

4.5

3.4

143.59

180.03

ng/l

0.45

295

Other protozoal intestinal diseases

379

1.23

0.63

2.5

2.7

142.70

164.05

ng/l

0.23

344

Endometriosis diagnosis and infertility diagnosis occurring together

177

1609

1.10

0.63

2.2

2.5

75.70

95.34

ng/l

1.01

166

1421

Malignant neoplasm of breast, ER-positive, including Hilmo

1073

7966

1.04

0.63

2.4

2.7

161.13

171.61

ng/l

0.47

981

7249

Complications following abortion and ectopic and molar pregnancy

781

0.85

0.62

2.5

2.9

117.33

158.09

ng/l

0.96

705

Ulcerative colitis (strict definition, all Crohn cases excluded)

372

3489

1.07

0.62

3.1

2.9

199.35

167.92

ng/l

0.57

337

3119

Varus deformity, not elsewhere classified

227

1.30

0.62

2.9

2.8

106.14

196.30

ng/l

1.52

210

Oral lichen planus and hypothyroidism or thyroxine medication

399

1.22

0.61

1.8

2.7

118.63

160.98

ng/l

0.29

366

Prolonged pregnancy

173

1664

0.91

0.61

1.8

2.3

48.94

78.53

ng/l

2.06

148

1469

LSIL lesion of the cervix uteri

159

1754

0.90

0.61

2.4

2.6

163.31

105.14

ng/l

0.72

141

1558

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.59

0.61

4.3

2.6

132.63

142.93

ng/l

—

Brain meningioma, including Hilmo

161

1462

1.11

0.61

2.4

3.1

157.78

189.86

ng/l

0.72

148

1334

Secondary malignant neoplasm of other and unspecified sites

551

0.82

0.61

3.0

3.1

222.05

223.51

ng/l

0.01

512

Malignant neoplasm of cervix uteri, including Hilmo

556

1.18

0.61

3.0

290.52

191.58

ng/l

0.67

507

Traumatic secondary and recurrent haemorrhage

1.85

0.61

4.8

3.6

183.17

170.17

ng/l

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.60

0.0

6.3

—

227.73

—

Abnormalities of ear ossicles

1.83

0.60

2.8

1.9

164.00

223.38

ng/l

—

Hereditary corneal dystrophies

109

970

1.14

0.60

2.4

3.1

205.40

193.09

ng/l

0.15

100

887

Malignant neoplasm of respiratory system and intrathoracic organs

878

7019

1.04

0.60

2.8

3.2

216.42

252.13

ng/l

1.65

806

6452

Other disorders of skin and subcutaneous tissue related to radiation

1.79

0.60

2.8

3.2

105.00

171.43

ng/l

—

Vestibular neuronitis

281

2618

1.08

0.59

3.0

2.9

204.44

193.42

ng/l

0.15

259

2385

Exposure to other and unspecified man-made environmental factors

282

1.26

0.59

2.7

2.9

147.76

181.72

ng/l

0.38

248

Burn and corrosion confined to eye and adnexa

428

1.20

0.59

3.5

2.6

134.80

150.37

ng/l

0.16

378

Type1 diabetes, definitions combined, early onset

807

0.86

0.59

2.9

3.3

263.25

109.42

ng/l

1.04

697

Urticaria due to cold and heat

123

1.40

0.59

2.7

2.9

217.50

127.13

ng/l

0.24

113

Leiomyoma of uterus

2072

11438

1.03

0.58

2.6

2.7

167.07

171.56

ng/l

0.17

1880

10408

Benign mammary dysplasia

459

4350

1.06

0.57

2.5

2.8

159.18

181.17

ng/l

0.89

407

3976

Syndrome of inappropriate secretion of antidiuretic hormone

142

1.38

0.57

2.6

2.4

249.66

205.58

ng/l

0.17

124

Other acantholytic disorders

1.58

0.57

4.1

2.0

158.44

233.26

ng/l

—

Pneumoconiosis due to asbestos and other mineral fibres

758

1.15

0.57

3.5

3.1

219.52

290.97

ng/l

1.26

685

Chromophobe cell carcinoma of kidney

151

1.36

0.57

3.2

3.5

310.25

216.23

ng/l

0.32

137

Carcinoma in situ of other and unspecified genital organs

403

1.21

0.57

2.4

2.8

225.50

170.33

ng/l

0.31

374

Systemic atrophies primarily affecting the central nervous system

137

1242

1.11

0.56

2.6

3.3

161.97

223.93

ng/l

1.04

131

1146

Other specified acquired deformities of limbs

1.50

0.56

1.9

2.4

81.42

159.37

ng/l

1.15

Other crystal arthropathies

572

1.17

0.55

3.5

2.7

337.35

245.29

ng/l

0.58

533

Adenocarcinoma and papillary adenocarcinoma of stomach

873

1.13

0.55

2.7

3.2

252.05

291.76

ng/l

0.40

812

Malignant melanoma, including Hilmo

655

6275

1.05

0.54

2.4

3.1

230.22

226.18

ng/l

0.08

585

5754

Hypogonadotropic hypogonadism

516

1.17

0.54

2.4

2.9

126.67

145.34

ng/l

0.15

446

Foreign body entering into or through eye or natural orifice

216

2002

1.08

0.54

4.1

2.9

152.16

186.80

ng/l

1.07

197

1808

Female infertility, tubal origin

731

1.14

0.54

2.4

2.5

87.92

107.82

ng/l

0.35

650

Premature rupture of membranes

290

2217

0.93

0.53

2.3

2.4

76.63

89.31

ng/l

0.31

257

1969

Enteritis due to Yersinia enterocolitica

1.47

0.53

6.2

2.1

120.75

141.62

ng/l

0.20

Brain meningioma

154

1409

1.10

0.53

2.3

3.0

155.78

191.37

ng/l

0.80

142

1283

Anisometropia and aniseikonia

746

0.86

0.52

2.7

3.1

103.30

198.70

ng/l

4.44

688

Procedures for purposes other than remedying health state

434

1.18

0.52

2.5

2.2

105.66

145.56

ng/l

0.86

397

All dysplastic lesions of the cervix uteri

454

4276

1.05

0.52

2.3

2.4

139.70

108.12

ng/l

0.86

400

3811

Sequelae of burns, corrosions and frostbite

1.44

0.52

2.2

2.5

103.08

128.50

ng/l

0.28

Otosclerosis

205

2209

0.92

0.52

3.0

2.9

165.71

198.61

ng/l

0.62

181

2019

Carcinoma in situ of breast, intraductal

213

2291

0.92

0.51

2.4

2.7

132.87

160.23

ng/l

0.80

188

2097

Sequelae of other and unspecified infectious and parasitic diseases

122

1105

1.11

0.51

2.5

2.8

137.27

166.59

ng/l

0.46

105

983

Iridocyclitis in diseases classified elsewhere

436

1.18

0.51

3.2

3.0

154.04

198.98

ng/l

0.68

397

Transient acantholytic dermatosis [Grover]

1.55

0.49

3.0

2.0

69.57

219.10

ng/l

—

Non-seminoma of testis, including Hilmo

1.47

0.49

3.6

2.8

57.27

175.97

ng/l

1.25

Benign neoplasm of breast

316

3346

0.94

0.48

2.3

2.8

206.19

170.05

ng/l

0.75

279

3048

Triptan medication for migraine, single purchase ok

2206

15265

0.98

0.48

2.4

2.7

98.21

151.12

ng/l

17.86

1943

13729

Migraine, single triptan purchase ok & required. ICD-code if available is included

2206

15265

0.98

0.48

2.4

2.7

98.21

151.12

ng/l

17.86

1943

13729

Sudden idiopathic hearing loss

339

3210

1.06

0.47

3.6

2.8

188.62

205.64

ng/l

0.35

317

2918

Other and unspecified injuries of ankle and foot

758

1.13

0.47

3.1

2.8

212.97

163.47

ng/l

0.56

675

Macular cyst

101

912

1.12

0.47

2.5

3.0

209.43

216.72

ng/l

0.06

845

Other infective (teno)synovitis

1.46

0.47

8.0

2.7

117.09

94.25

ng/l

0.25

Carcinoma in situ of other and unspecified sites

134

1229

1.10

0.47

3.5

3.1

285.02

242.16

ng/l

0.48

124

1125

Demyelinating diseases of the central nervous system

178

1649

1.08

0.47

2.2

2.9

97.84

147.63

ng/l

2.71

152

1469

Non-small cell lung cancer, including Hilmo

613

5550

1.04

0.46

2.9

3.2

188.30

258.46

ng/l

4.62

572

5098

Infections of genitourinary tract in pregnancy

184

1707

1.08

0.46

2.3

2.7

123.15

133.24

ng/l

0.16

169

1549

Diabetic maculopathy

458

4121

1.05

0.46

3.8

3.4

368.21

224.69

ng/l

4.87

422

3721

Examination and encounter for administrative purposes

137

1257

1.10

0.46

2.3

153.94

186.14

ng/l

0.84

128

1158

Benign neoplasm: Rectum/anal canal icd-9

256

1.23

0.46

2.8

3.1

274.75

270.47

ng/l

0.02

237

Crystal arthropathies, rheuma endpoint

583

1.15

0.45

3.5

2.8

337.35

235.54

ng/l

0.66

539

Malignant melanoma of skin, including Hilmo

531

5094

1.05

0.45

2.4

3.0

227.76

223.38

ng/l

0.08

476

4664

Other disorders of amniotic fluid and membranes

158

1669

0.92

0.45

2.2

2.4

51.98

81.17

ng/l

2.85

134

1489

Burn and corrosion of wrist and hand

743

1.12

0.45

2.4

3.0

161.43

164.99

ng/l

0.04

661

Laparoscopic left hemicolectomy

462

1.16

0.44

1.8

3.0

235.37

195.84

ng/l

0.27

421

Small cell lung cancer, helper endpoint

775

0.88

0.43

2.3

3.1

212.73

268.95

ng/l

0.56

710

Retained placenta and membranes, without haemorrhage

263

2479

1.06

0.43

2.6

2.5

93.36

122.00

ng/l

1.55

245

2251

Uterine polyps

264

2490

1.06

0.43

2.6

2.7

142.16

184.65

ng/l

1.34

232

2273

Embedded and impacted teeth

446

3517

1.05

0.43

3.0

2.7

134.04

120.69

ng/l

0.33

408

3023

Subclinical iodine-deficiency hypothyroidism

1.57

0.43

1.8

63.80

131.81

ng/l

—

Hookworm diseases

0.00

0.42

0.0

2.5

—

330.37

—

Postpartum haemorrhage due to retained placenta

152

1642

0.92

0.42

1.7

2.2

56.04

70.19

ng/l

0.60

136

1458

Diphyllobothriasis and sparganosis

0.00

0.42

0.0

3.1

—

119.33

—

Multiple gestation

132

1214

1.09

0.42

2.0

2.3

54.78

86.73

ng/l

2.02

116

1086

Benign neoplasm: Brain, supratentorial

314

1.19

0.42

2.8

3.1

168.48

170.64

ng/l

0.01

276

Intentional self-harm by jumping or lying before moving object

0.00

0.41

0.0

5.9

—

52.44

—

Maternal care for other known or suspected fetal problems

289

1935

0.94

0.41

2.0

2.3

70.28

72.73

ng/l

0.07

255

1708

Trichomoniasis

186

1.25

0.41

3.8

3.1

293.13

157.50

ng/l

0.60

174

Hallux rigidus

452

4332

1.05

0.41

2.4

2.7

186.83

196.56

ng/l

0.19

404

3968

Endovascular or surgical operations to intracerebral aneurysms

159

1709

0.93

0.41

2.8

2.9

227.94

187.49

ng/l

0.50

143

1547

Hookworm diseases

0.00

0.41

0.0

2.3

—

281.53

—

Qualitative platelet defects

1.44

0.40

3.3

2.5

122.00

184.86

ng/l

—

Malignant neoplasm of breast, HER-negative

634

6440

0.96

0.40

2.6

2.9

201.51

187.33

ng/l

0.34

578

5875

Malignant neoplasm of breast, HER-positive

1046

7935

1.03

0.39

2.4

2.7

163.14

172.05

ng/l

0.37

956

7223

Other sexually transmitted chlamydial diseases

702

1.11

0.39

1.9

2.7

117.02

82.96

ng/l

0.42

586

Tic and related disorders

178

1.25

0.39

3.6

3.9

87.33

143.70

ng/l

0.83

158

Sexual dysfunction

289

1.19

0.39

2.4

2.9

145.47

148.58

ng/l

0.02

260

Gastrojejunal ulcer

308

1.18

0.38

2.9

3.1

270.44

209.50

ng/l

0.41

283

Diabetic retinopathy, strict definition

641

5472

1.04

0.38

4.1

3.4

390.05

228.24

ng/l

6.84

608

4951

Malignant neoplasm of palate

1.32

0.38

1.7

4.1

85.56

178.69

ng/l

—

Congenital malformations of uterus and cervix

234

1.20

0.37

2.9

2.6

160.71

109.57

ng/l

0.55

201

Malignant neoplasm of oropharynx, including Hilmo

573

1.13

0.37

2.8

3.1

214.44

216.92

ng/l

0.02

527

Malignant neoplasm of tonsil, including Hilmo

469

1.14

0.37

2.7

3.0

230.24

210.47

ng/l

0.15

433

Other and unspecified hydrocephalus

488

1.14

0.37

3.1

178.81

206.47

ng/l

0.25

442

Malignant neoplasm, without specification of site

102

1109

0.91

0.37

3.0

3.3

290.71

295.11

ng/l

0.02

1022

Chorioretinal scars

0.64

0.37

4.2

3.5

421.20

139.58

ng/l

—

Sixth [abducent] nerve palsy

105

966

1.09

0.37

2.8

3.0

254.53

232.99

ng/l

0.11

892

Tonsillectomy and adenotomy

1341

9118

1.02

0.37

2.5

2.8

104.15

133.97

ng/l

2.88

1160

8081

Hydrocephalus in other diseases

122

0.73

0.36

3.0

2.3

135.56

171.45

ng/l

—

111

Endometriosis ASRM stages 3,4

609

5892

1.04

0.36

2.7

2.6

121.75

157.51

ng/l

3.07

560

5343

Mononeuritis multiplex

1.41

0.36

2.1

110.70

116.50

ng/l

—

ILD medications: acetylcysteine

199

1.22

0.36

2.4

2.8

151.87

216.68

ng/l

0.51

182

Other cestode infections

1.40

0.36

1.6

2.1

94.20

240.26

ng/l

—

conjunctival degenerations and deposits

528

1.13

0.35

2.8

2.9

148.77

207.52

ng/l

1.01

483

Malignant neoplasm of brain, including Hilmo

125

1345

0.92

0.35

2.0

3.2

100.47

216.61

ng/l

8.93

111

1239

Viral conjunctivitis

348

1.16

0.35

2.4

2.8

168.79

160.70

ng/l

0.04

308

Haemorrhagic and haematological disorders of fetus and newborn

252

1.18

0.35

3.6

7.3

173.46

232.44

ng/l

0.35

233

Exposure to sunlight

1.36

0.34

7.0

2.3

239.67

219.22

ng/l

—

Other congenital malformations of limb(s)

1.35

0.34

3.7

2.8

147.47

113.79

ng/l

0.10

Female infertility, uterine origin

1.35

0.34

1.3

2.9

26.67

161.67

ng/l

—

Other conditions related to polyarteritis nodosa

1.33

0.34

5.0

2.7

667.50

210.37

ng/l

—

Congenital malformations of ear causing impairment of hearing

1.32

0.33

1.8

2.5

100.00

160.32

ng/l

—

Supernumerary teeth EXCLUDE clefts and syndromes

1.32

0.33

1.2

2.5

36.00

91.88

ng/l

—

Small cell lung cancer, including Hilmo

759

0.90

0.33

2.3

3.2

212.73

300.54

ng/l

1.01

706

Small cell lung cancer

759

0.90

0.33

2.3

3.2

212.73

300.54

ng/l

1.01

706

Renal cell carcinoma of kidney

103

1112

0.92

0.33

3.0

3.2

343.94

278.70

ng/l

0.54

1031

Other deformity of hallux (acquired)

192

1.21

0.33

2.9

2.8

185.30

191.99

ng/l

0.04

181

Cervical root disorders

137

1.26

0.33

2.3

2.8

147.12

189.82

ng/l

0.27

125

Chondrosarcoma, including Hilmo

110

1.30

0.33

1.9

4.5

266.21

204.43

ng/l

0.15

100

Other specified/unspecified hearing loss

290

2774

1.05

0.32

2.7

2.9

155.21

240.24

ng/l

4.57

271

2519

Hereditary retinal dystrophy

304

1.16

0.32

2.5

4.1

119.10

196.29

ng/l

1.80

275

Oesophagitis, drug-induced

1.41

0.32

2.4

2.6

137.00

247.79

ng/l

—

Renal agenesis and other reduction defects of kidney

1.32

0.32

1.6

2.6

623.33

167.45

ng/l

0.90

Alzheimer’s disease (Early onset), excluding more controls

119

1203

0.93

0.32

2.5

2.7

236.77

335.74

ng/l

1.67

1081

Malignant neoplasm of eye, brain and central nervous system

123

1147

1.08

0.32

2.0

3.3

166.88

215.75

ng/l

0.66

109

1048

Unspecified urinary incontinence

290

2776

1.05

0.32

3.4

2.9

197.78

201.38

ng/l

0.06

254

2518

Type 1 diabetes, strict definition

1016

0.92

0.32

2.6

3.1

219.06

91.91

ng/l

1.26

869

Dementia in other diseases classified elsewhere

166

1567

1.07

0.31

2.5

3.0

235.66

258.97

ng/l

0.31

151

1431

Cyst of Bartholin Gland

676

1.10

0.31

1.7

3.1

95.41

152.50

ng/l

1.89

606

Insomnia

3026

21749

1.01

0.31

2.5

2.8

156.09

182.37

ng/l

3.30

2742

19656

Dentofacial anomalies [including malocclusion]

2048

16181

1.02

0.31

2.7

108.38

154.93

ng/l

9.41

1822

14565

Non-small cell lung cancer, squamous

148

1571

0.94

0.30

2.9

3.2

167.75

292.48

ng/l

6.59

139

1446

Pre-eclampsia superimposed on chronic hypertension

1.26

0.29

2.1

2.6

54.14

78.28

ng/l

—

Palindromic rheumatism

232

1.18

0.29

1.9

2.7

129.50

175.80

ng/l

0.35

217

Congenital hydrocephalus

1.24

0.29

1.7

2.0

32.57

113.39

ng/l

—

Carcinoma in situ, bladder

121

1135

1.07

0.29

3.6

3.1

289.03

238.41

ng/l

0.55

113

1039

Carcinoma in situ of breast

103

1.28

0.29

2.4

2.8

98.31

133.97

ng/l

0.54

Bacterial meningitis

786

1.09

0.29

3.1

2.9

160.93

185.08

ng/l

0.24

716

Benign neoplasm of male genital organs

616

0.90

0.28

2.6

3.0

296.18

234.48

ng/l

0.30

560

Radiodermatitis

1.28

0.28

1.3

3.0

115.63

201.15

ng/l

—

Vertical strabismus

806

1.09

0.28

2.4

2.9

160.49

182.14

ng/l

0.24

741

Type 1 diabetes, strict (exclude DM2)

162

1530

1.06

0.28

2.7

3.0

193.82

124.59

ng/l

1.09

150

1338

Primary angle-closure glaucoma

160

1517

1.06

0.28

2.9

3.0

232.89

233.73

ng/l

0.01

147

1396

Communicating hydrocephalus

594

0.90

0.27

2.4

3.2

186.62

239.15

ng/l

0.55

546

Malignant neoplasm of larynx, including Hilmo

596

1.10

0.27

2.6

3.1

326.77

264.77

ng/l

0.29

551

Melanoma in situ, other sites/unspecified

1.31

0.27

2.6

3.2

121.91

205.09

ng/l

0.64

Crohn disease (strict definition, all UC cases excluded)

104

972

1.07

0.27

2.3

2.8

125.62

157.38

ng/l

0.48

867

Mumps

548

1.10

0.27

2.1

2.6

81.73

158.84

ng/l

3.48

489

Occupant of special vehicle mainly used on industrial premises injured in transport accident

1.30

0.27

3.3

3.6

80.36

247.23

ng/l

2.07

Renal agenesis and other reduction defects of kidney

1.32

0.26

1.7

2.6

561.60

175.57

ng/l

—

Male infertility

739

0.92

0.26

4.2

2.8

148.95

145.44

ng/l

0.02

628

LSIL lesion of the cervix uteri, vagina or vulva

254

2437

1.04

0.26

2.2

2.5

173.00

121.10

ng/l

0.89

223

2180

Malignant neoplasm of larynx

463

1.11

0.26

2.5

3.3

387.22

264.32

ng/l

0.52

432

Benign neoplasm of thyroid gland

810

1.08

0.26

3.7

2.9

114.80

194.98

ng/l

3.91

740

Bicornuate uterus

1.24

0.25

2.4

2.2

123.78

65.15

ng/l

—

Benign neoplasm: Cranial nerves

757

0.92

0.25

2.9

125.89

189.24

ng/l

1.31

694

Pneumoconiosis due to dust containing silica

1.29

0.25

2.5

3.5

298.82

254.57

ng/l

0.12

Calculus of lower urinary tract

184

1758

1.05

0.25

2.7

3.0

281.78

250.74

ng/l

0.27

168

1612

Malignant melanoma of skin

385

3733

1.03

0.25

2.2

3.1

236.82

219.36

ng/l

0.28

344

3430

Type 1 diabetes, definitions combined

162

1537

1.05

0.25

2.7

2.9

193.82

122.19

ng/l

1.15

150

1342

Psoas tendinitis

0.73

0.24

3.3

2.2

147.50

109.14

ng/l

—

MS-disease / Multiple Sclerosis

137

1298

1.06

0.24

2.2

2.9

95.32

137.90

ng/l

1.77

116

1156

Contraceptive management

955

6566

1.02

0.24

2.8

2.5

102.49

118.66

ng/l

0.92

864

5821

N06DA Anticholinesterases

1675

13020

1.02

0.24

2.8

3.2

208.21

278.16

ng/l

10.31

1524

11993

Use of anticholinesterases

1675

13020

1.02

0.24

2.8

3.2

208.21

278.16

ng/l

10.31

1524

11993

Other puerperal infections

843

1.07

0.23

1.6

2.5

39.53

77.74

ng/l

3.92

725

Benign neoplasm: Testis

1.27

0.23

3.4

2.3

301.36

233.78

ng/l

0.16

Carcinoma in situ, eye

0.00

0.23

0.0

1.9

—

191.44

—

Benign lipomatous neoplasm of other sites/unspecified

278

2877

0.96

0.23

3.0

265.43

214.32

ng/l

0.74

259

2624

Mesothelioma, including Hilmo

410

1.11

0.23

2.0

3.0

170.64

257.41

ng/l

1.34

381

Macular hole, drug-induced

0.00

0.23

0.0

2.2

—

194.36

—

Malignant neoplasm of trachea

0.00

0.22

0.0

3.3

—

134.91

—

Malignant cancer of tonsil and base of tongue, including Hilmo

662

1.08

0.22

2.5

3.1

247.29

212.70

ng/l

0.25

613

Toxic effect of other inorganic substances

0.00

0.22

0.0

1.7

—

166.55

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.22

0.0

2.3

—

84.83

—

Spotted fever [tick-borne rickettsioses]

0.00

0.22

0.0

1.9

—

134.58

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.22

0.0

2.3

—

199.30

—

Unspecified maternal hypertension

107

1.22

0.22

2.6

2.5

42.31

74.99

ng/l

1.57

Microcephaly

0.00

0.22

0.0

4.4

—

283.17

—

Malignant neoplasm of oropharynx

450

1.10

0.21

2.7

3.1

218.17

209.18

ng/l

0.06

411

Trichomoniasis

173

1.17

0.21

4.1

3.1

334.65

161.59

ng/l

0.70

161

Eosinophilic cellulitis [Wells]

0.00

0.21

0.0

2.1

—

203.69

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

316

1.12

0.21

2.1

3.1

118.93

197.09

ng/l

1.49

290

Diseases of thymus

1.27

0.20

2.5

1.8

248.83

130.78

ng/l

—

Abnormal findings in cerebrospinal fluid

1.26

0.20

3.3

2.3

232.83

93.49

ng/l

—

Optic neuritis

742

1.07

0.20

2.3

3.0

162.48

146.64

ng/l

0.19

664

Benign neoplasm: Pancreas

808

0.94

0.20

2.8

3.0

195.13

209.36

ng/l

0.11

745

Seminoma of testis, including Hilmo

184

1.15

0.19

2.7

3.2

88.90

178.72

ng/l

1.50

164

Vitreous prolapse

1.16

0.19

2.0

3.0

505.67

192.02

ng/l

—

Disorder of carbohydrate metabolism, other/unspecified

1.16

0.19

2.3

3.0

52.50

100.99

ng/l

—

Brain glioblastoma and astrocytoma

395

1.09

0.19

2.0

3.3

53.97

186.31

ng/l

8.51

364

Other and unspecified cicatricial alopecia

1.25

0.19

1.7

2.6

95.29

82.40

ng/l

—

Other benign neoplasm of uterus: Cervix uteri

128

1.18

0.18

2.7

2.4

112.93

144.61

ng/l

0.31

115

Other or unspecified paralytic strabismus

132

0.83

0.18

3.2

2.7

282.82

172.85

ng/l

0.23

118

Carcinoma in situ of cervix uteri

149

1430

1.04

0.18

2.3

2.7

157.55

129.01

ng/l

0.43

131

1265

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

1.18

0.18

3.7

3.4

473.00

157.85

ng/l

—

Paralytic strabismus

226

2190

1.03

0.18

3.3

2.9

262.22

215.07

ng/l

0.54

205

1988

Endometriosis of rectovaginal septum and vagina

215

2082

1.03

0.17

3.0

2.8

132.15

195.46

ng/l

3.59

194

1901

Allergic contact dermatitis due to drugs in contact with skin

494

1.08

0.17

3.8

2.8

197.25

187.04

ng/l

0.08

451

Type 1 diabetes, strict definition, subgroup 1

925

0.95

0.17

2.4

3.0

189.34

91.21

ng/l

0.90

788

Other disorders of breast and lactation associated with childbirth

183

0.87

0.16

1.9

2.5

44.73

96.12

ng/l

1.99

155

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

535

1.07

0.16

3.3

127.50

256.84

ng/l

4.21

495

Endometroid carcinoma of ovary, including Hilmo

235

1.12

0.16

4.6

3.5

108.86

228.14

ng/l

1.39

215

Seminoma of testis

149

1.15

0.16

2.6

3.4

103.88

168.63

ng/l

0.76

132

Melanoma in situ

147

1418

1.04

0.16

2.4

3.0

203.22

222.54

ng/l

0.23

129

1306

Atopic dermatitis

1578

13063

0.99

0.16

2.4

2.7

163.19

154.12

ng/l

0.37

1398

11697

Malignant neoplasm of base of tongue

140

0.85

0.15

1.5

3.5

349.83

189.06

ng/l

0.29

127

Other inflammation of vagina/vulva

516

1.07

0.15

2.6

2.8

134.31

132.17

ng/l

0.01

465

Other noninflammatory disorders of vagina

204

1980

1.03

0.15

2.6

2.8

180.26

197.08

ng/l

0.21

184

1798

Placental disorders

1.14

0.15

1.6

2.5

19.89

109.69

ng/l

—

Ulcerative colitis (strict) with PSC

102

1.18

0.15

3.8

3.0

117.42

125.72

ng/l

0.06

Dementia due to Parkinson's disease

909

1.05

0.15

2.7

3.0

232.28

256.23

ng/l

0.20

836

Malignant neoplasm of oesophagus

819

0.95

0.15

2.4

3.2

200.92

248.55

ng/l

0.64

757

Infections specific to the perinatal period

150

0.86

0.15

7.8

5.8

125.85

176.99

ng/l

0.41

141

Malignant neoplasm of tonsil

401

1.08

0.15

2.7

3.1

237.16

209.49

ng/l

0.18

368

Benign neoplasm: Skin of ear and external auricular canal

125

1205

1.04

0.14

4.3

3.0

250.77

232.02

ng/l

0.18

115

1103

Optic atrophy

417

0.93

0.13

3.0

3.3

340.90

216.10

ng/l

0.45

379

Gender identity disorders

110

0.82

0.13

1.7

3.0

28.33

52.81

ng/l

—

Deep endometriosis

234

2285

1.03

0.13

2.8

2.9

124.96

169.77

ng/l

2.34

211

2064

Other and unspecified disease of Bartholin gland

692

0.95

0.12

3.0

146.77

185.70

ng/l

0.60

633

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1709

13635

0.99

0.12

2.7

166.49

169.64

ng/l

0.07

1553

12361

Rubella [German measles]

728

1.05

0.12

2.9

2.7

104.80

133.60

ng/l

0.51

641

Use of rasagiline

772

0.95

0.12

2.8

3.0

175.09

203.95

ng/l

0.37

711

Infections of breast associated with childbirth

434

1.06

0.12

2.6

104.05

88.84

ng/l

0.17

376

Maternal care for known or suspected abnormality of pelvic organs

390

2701

0.98

0.12

2.0

2.4

83.57

94.63

ng/l

0.32

334

2408

Spontaneous abortion

1137

7591

1.01

0.11

2.4

2.5

106.66

131.79

ng/l

2.30

1048

6867

Use of interferon beta-1a

308

1.07

0.11

2.1

2.6

78.85

88.28

ng/l

0.15

267

Malignant neoplasm of bronchus and lung

754

6189

1.01

0.11

2.9

3.2

214.37

259.31

ng/l

2.14

697

5684

Other obstructed labour

132

1357

0.97

0.10

2.3

2.7

138.07

108.73

ng/l

0.46

118

1228

Miliary tuberculosis

1.12

0.10

2.8

3.1

191.80

230.14

ng/l

—

Rapidly progressive nephritic syndrome

1.07

0.09

8.0

1.9

270.60

136.95

ng/l

—

Motorcycle rider injured in noncollision transport accidents

503

0.95

0.09

3.1

2.9

144.96

150.84

ng/l

0.07

442

All dysplastic lesions of the vagina

507

1.05

0.09

2.8

2.7

106.64

152.06

ng/l

1.43

467

Peroneal tendinitis

262

1.07

0.09

1.5

2.7

77.50

164.76

ng/l

2.23

239

Malignant neoplasm of ovary, including Hilmo

183

1868

0.98

0.09

2.6

2.9

121.60

175.72

ng/l

3.68

165

1701

Senile degeneration of the brain, not elsewhere classified

1.14

0.09

2.6

3.0

120.98

348.49

ng/l

2.63

Pneumonia due to Haemophilus influenzae

1.06

0.08

1.7

1.9

178.17

186.69

ng/l

—

Follicular adenocarcinoma of thyroid gland

146

1.10

0.08

2.4

3.5

284.21

272.50

ng/l

0.02

134

Benign neoplasm: Brain, unspecified

117

1.12

0.08

2.7

3.5

71.54

206.48

ng/l

2.75

105

Colour vision deficiencies

1.10

0.08

2.4

2.1

113.14

145.67

ng/l

—

Dislocation, sprain and strain of joints and ligaments of head

736

1.03

0.08

2.6

3.1

127.16

155.71

ng/l

0.50

657

Sequelae of inflammatory diseases of the central nervous system

1.05

0.08

3.7

1.8

465.71

118.09

ng/l

—

Other noninflammatory disorders of cervix uteri

142

1392

1.02

0.07

2.9

277.17

204.14

ng/l

0.85

126

1274

Use of riluzole

1.08

0.07

2.1

2.4

263.78

219.46

ng/l

—

Hydatidiform mole

204

0.93

0.07

1.8

2.4

53.84

129.27

ng/l

1.79

176

Malignant neoplasm of oesophagus, including Hilmo

117

1145

1.02

0.07

2.4

3.2

236.12

230.38

ng/l

0.05

105

1069

Pneumoconiosis due to other inorganic dusts

0.86

0.07

4.6

2.8

198.75

211.70

ng/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

482

1.04

0.07

2.6

3.4

194.36

284.06

ng/l

1.03

447

Malignant neoplasm of brain

842

0.97

0.07

1.8

3.1

83.51

211.31

ng/l

7.52

768

Supervision of high-risk pregnancy

306

1818

1.01

0.06

2.2

76.51

79.51

ng/l

0.09

270

1601

Peripheral retinal degeneration

801

0.97

0.06

2.6

3.0

130.96

200.82

ng/l

2.03

736

Acute appendicitis, with complications

610

6054

1.01

0.06

2.7

2.9

210.98

195.92

ng/l

0.15

544

5495

Malignant neoplasm of base of tongue, including Hilmo

213

0.93

0.06

1.8

3.4

264.45

202.18

ng/l

0.17

196

Nontoxic single thyroid nodule

190

1928

0.98

0.06

3.2

2.7

198.20

173.35

ng/l

0.37

172

1751

Premature separation of placenta [abruptio placentae]

296

1.05

0.06

2.1

2.8

68.97

101.91

ng/l

0.52

265

Optic atrophy

395

0.96

0.05

3.0

3.4

348.97

216.87

ng/l

0.46

357

Melanoma in situ of trunk

455

1.04

0.05

2.8

3.1

160.40

201.72

ng/l

0.50

413

Malignant neoplasm, without specification of site, including Hilmo

159

1612

0.98

0.05

2.8

3.2

263.26

267.70

ng/l

0.03

148

1479

Desensitization to allergens

707

0.98

0.05

2.7

2.8

98.62

96.57

ng/l

0.03

605

Dermatitis due to ingested food

408

1.03

0.05

4.9

5.8

113.50

175.55

ng/l

0.94

360

Melanoma in situ of other and unspecified parts of face

387

1.04

0.04

2.0

3.0

295.52

230.76

ng/l

0.25

354

Abrasion of teeth

1017

10132

1.00

0.04

2.5

2.7

124.21

167.12

ng/l

5.53

920

9187

Benign neoplasm of other and unspecified female genital organs

108

1064

1.02

0.04

2.8

2.9

275.27

181.08

ng/l

0.53

102

965

therapeutic use

895

1.02

0.04

3.5

2.8

257.07

199.76

ng/l

0.58

825

Other appendicitis

212

2100

1.01

0.04

2.4

2.8

191.21

178.53

ng/l

0.14

186

1901

Viral conjunctivitis

687

1.02

0.03

2.6

2.8

121.61

154.67

ng/l

0.40

610

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1004

0.99

0.03

2.9

2.7

130.81

128.55

ng/l

0.03

913

Pediculosis and phthiriasis

1.09

0.03

2.1

2.6

148.42

136.51

ng/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

581

0.98

0.03

4.3

3.2

378.47

247.82

ng/l

0.55

535

Benign neoplasm of brain and other parts of central nervous system

179

1777

1.01

0.02

2.9

133.39

194.30

ng/l

2.01

157

1613

Toxic effect of contact with venomous animals

949

1.01

0.02

2.9

190.54

182.43

ng/l

0.05

862

Malignant neoplasm of pancreas

240

2414

0.99

0.02

2.7

3.3

197.71

240.27

ng/l

1.01

221

2224

Adenocarcinoma and ductal carcinoma of pancreas

109

1101

0.99

0.02

2.5

3.2

232.24

237.77

ng/l

0.04

101

1020

Adenomyosis (Endometriosis of uterus)

384

3824

1.00

0.02

2.4

2.8

120.83

197.55

ng/l

8.94

341

3488

Dysplasia of cervi uteri

519

3769

1.00

0.02

2.4

2.6

145.78

162.02

ng/l

0.40

466

3403

Degeneration of the brain due to alcohol

621

1.02

0.02

4.0

2.9

184.74

225.19

ng/l

0.39

563

Maternal care for cervical incompetence

771

1.01

0.01

3.0

2.9

148.12

142.12

ng/l

0.08

705

Ulcerative ileocolitis

772

1.01

0.01

2.4

2.8

217.31

159.31

ng/l

0.36

688

Medical abortion

1950

10584

1.00

0.01

2.5

2.7

165.58

166.49

ng/l

0.03

1760

9631

Degeneration of nervous system due to alcohol

623

1.01

0.01

4.0

2.9

184.74

215.66

ng/l

0.28

563

Erosion and ectropion of cervix uteri

737

0.99

0.01

3.2

2.9

270.59

205.18

ng/l

0.61

673

Use of entacapone

226

0.97

0.00

2.4

3.1

115.71

231.97

ng/l

2.14

199

Eustachian salpingitis and obstruction

134

1334

1.00

0.00

2.4

2.7

156.45

132.32

ng/l

0.29

119

1159

Malignant neoplasm of breast, ER-negative, including Hilmo

716

6817

1.00

0.00

2.7

2.8

190.90

185.21

ng/l

0.13

654

6222

Malignant neoplasm of ovary

135

1349

1.00

0.00

2.7

3.0

122.76

176.37

ng/l

2.77

122

1228

190

1891

1.00

0.00

4.3

3.3

251.52

309.24

ng/l

0.97

177

1714

Frontotemporal dementia, wide, incl. Pick's disease

172

0.99

0.00

1.8

2.7

139.76

221.06

ng/l

0.79

153

Other disorders of choroid

387

1.01

0.00

3.3

3.1

206.85

219.05

ng/l

0.07

354

Malignant neoplasm of bladder

254

2539

1.00

0.00

2.9

3.4

258.50

290.55

ng/l

0.59

232

2349

Malignant cancer of tonsil and base of tongue

537

1.01

0.00

2.5

3.2

269.27

205.72

ng/l

0.40

496

Malignant neoplasm of uterus, part unspecified, including Hilmo

154

0.97

0.00

4.5

3.8

744.13

314.73

ng/l

0.91

141

Microscopic polyangiitis

154

0.97

0.00

4.1

3.3

561.73

185.65

ng/l

0.62

139

Frontotemporal dementia

141

0.99

0.00

1.6

2.8

139.57

229.23

ng/l

0.71

125

Use of levodopa decarbox-comt-inhibitor

106

1058

1.00

0.00

2.6

3.0

236.29

226.84

ng/l

0.08

974

Other sexually transmitted chlamydial diseases

108

1081

1.00

0.00

1.9

2.7

104.19

80.61

ng/l

0.39

895

Disorders of acoustic nerve

729

1.00

0.00

2.7

2.9

183.55

191.76

ng/l

0.05

664

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

137

1.02

0.00

1.6

3.3

143.14

168.90

ng/l

0.16

123

Haemophagocytic syndrome, infection-associated

0.00

0.0

1.6

—

85.00

—

Toxic liver disease with acute hepatitis, drug-induced

0.00

0.0

1.6

—

223.75

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

4.1

—

438.00

—

Toxic effect of metals

0.00

0.0

2.2

—

182.44

—

Drug-induced folate deficiency anaemia

0.00

0.0

3.0

—

205.60

—

Other transitory neonatal endocrine disorders

0.00

0.0

1.2

—

113.00

—

Intracranial laceration and haemorrhage due to birth injury

0.00

0.0

2.6

—

188.50

—

Taeniasis

0.00

0.0

2.0

—

360.00

—

Brain medulloblastoma, including Hilmo

0.00

0.0

7.8

—

86.50

—

Brain medulloblastoma

0.00

0.0

7.8

—

86.50

—

Retained (old) foreign body following penetrating wound of orbit

0.00

0.0

2.0

—

142.67

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

7.8

—

349.40

—

Fetal blood loss

0.00

-0.00

0.0

4.9

—

324.00

—

Mental and behavioural disorders due to hallucinogens

0.91

-0.00

3.0

2.2

38.60

134.51

ng/l

—

Unspecified visual impairment

0.00

-0.00

0.0

1.6

—

304.20

—

Other congenital malformations of female genitalia

0.98

-0.00

5.4

2.1

133.88

101.45

ng/l

—

Monkeypox

0.00

-0.00

0.0

2.5

—

318.50

—

Post-traumatic hydrocephalus, unspecified

0.84

-0.00

2.2

4.1

75.40

258.64

ng/l

—

Defects in glycoprotein degradation

0.00

-0.00

0.0

4.0

—

218.75

—

Pediculosis and phthiriasis

0.89

-0.00

1.6

3.2

173.44

157.32

ng/l

—

Hypervitaminosis D

0.00

-0.00

0.0

2.3

—

318.14

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.93

-0.00

2.0

2.1

452.44

124.84

ng/l

—

Chondrosarcoma

0.88

-0.00

1.6

4.1

433.29

205.74

ng/l

—

Protrusioacetabuli

0.00

-0.00

0.0

1.6

—

62.80

—

Use of dimethyl fumarate

1.01

-0.00

1.6

2.3

89.15

62.63

ng/l

—

Malignant neoplasm of placenta

0.00

-0.00

0.0

1.7

—

82.00

—

Motorcycle rider injured in other and unspecified transport accidents

101

1010

1.00

-0.00

3.0

2.9

185.85

146.42

ng/l

0.36

881

Hereditary factor XI deficiency

0.00

-0.00

0.0

2.4

—

31.80

—

Psoriatic arthropathies, strict definition

0.00

-0.00

0.0

2.0

—

45.20

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

2.4

—

81.00

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

2.2

—

130.60

—

Diastrofic dysplasy

0.00

-0.00

0.0

1.4

—

35.57

—

Osteochondrosis of ankle, juvenile

0.84

-0.00

2.6

2.7

86.40

103.35

ng/l

—

Other early complications of trauma

0.00

-0.00

0.0

2.9

—

71.14

—

Exposure to ignition of highly flammable material

0.92

-0.00

3.7

2.3

84.71

147.32

ng/l

—

Dietary selenium deficiency

0.00

-0.00

0.0

1.8

—

266.80

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Natriuretic peptide B [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS